Psychological interventions for post-traumatic stress disorder (PTSD) in people with severe mental illness by Sin, Jacqueline et al.
Psychological interventions for post­
traumatic stress disorder (PTSD) in 
people with severe mental illness 
Article 
Accepted Version 
Sin, J., Spain, D., Furuta, M., Murrells, T. and Norman, I. 
(2017) Psychological interventions for post­traumatic stress 
disorder (PTSD) in people with severe mental illness. 
Cochrane Database of Systematic Reviews, 2017 (1). 
CD011464. ISSN 1465­1858 doi: 
https://doi.org/10.1002/14651858.CD011464.pub2 Available at 
http://centaur.reading.ac.uk/70086/ 
It is advisable to refer to the publisher’s version if you intend to cite from the 
work. 
Published version at: http://dx.doi.org/10.1002/14651858.CD011464.pub2 
To link to this article DOI: http://dx.doi.org/10.1002/14651858.CD011464.pub2 
Publisher: Wiley 
All outputs in CentAUR are protected by Intellectual Property Rights law, 
including copyright law. Copyright and IPR is retained by the creators or other 
copyright holders. Terms and conditions for use of this material are defined in 
the End User Agreement . 
www.reading.ac.uk/centaur 
CentAUR 
Central Archive at the University of Reading 
Reading’s research outputs online
Cochrane Database of Systematic Reviews
Psychological interventions for post-traumatic stress disorder
(PTSD) in people with severe mental illness (Review)
Sin J, Spain D, Furuta M, Murrells T, Norman I
Sin J, Spain D, Furuta M, Murrells T, Norman I.
Psychological interventions for post-traumatic stress disorder (PTSD) in people with severe mental illness.
Cochrane Database of Systematic Reviews 2017, Issue 1. Art. No.: CD011464.
DOI: 10.1002/14651858.CD011464.pub2.
www.cochranelibrary.com
Psychological interventions for post-traumatic stress disorder (PTSD) in peoplewith severe mental illness (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Fo
r P
re
vie
w 
On
ly
T A B L E O F C O N T E N T S
1HEADER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
1ABSTRACT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2PLAIN LANGUAGE SUMMARY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
4SUMMARY OF FINDINGS FOR THE MAIN COMPARISON . . . . . . . . . . . . . . . . . . .
7BACKGROUND . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
9OBJECTIVES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
9METHODS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
16RESULTS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Figure 1. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 17
Figure 2. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 22
Figure 3. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 23
28ADDITIONAL SUMMARY OF FINDINGS . . . . . . . . . . . . . . . . . . . . . . . . . .
35DISCUSSION . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
38AUTHORS’ CONCLUSIONS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
39ACKNOWLEDGEMENTS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
39REFERENCES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
44CHARACTERISTICS OF STUDIES . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
55DATA AND ANALYSES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Analysis 1.1. Comparison 1 TF-CBT versus WAITING LIST/TAU, Outcome 1 PTSD symptom severity: 1. Clinician-
rated severity - average endpoint CAPS total score (high = poor). . . . . . . . . . . . . . . . . 61
Analysis 1.2. Comparison 1 TF-CBT versus WAITING LIST/TAU, Outcome 2 PTSD symptom severity: 1a. Clinician-
rated severity - average endpoint CAPS total score (high = poor) - skewed data. . . . . . . . . . . . 62
Analysis 1.3. Comparison 1 TF-CBT versus WAITING LIST/TAU, Outcome 3 PTSD symptom severity: 2. Self-reported
trauma-related cognition - average endpoint PTCI total score (high = poor). . . . . . . . . . . . . 63
Analysis 1.4. Comparison 1 TF-CBT versus WAITING LIST/TAU, Outcome 4 PTSD symptom severity: 3. Self-reported
frequency of PTSD symptoms - average endpoint PSS-SR total score (high = poor) - skewed data. . . . . . 64
Analysis 1.5. Comparison 1 TF-CBT versus WAITING LIST/TAU, Outcome 5 PTSD symptom severity: 4. Remission
from PTSD: Symptoms below diagnostic threshold - CAPS total score < 40. . . . . . . . . . . . . 65
Analysis 1.6. Comparison 1 TF-CBT versus WAITING LIST/TAU, Outcome 6 PTSD symptom severity: 5. Recovery
from PTSD: Asymptomatic or few symptoms - CAPS total score < 20. . . . . . . . . . . . . . . 66
Analysis 1.7. Comparison 1 TF-CBT versus WAITING LIST/TAU, Outcome 7 Quality of life: 1. General quality of life -
average endpoint QLS total score (high = good). . . . . . . . . . . . . . . . . . . . . . . 67
Analysis 1.8. Comparison 1 TF-CBT versus WAITING LIST/TAU, Outcome 8 Quality of life: 2. Overall functioning -
average endpoint GAF total score (high = good). . . . . . . . . . . . . . . . . . . . . . . 68
Analysis 1.9. Comparison 1 TF-CBT versus WAITING LIST/TAU, Outcome 9 Quality of life: 3. Mental health
functioning - average endpoint SF-12 mental component total score (high = good). . . . . . . . . . . 69
Analysis 1.10. Comparison 1 TF-CBT versus WAITING LIST/TAU, Outcome 10 Quality of life: 4. Physical functioning
- average endpoint SF-12 physical component total score (high = good). . . . . . . . . . . . . . . 70
Analysis 1.11. Comparison 1 TF-CBT versus WAITING LIST/TAU, Outcome 11 Symptoms of co-morbid psychosis: 1.
Overall mental state - average endpoint BPRS total score (high = poor). . . . . . . . . . . . . . . 71
Analysis 1.12. Comparison 1 TF-CBT versus WAITING LIST/TAU, Outcome 12 Symptoms of co-morbid psychosis: 2.
Positive symptoms - average endpoint PANSS positive subscale total score (high = poor). . . . . . . . . 72
Analysis 1.13. Comparison 1 TF-CBT versus WAITING LIST/TAU, Outcome 13 Symptoms of co-morbid psychosis: 4.
Negative symptoms - average endpoint PANSS negative subscale total score (high = poor). . . . . . . . 73
Analysis 1.14. Comparison 1 TF-CBT versus WAITING LIST/TAU, Outcome 14 Symptoms of co-morbid psychosis: 3.
Hallucinations - average endpoint PSYRATS-hallucinations subscale total score (high = poor) - skewed data. . 74
Analysis 1.15. Comparison 1 TF-CBT versus WAITING LIST/TAU, Outcome 15 Symptoms of co-morbid psychosis: 5.
Delusions - average endpoint PSYRATS-delusions subscale total score (high = poor) - skewed data. . . . . 75
Analysis 1.16. Comparison 1 TF-CBT versus WAITING LIST/TAU, Outcome 16 Anxiety symptoms: 1a. average
endpoint BAI total score (high = poor). . . . . . . . . . . . . . . . . . . . . . . . . . 76
iPsychological interventions for post-traumatic stress disorder (PTSD) in people with severe mental illness (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Fo
r P
re
vie
w 
On
ly
Analysis 1.17. Comparison 1 TF-CBT versus WAITING LIST/TAU, Outcome 17 Anxiety symptoms: 1b. average
endpoint BAI total score (high = poor) - skewed data. . . . . . . . . . . . . . . . . . . . . 77
Analysis 1.18. Comparison 1 TF-CBT versus WAITING LIST/TAU, Outcome 18 Depressive symptoms: 1. average
endpoint BDI-II total (high = poor) - skewed data. . . . . . . . . . . . . . . . . . . . . . 78
Analysis 1.19. Comparison 1 TF-CBT versus WAITING LIST/TAU, Outcome 19 Adverse events - incidents of unspecified
severe adverse events. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 79
Analysis 1.20. Comparison 1 TF-CBT versus WAITING LIST/TAU, Outcome 20 Leaving the study early. . . . 80
Analysis 2.1. Comparison 2 EMDR versus WAITING LIST, Outcome 1 PTSD symptom severity: 1. Clinician-rated
severity - average endpoint CAPS total score (high = poor) - skewed data. . . . . . . . . . . . . . 81
Analysis 2.2. Comparison 2 EMDR versus WAITING LIST, Outcome 2 PTSD symptom severity: 2. Self-reported trauma-
related cognition - average endpoint PTCI total score (high = poor). . . . . . . . . . . . . . . . 82
Analysis 2.3. Comparison 2 EMDR versus WAITING LIST, Outcome 3 PTSD symptom severity: 3. Self-reported
frequency of PTSD symptoms - average endpoint PSS-SR total score (high = poor) - skewed data. . . . . . 83
Analysis 2.4. Comparison 2 EMDR versus WAITING LIST, Outcome 4 PTSD symptom severity: 4. Remission from
PTSD: Symptoms below diagnostic threshold - CAPS total score < 40. . . . . . . . . . . . . . . 84
Analysis 2.5. Comparison 2 EMDR versus WAITING LIST, Outcome 5 PTSD symptom severity: 5. Recovery from
PTSD: Asymptomatic or few symptoms - CAPS total score < 20. . . . . . . . . . . . . . . . . 85
Analysis 2.6. Comparison 2 EMDR versus WAITING LIST, Outcome 6 Adverse events - incidents of unspecified severe
adverse events. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 86
Analysis 2.7. Comparison 2 EMDR versus WAITING LIST, Outcome 7 Leaving the study early. . . . . . . . 87
Analysis 3.1. Comparison 3 TF-CBT versus EMDR, Outcome 1 PTSD symptom severity: 1. Clinician-rated severity -
average endpoint CAPS total score (high = poor) - skewed data. . . . . . . . . . . . . . . . . 88
Analysis 3.2. Comparison 3 TF-CBT versus EMDR, Outcome 2 PTSD symptom severity: 2. Self-reported trauma-related
cognition - average endpoint PTCI total score (high = poor). . . . . . . . . . . . . . . . . . 89
Analysis 3.3. Comparison 3 TF-CBT versus EMDR, Outcome 3 PTSD symptom severity: 3. Self-reported frequency of
PTSD symptoms - average endpoint PSS-SR total score (high = poor) - skewed data. . . . . . . . . . 90
Analysis 3.4. Comparison 3 TF-CBT versus EMDR, Outcome 4 PTSD symptom severity: 4. Remission from PTSD:
Symptoms below diagnostic threshold - CAPS total score < 40. . . . . . . . . . . . . . . . . . 91
Analysis 3.5. Comparison 3 TF-CBT versus EMDR, Outcome 5 PTSD symptom severity: 5. Recovery from PTSD:
Asymptomatic or few symptoms - CAPS total score < 20. . . . . . . . . . . . . . . . . . . . 92
Analysis 4.1. Comparison 4 Individual TF-CBT versus brief PTSD psychoeducation, Outcome 1 PTSD symptom severity:
1a. Clinician-rated severity - average endpoint CAPS total score (high = poor). . . . . . . . . . . . 93
Analysis 4.2. Comparison 4 Individual TF-CBT versus brief PTSD psychoeducation, Outcome 2 PTSD symptom severity:
1b. Clinician-rated severity - average endpoint CAPS total score (high = poor) - skewed data. . . . . . . 94
Analysis 4.3. Comparison 4 Individual TF-CBT versus brief PTSD psychoeducation, Outcome 3 PTSD symptom severity:
2. Self-reported trauma-related cognition - average endpoint PTCI total score (high = poor). . . . . . . . 95
Analysis 4.4. Comparison 4 Individual TF-CBT versus brief PTSD psychoeducation, Outcome 4 PTSD symptom severity:
4. Remission from PTSD: Symptoms below diagnostic threshold - CAPS total score < 40. . . . . . . . 96
Analysis 4.5. Comparison 4 Individual TF-CBT versus brief PTSD psychoeducation, Outcome 5 PTSD symptom severity:
5. Remission from severe PTSD: Loss of severe PTSD diagnosis - CAPS total score < 65. . . . . . . . . 97
Analysis 4.6. Comparison 4 Individual TF-CBT versus brief PTSD psychoeducation, Outcome 6 Quality of life: 1. General
quality of life - average endpoint QoLI total score (high = good). . . . . . . . . . . . . . . . . 98
Analysis 4.7. Comparison 4 Individual TF-CBT versus brief PTSD psychoeducation, Outcome 7 Quality of life: 2. Overall
functioning - average endpoint GAF total score (high = good). . . . . . . . . . . . . . . . . . 99
Analysis 4.8. Comparison 4 Individual TF-CBT versus brief PTSD psychoeducation, Outcome 8 Quality of life: 3. Social
functioning - average endpoint CAPS social functioning subscale total score (high = poor) - skewed data. . . 100
100ADDITIONAL TABLES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
101CONTRIBUTIONS OF AUTHORS . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
102DECLARATIONS OF INTEREST . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
102SOURCES OF SUPPORT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
103DIFFERENCES BETWEEN PROTOCOL AND REVIEW . . . . . . . . . . . . . . . . . . . . .
iiPsychological interventions for post-traumatic stress disorder (PTSD) in people with severe mental illness (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Fo
r P
re
vi
w 
On
ly
[Intervention Review]
Psychological interventions for post-traumatic stress disorder
(PTSD) in people with severe mental illness
Jacqueline Sin1, Debbie Spain2, Marie Furuta3, Trevor Murrells4, Ian Norman4
1Health Service & Population Research Department, Institute of Psychiatry, Psychology & Neuroscience, King’s College London,
London, UK. 2MRC Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology &Neuroscience, King’s
College London, London, UK. 3Department of Human Health Sciences, Graduate School of Medicine, Kyoto University, Kyoto,
Japan. 4Florence Nightingale Faculty of Nursing and Midwifery, King’s College London, London, UK
Contact address: Jacqueline Sin, Health Service & Population Research Department, Institute of Psychiatry, Psychology & Neu-
roscience, King’s College London, David Goldberg Centre, 16 de Crespigny Park, Denmark Hill, London, SW5 8AF, UK.
Jacqueline.sin@kcl.ac.uk, jacqueline@urbanfuture.org.
Editorial group: Cochrane Schizophrenia Group.
Publication status and date: New, published in Issue 1, 2017.
Review content assessed as up-to-date: 10 March 2016.
Citation: Sin J, Spain D, Furuta M, Murrells T, Norman I. Psychological interventions for post-traumatic stress disorder
(PTSD) in people with severe mental illness. Cochrane Database of Systematic Reviews 2017, Issue 1. Art. No.: CD011464. DOI:
10.1002/14651858.CD011464.pub2.
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
A B S T R A C T
Background
Increasing evidence indicates that individuals who develop severe mental illness (SMI) are also vulnerable to developing post-traumatic
stress disorder (PTSD), due to increased risk of exposure to traumatic events and social adversity. The effectiveness of trauma-focused
psychological interventions (TFPIs) for PTSD in the general population is well-established. TFPIs involve identifying and changing
unhelpful beliefs about traumatic experiences, processing of traumatic memories, and developing new ways of responding to cues
associated with trauma. Little is known about the potential feasibility, acceptability and effectiveness of TFPIs for individuals who have
a SMI and PTSD.
Objectives
To evaluate the effectiveness of psychological interventions for PTSD symptoms or other symptoms of psychological distress arising
from trauma in people with SMI.
Search methods
We searched the Cochrane Schizophrenia Group’s Trials Study-Based Register (up until March 10, 2016), screened reference lists of
relevant reports and reviews, and contacted trial authors for unpublished and/or specific outcome data.
Selection criteria
We included all relevant randomised controlled trials (RCTs) which investigated TFPIs for people with SMI and PTSD, and reported
useable data.
Data collection and analysis
Three review authors (DS, MF, IN) independently screened the titles and abstracts of all references identified, and read short-listed full
text papers.We assessed risk of bias in each case.We calculated the risk ratio (RR) and 95% confidence interval (CI) for binary outcomes,
and the mean difference (MD) and 95% CI for continuous data, on an intention-to-treat basis. We assessed quality of evidence using
the Grading of Recommendations Assessment, Development and Evaluation (GRADE) and created ’Summary of findings’ tables.
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Main results
Four trials involving a total of 300 adults with SMI and PTSD are included. These trials evaluated three active intervention therapies:
trauma-focused cognitive behavioural therapy (TF-CBT), eyemovement desensitisation and reprocessing (EMDR), and brief psychoe-
ducation for PTSD, all delivered via individual sessions. Our main outcomes of interest were PTSD symptoms, quality of life/well-
being, symptoms of co-morbid psychosis, anxiety symptoms, depressive symptoms, adverse events and health economic outcomes.
1. TF-CBT versus usual care/waiting list
Three trials provided data for this comparison, however, continuous outcome data available were more often found to be skewed
than unskewed, leading to the necessity of conducting analyses separately for the two types of continuous data. Using the unskewed
data only, results showed no significant differences between TF-CBT and usual care in reducing clinician-rated PTSD symptoms at
short term (1 RCT, n =13, MD 13.15, 95% CI -4.09 to 30.39,low-quality evidence). Limited unskewed data showed equivocal results
between groups in terms of general quality of life (1 RCT, n = 39, MD -0.60, 95% CI -4.47 to 3.27, low-quality evidence), symptoms
of psychosis (1 RCT, n = 9, MD -6.93, 95% CI -34.17 to 20.31, low-quality evidence), and anxiety (1 RCT, n = 9, MD 12.57, 95%
CI -5.54 to 30.68, very low-quality evidence), at medium term. The only available data on depression symptoms were skewed and were
equivocal across groups at medium term (2 RCTs, n = 48, MD 3.26, 95% CI -3.66 to 10.18, very low-quality evidence). TF-CBT was
not associated with more adverse events (1 RCT, n = 100, RR 0.44, 95% CI 0.09 to 2.31, low-quality evidence) at medium term. No
data were available for health economic outcomes. Very limited data for PTSD and other symptoms were available over the long term.
2. EMDR versus waiting list
One trial provided data for this comparison. Favourable effects were found for EMDR in terms of PTSD symptom severity at medium
term but data were skewed (1 RCT, n = 83, MD -12.31, 95% CI -22.72 to -1.90, very low-quality evidence). EMDR was not associated
with more adverse events (1 RCT, n = 102, RR 0.21, 95% CI 0.02 to 1.85, low-quality evidence). No data were available for quality of
life, symptoms of co-morbid psychosis, depression, anxiety and health economics.
3. TF-CBT versus EMDR
One trial compared TF-CBT with EMDR. PTSD symptom severity, based on skewed data (1 RCT, n = 88, MD -1.69, 95% CI -
12.63 to 9.23, very low-quality evidence) was similar between treatment groups. No data were available for the other main outcomes.
4. TF-CBT versus psychoeducation
One trial compared TF-CBT with psychoeducation. Results were equivocal for PTSD symptom severity (1 RCT, n = 52, MD 0.23,
95% CI -14.66 to 15.12, low-quality evidence) and general quality of life (1 RCT, n = 49, MD 0.11, 95% CI -0.74 to 0.95, low-quality
evidence) by medium term. No data were available for the other outcomes of interest.
Authors’ conclusions
Very few trials have investigated TFPIs for individuals with SMI and PTSD. Results from trials of TF-CBT are limited and inconclusive
regarding its effectiveness on PTSD, or on psychotic symptoms or other symptoms of psychological distress. Only one trial evaluated
EMDR and provided limited preliminary evidence favouring EMDR compared to waiting list. Comparing TF-CBT head-to-head with
EMDR and brief psychoeducation respectively, showed no clear effect for either therapy. Both TF-CBT and EMDR do not appear
to cause more (or less) adverse effects, compared to waiting list or usual care; these findings however, are mostly based on low to very
low-quality evidence. Further larger scale trials are now needed to provide high-quality evidence to confirm or refute these preliminary
findings, and to establish which intervention modalities and techniques are associated with improved outcomes, especially in the long
term.
P L A I N L A N G U A G E S U M M A R Y
Psychological interventions for post-traumatic stress disorder (PTSD) in people with severe mental illness
Background
Post-traumatic stress disorder (PTSD) typically develops after a traumatic event is experienced or witnessed by an individual, or may
develop when trauma is experienced by someone close to them. There is growing evidence that people with a severe mental illness (SMI)
are vulnerable to developing PTSD due to increased risk of childhood and adulthood trauma. It is estimated that around a third of
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individuals with SMI also suffer from PTSD. A number of psychological interventions are available for the treatment of PTSD which
are collectively known as ’trauma-focused psychological interventions’ (TFPIs).
Searching for evidence
We searched the Cochrane Schizophrenia Group Trial’s Register in January 2015 and March 2016 and found four relevant studies
involving 300 adults diagnosed with both SMI and PTSD. The participants received treatments that included trauma-focused cognitive
behavioural therapy (TF-CBT), eye movement desensitisation and reprocessing (EMDR), and brief psychoeducation. All of these
therapies support individuals to work through and process the memories, emotions and behaviours associated with trauma.
Key results
When TF-CBT was compared to the care usually received, no effect for reducing PTSD, psychotic, depressive or anxiety symptoms or
improving quality of life, was noted. There was some low-quality evidence from two studies that people with SMI and PTSD receiving
TF-CBT were more likely to recover from PTSD, that is, having PTSD symptoms which are below diagnostic threshold. TF-CBT was
not linked to an increase in side effects.
A comparison of people receiving EMDR against those awaiting treatment showed a favourable effect for reducing the symptoms of
PTSD (very low-quality evidence). Again, there was no difference in side effects. No data were available for the effect of EMDR on
quality of life, psychosis, depression or anxiety.
A comparison of TF-CBT with EMDR indicated no difference in reduction of PTSD symptom severity (very low-quality evidence).
Finally, when TF-CBT was compared with brief psychoeducation there was no evidence that either therapy was superior in treating a
range of PTSD symptoms.
Quality of the evidence
The review identifies limited, low-quality evidence on TF-CBTand EMDR. The effects of these treatments in reducing the symptoms of
PTSD remain unclear although they do not appear to cause any more side effects than waiting for treatment. However, many important
outcomes of interest have not been reported on and more research into the benefits of trauma-focused psychological interventions for
individuals with SMI and PTSD is required.
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S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
Individual TF-CBT compared to wait ing list / usual care for PTSD and severe mental illness
Patient or population: Adults with co-morbid PTSD and SMI
Settings: Community
Intervention: Individual TF-CBT
Comparison: Wait ing list / usual care
Outcomes Illustrative comparative risks* (95% CI) No of Participants
(studies)
Quality of the evidence
(GRADE)
Comments
Assumed risk Corresponding risk
Waiting list/ usual care Individual TF-CBT
PTSD symptoms: Clini-
cian- rated PTSD symptom
severity - average endpoint
CAPS total score (high
= poor) - short term (6
months)
The mean clinician-rated
PTSD symptom severity -
average endpoint caps total
score (high = poor) - short
term - unskewed data in the
intervent ion groups was
13.15 higher
(4.09 lower to 30.39 higher)
13
(1 study)
⊕⊕©©
low1,2
Other data available for this
outcome were skewed.
Quality of life: 1. General
quality of life - average
endpoint QLS total score
(high = good) - medium
term
The average endpoint QLS
total score - medium term
(10-12 months) in the in-
tervent ion groups was 0.60
lower
(4.47 lower to 3.27 higher)
39
(1 study)
⊕⊕©©
low1,2
Symptoms of co-morbid
psychosis: 1. Overall men-
tal state - average endpoint
BPRS total score (high =
poor) - medium term
The mean overall mental
state - average endpoint
BPRS total score (high =
poor) - medium term, in the
intervent ion groups was
6.93 lower
9
(1 study)
⊕⊕©©
low1,2
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(34.17 lower to 20.31
higher)
Anxiety symptoms - av-
erage endpoint BAI to-
tal score (high = poor) -
medium term (12 months)
The mean anxiety symp-
toms in the intervent ion
groups was
12.57 higher
(5.54 lower to 30.68 higher)
9
(1 study)
⊕©©©
very low1,2
Depressive symptoms - av-
erage endpoint BDI- II total
(high = poor) - medium term
(12 months) - skewed data
The mean depressive symp-
toms - average endpoint
BDI-II total (high = poor) in
the intervent ion groups was
3.26 higher
(3.66 lower to 10.18 higher)
48
(2 studies)
⊕©©©
very low1,3
No unskewed data avail-
able.
Adverse events - incidents
of unspecified severe ad-
verse events - medium term
Study population 100
(1 study)
RR (0.44) CI 0.09 to 2.31
⊕⊕©©
low2
85 per 1000 37 per 1000
(8 to 197)
M oderate
85 per 1000 37 per 1000
(8 to 196)
Health economics - - - - No data available.
* The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% conf idence interval) is
based on the assumed risk in the comparison group and the relative effect of the intervent ion (and its 95% CI).
CI: Conf idence interval; RR: risk rat io.
GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our conf idence in the est imate of ef fect.
M oderate quality: Further research is likely to have an important impact on our conf idence in the est imate of ef fect and may change the est imate.
Low quality: Further research is very likely to have an important impact on our conf idence in the est imate of ef fect and is likely to change the est imate.
Very low quality: We are very uncertain about the est imate.
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1 Indirectness: downgraded by one level to ’serious’ - cont inuous measure with a wide score range used which may not ref lect
clinical signif icant change accurately.
2 Imprecision: downgraded by one level to ’serious’ - only one study with a small sample size (or subgroup sample size)
provides data for this outcome.
3 Imprecision: downgraded by one level to ’serious’ - all available data f rom 2 studies were skewed.
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
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B A C K G R O U N D
Description of the condition
Severe mental illness (SMI) is defined according to three dimen-
sions: 1) a non-organic psychotic disorder; 2) treatment duration
lasting for two years or more; and 3) disability resulting in im-
pairments in social and occupational functioning (Ruggeri 2000).
Psychosis is manifested by delusions or hallucinations into which
an individual has limited insight (APA 2013), and which subse-
quently causes disturbances in functioning and relationships, de-
spite ongoing treatment and care. Psychosis is characterised by pos-
itive and negative symptoms, for example: delusions, hallucina-
tions, thought disorder, perceptual disturbances, and blunting or
incongruity of emotional responses. The cluster of schizophrenia
and related disorders (e.g. schizoaffective disorder, schizophreni-
form disorder and delusional disorder) are considered to be the
most common psychotic disorders (WHO 1992). Individuals liv-
ing with ’early onset psychosis’ or ’first episode psychosis’ and
those who are receiving treatment and support from early inter-
vention services are also considered to meet criteria for SMI due
to the similarities in their clinical presentation and the resultant
impairment and disability (NICE 2014). Bipolar disorder (Type
1) diagnoses also fall within the remit of SMI. Bipolar disorder is
primarily characterised by episodes of fluctuating mood: alternat-
ing between elevated mood and increased activity - that is often
accompanied by psychotic symptoms, and decreased energy and
activity (WHO 1992).
The onset of SMI tends to occur around late adolescence and early
adulthood (NICE 2014). The prevalence of schizophrenia - based
on a 2005 review of surveys undertaken in 46 countries - has been
reported to be 0.4% for lifetime prevalence up to the point of
assessment, and 0.3% in the 12-month period prior to assessment
(Saha 2005). The 12-month prevalence rate of Type 1 bipolar
disorder is estimated to be 0.72% and the lifetime prevalence rate
is reported to be 0.8%, according to a 2004 review of previous
surveys (Waraich 2004). It is well-established that people living
with SMI often have co-morbid mental health problems, most
commonly depression, anxiety disorders, and post-traumatic stress
disorder (PTSD; NICE 2014; Read 2008).
The relationship between SMI and co-morbid PTSD is complex
and poorly understood, but there is increasing evidence to suggest
that the much higher prevalence of childhood sexual and physical
abuse, and social adversity continuing into adulthood amongst
people affected by SMI are likely to be risk mechanisms for PTSD
(Bebbington 2011; Read 2008). It is estimated that around a third
of individuals with SMI also suffer from PTSD (Brunet 2012;
Kilcommons 2005; NICE 2014).
Post-traumatic stress disorder is a trauma and stress-related dis-
order. An individual may develop PTSD in response to directly
experiencing or witnessing a traumatic event in person or vi-
cariously, for example to a family member or close friend (APA
2013). The Diagnostic and Statistical Manual of Mental Disor-
ders (DSM) criteria highlights that a traumatic stressor usually
involves a perceived threat to life (either one’s own life or that
of another person), or physical integrity (A1 - stressor criteria),
and intense fear, helplessness or horror (A2 - specific subjective
emotional reaction criteria; APA 2013; APA, 2000). DSM diag-
nostic criteria are considered to be more strict than the Interna-
tional Classification of Diseases-10 (ICD-10) diagnostic criteria;
hence most randomised controlled trials (RCTs) of PTSD use
DSM criteria (NICE 2005). DSM-5 outlines four distinct diag-
nostic clusters of PTSD symptoms (APA 2013), instead of the
three clusters described in the previous version (APA, 2000), as
follows: re-experiencing (e.g. intrusive thoughts/images related to
the trauma), avoidance (e.g. sites or cues related to the trauma),
arousal (e.g. ’fight or flight’ reactions, or panic), and negative cog-
nitions and low mood. PTSD is relatively common, with preva-
lence rates estimated as 0.4% and 3.5% in the general adult pop-
ulation (Bisson 2013; Darves-Bornoz 2008; Kessler 1995; NICE
2005). The symptoms of PTSD often cause intense distress, phys-
iological reactions, and can significantly impair individuals’ qual-
ity of life and functioning in multiple domains including interper-
sonal relationships (e.g. difficulties with trusting others, avoidance
of intimacy; APA 2013; NICE 2005). PTSD is also commonly
associated with other co-morbid conditions, such as substance use,
depression, and/or ongoing physical health concerns such as pain
and disability resulting from the traumatic event (NICE 2005;
NICE 2013).
While the concept of PTSD has been conventionally applied to
survivors of combat, accidents and disasters, and victims of violent
crimes such as physical and sexual assaults, it has recently been
suggested that the illness experience of SMI itself, for example,
experiencing threatening or persecutory psychotic symptoms, can
be traumatic (Jackson 2009; Kilcommons 2005). In about one-
third of people with SMI, the experience of a recent onset of
psychosis is an event of such severity that it can lead to PTSD or at
least to PTSD symptoms (Brunet 2012; Morrison 2003; Mueser
2010), with the traumagenic elements of the psychotic experiences
meeting the criteria for a traumatic event according to the DSM-
IV-tr A1 and A2 criteria (APA, 2000).
Description of the intervention
Several psychological therapies have been found to be effective
treatments for PTSD in the general population. These include
several modes of exposure therapy, trauma-focused cognitive be-
havioural therapy (TF-CBT) and eye movement desensitisation
and reprocessing (EMDR) (Bisson 2013; Bradley 2005; NICE
2005). All these therapies share some core elements that support
individuals to work through and process their trauma memories,
cognitions and attributions of traumatic events, and hence they
are collectively known as ’trauma-focused psychological therapies’
(Bisson 2013; Ehlers 2010; NICE 2005; NICE 2013; Schnyder
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2015). Both TF-CBT and EMDR are recommended by the UK
National Institute for Health and Care Excellence (NICE) guide-
line about the treatment of PTSD in child and adult populations;
with a course of eight to 12 individual outpatient sessions of TF-
CBTorEMDRbeing themost common formof treatment (NICE
2005; NICE 2013). Exposure therapy typically involves asking
the person to relive the trauma, either in their imagination or by
writing or audio-recording a trauma narrative to create a detailed
account of the event. The individual is then asked repeatedly to
listen to or read the narrative in order to become habituated to the
anxiety symptoms that are generated. An alternative form of expo-
sure therapy involves graded re-exposure to cues associated with
the traumatic event, for example, using a hierarchy of cues (which
are related to the trauma) (Creamer 2004; Schnyder 2015). Pro-
longed exposure (PE) therapy stipulates two such principal com-
ponents: imaginal exposure (i.e. repeated revisiting and recount-
ing of distressing trauma memories) followed by 15-20 minutes of
processing in which the imaginal exposure experience and other
related emotions and perceptions are discussed, and, in vivo ex-
posure (i.e. gradual approaching of avoided, safe trauma-related
situations) (Foa 2007). TF-CBT primarily involves supporting
individuals to identify, examine and change unhelpful thoughts
about others (e.g. people are not trustworthy), themselves (e.g.
it is my fault this happened, I am a failure), the world (e.g. the
world is dangerous); or unhelpful behavioural responses that may
perpetuate trauma symptoms or hamper functioning (e.g. avoid-
ing using public transport in London following the 7 July 2005
(7/7) bombing; or drinking to excess in an attempt to promote
sleep), or both (Ehlers 2005; Resick 2003). EMDR was discov-
ered accidentally by Shapiro through her personal experience of
rapid eye movements easing distress (Shapiro 1989). Shapiro fur-
ther developed EMDR into a structured protocol-driven trauma-
focused therapy to alleviate the distress associated with traumatic
memories, based upon the adaptive information process model of
PTSD (Shapiro 2001). EMDR therapy consists of eight phases
that includes the individual recalling an image, thought, emotion
and a bodily sensation associated with the traumatic event, whilst
receiving bilateral stimulation, most commonly in the form of eye
movements (Shapiro 2001).
How the intervention might work
Exposure therapy and exposure-based TF-CBT are thought to
work by promoting emotional habituation by repeated exposure
to the traumatic events or cues associated with the events (Bryant
2003; Ehlers 2005; Marks 1998). Psychoeducation about com-
mon reactions to trauma is a key feature of all TF-CBT thera-
pies, which aim to normalise the individual’s symptoms and give
a rationale for the interventions that follow (Ehlers 2010; NICE
2005). TF-CBT, whilst relying on repeated exposure to the trauma
memory and in vivo exposure to situations avoided since the event,
also actively incorporates cognitive restructuring to modify the
excessively negative appraisals of the trauma or its sequelae, or
both (Ehlers 2005; Ehlers 2010). Cognitive therapy for PTSD
focuses on identifying and modifying the idiosyncratic meanings
of the trauma and problematic appraisal of trauma sequelae (e.g.
initial PTSD symptoms, other peoples’ responses after the event)
and a wide range of behavioural and cognitive maintaining strate-
gies (e.g. rumination, overt and covert safety behaviours that of-
ten hamper functioning; Bisson 2013; Ehlers 2005). In some TF-
CBT, behavioural experiments are also used to demonstrate the
way in which various maintaining processes (such as thought sup-
pression, hypervigilance for danger, avoidance of any cues) oper-
ate and support the individual to adopt more adaptive or effective
coping mechanisms (Ehlers 2005; Resick 2003). Despite its well-
established effectiveness in treating PTSD in the general popula-
tion, there is no agreed mechanism by which EMDR is thought to
operate, hence there is no definitive explanatory model of how it
works, although it is suggested that bilateral stimulation aids the
processing of traumatic memories (Shapiro 1989).
Why it is important to do this review
People with SMI have been found to be at increased risk of experi-
encing traumatic events (Bebbington 2004; Fisher 2013;Morrison
2003; Read 2008). These include traumatic events during child-
hood (such as physical and sexual abuse; Bebbington 2004; Varese
2012), as well as in adulthood (such as being a victim of crime and
abusive relationships (Darves-Bornoz 2008; Fisher 2013). Also,
there is some evidence to suggest that the illness experience of SMI
itself, such as experiences of threatening or persecutory psychotic
symptoms (Jackson 2009; Kilcommons 2005), can be traumatic.
Subsequently, it is estimated that around a third of individuals
with SMI also suffer from PTSD, across different phases of the
illness, from early onset, to acute and remission from positive
symptoms (Brunet 2012; Kilcommons 2005; NICE 2014). This
rate far exceeds that of the general population. Prolonged and un-
treated PTSD is associated with exacerbation of both PTSD and
psychotic symptoms, associated affective symptoms and a reduc-
tion in overall functioning and quality of life in affected individu-
als (Mueser 2009; Read 2008). However, despite trauma-focused
psychological interventions being consistently demonstrated to be
effective for the treatment of PTSD (Bisson 2013; Bradley 2005;
NICE 2005), empirical studies investigating feasibility, acceptabil-
ity, and clinical and cost-effectiveness of psychological interven-
tions for PTSD tend to exclude people with psychosis (Mueser
2010; NICE 2014). In routine service settings, provision of psy-
chological interventions (targeting psychotic symptoms specifi-
cally or other common co-morbid problems such as PTSD) has
also been criticised to be limited for people with psychotic dis-
orders (The Schizophrenia Commission 2012). This may be at-
tributed to clinical andmethodological factors, including: 1) diag-
nostic overshadowing whereby there are overlaps in the symptom
presentations of psychosis and PTSD (Calvert 2008; Jones 2014);
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2) concerns that this clinical population may find it hard to engage
with psychological therapies (Callcott 2004;Gairns 2015); 3) con-
cern that standard treatment/interventions may exacerbate posi-
tive symptoms (Gairns 2015); and 4) potential high attrition rates
(Callcott 2004; Jackson 2009). Hence, relatively little is known
about the utility and effectiveness of such treatments for this co-
morbid population. This review aims to address this knowledge
gap by investigating the effectiveness of psychological interven-
tions in improving PTSD symptoms and well-being of individuals
affected by PTSD and SMI. This information can then be used
to inform the development of clinical services for this highly co-
morbid group.
O B J E C T I V E S
To evaluate the effectiveness of psychological interventions for
post-traumatic stress disorder (PTSD) symptoms or other symp-
toms of psychological distress arising from trauma in people with
severe mental illness (SMI).
M E T H O D S
Criteria for considering studies for this review
Types of studies
All relevant randomised controlled trials that investigate psycho-
logical interventions for the co-morbid post-traumatic stress disor-
der (PTSD) and severemental illness (SMI) group. If a trial was de-
scribed as ’double-blind’ and implied randomisation, we planned
to include such trials in a sensitivity analysis (see Sensitivity
analysis). We excluded quasi-randomised studies, such as those al-
locating to interventions by alternate days of the week.Where par-
ticipants were given additional treatments within a psychological
intervention for PTSD, we planned to only include the data if the
adjunct treatmentwas evenly distributed between the intervention
and control groups, and it was the only psychological intervention
(with the primary purpose of treating PTSD or alleviating PTSD
symptoms) that was randomised.
Types of participants
Adolescents (aged 11 to 17 years) and adults (aged 18 years and
over) with SMI as defined above, and also diagnosed with PTSD,
and treated in any (clinical) setting. We also included studies with
participants diagnosed with PTSD and co-morbid primary diag-
noses other than SMI as defined by this review (e.g. severe depres-
sion or bipolar disorder), but only if at least 50% or more of the
participants had a psychosis-related disorder; or if data specific to
the participants with co-morbid psychosis were reported indepen-
dently, or obtainable from the study’s authors.
Types of interventions
1. Psychological interventions
We included psychological interventions if they were trauma-fo-
cused treatments or other psychological treatments that had been
used with the explicit intention of treating PTSD, that is, they
aimed to reduce PTSD symptoms or other related distress that
developed in relation to traumatic events relating to life events, or
the experience of SMI. These included the following.
1. Individual trauma-focused cognitive behavioural therapy
(TF-CBT): any psychological therapy that predominately used
trauma-focused cognitive or behavioural techniques or a
combination to address PTSD symptoms or other symptoms of
psychological distress arising from trauma (Ehlers 2005). Using
the definition adopted by the Cochrane review for psychological
therapies for PTSD (Bisson 2013), this category also includes
exposure therapy.
2. Group TF-CBT: any approach delivered in a group setting
using predominately trauma-focused cognitive, behavioural or
cognitive-behavioural techniques.
3. Eye movement desensitisation and reprocessing (EMDR;
Shapiro 1989; Shapiro 2001).
4. Any other psychological intervention that did not fit the
above categories of modalities, but clearly described its
theoretical underpinnings and was intended to target PTSD
symptoms and related distress in people with SMI.
2. Control conditions
Comparator interventions included either:
1. usual care/treatment as usual/ waiting list: this usually
includes care co-ordination or case management and
(antipsychotic) medication;
2. any other intervention: any alternative (psychological)
intervention other than a specific trauma-focused psychological
intervention whose content, mode of delivery and design were
clearly defined, e.g. non-trauma-focused CBT, non-directive/
supportive counselling (Rogers 1961), stress inoculation training
(SIT; Meichenbaum 1988); and less structured approaches such
as befriending and psychodynamic therapies.
We conducted separate analyses focusing on each category of active
psychological interventions based on a sharedmodality and format
of delivery (i.e. TF-CBT - individual or group based, EMDR, or
any other psychological intervention for PTSD), comparing them
to all the control conditions pooled together.Whenever there were
sufficient data extracted from included studies, we then proceeded
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to analyse each category of active psychological intervention tar-
geting PTSD comparing each modality and format of active in-
tervention against: 1) active control conditions (i.e. non-PTSD
focused intervention/s); 2) usual care/treatment as usual/waiting
list; and 3) other modality and format of trauma-focused psycho-
logical intervention, for primary outcomes.
Types of outcome measures
We divided all outcomes into short-term (less than six months),
medium-term (seven to 12 months) and long-term (over one year)
categories.
Primary outcomes
1. PTSD symptom severity - as reported by validated
measures
1.1 Average change or endpoint in PTSD symptom severity us-
ing a clinician-conducted standardised and validatedmeasure (but
not administered by the treating therapist), such as the Clinician
Administered PTSD Symptom Scale (CAPS) (Blake 1995).
1.2 Average change or endpoint in self-reported PTSD symptoms
using a standardised measure, for example, Impact of Events Scale
(IES) by Horowitz 1979), post-traumatic stress diagnostic scale
(PDS) by Foa 1995.
1.3 Recovery or remission from PTSD (i.e. no longer meeting
diagnostic criteria of PTSD).
2. Quality of life or well-being - as measured by validated
self-reported scales
2.1Clinically important change or endpoint scores in general qual-
ity of life or well-being scores, generic or specific to the partici-
pants’ physical, psychological, social, or cognitive functioning.
2.2 Average change or endpoint scores in general quality of life or
well-being scores, generic or specific to the participants’ physical,
psychological, social, or cognitive functioning.
Secondary outcomes
3. Symptoms of co-morbid psychosis
3.1 Endpoint or average change in severity of overall or general
mental state score, asmeasured by validated scales, such as the Brief
Psychiatric Rating Scale (BPRS, Overall 1962) or the Positive and
Negative Symptoms Scale (PANSS, Kay 1986).
3.2 Endpoint or average change in severity of positive psychotic
symptoms.
3.3 Endpoint or average change in severity of negative psychotic
symptoms.
3.4Recovery or remission from the pre-existing psychotic disorder.
4. Depressive symptoms
4.1 Endpoint or average change in severity of depressive symp-
toms, as measured by validated scales, for example the Beck De-
pression Inventory (BDI) (Beck 1996).
4.2 Recovery or remission from depression.
5. Anxiety symptoms
5.1 Endpoint or average change in severity of anxiety symptoms, as
reported by validated measures, e.g. the Spielberger State Anxiety
Inventory (STAI) (Spielberger 1973) or Beck Anxiety Inventory
(BAI) (Beck 1990).
5.2 Recovery or remission from anxiety disorder.
6. Adverse events
6.1 Increased PTSD symptoms or severity.
6.2 Increased severity of overall psychotic symptoms.
6.3 Any other adverse events, e.g. death including suicide and
natural causes.
7. Leaving the study early
7.1 Withdrawal from the treatment programme.
7.2 Loss to follow-up.
8. Satisfaction or perceived acceptability of treatment
8.1 Subjective satisfaction with treatment, as measured by vali-
dated self-report scales.
8.2 Perceived acceptability of treatment, as measured by validated
self-report scales.
9. Health economic outcomes
9.1 Direct costs, e.g. treatment costs, service use.
9.2 Indirect costs.
’Summary of findings’ table/s
Weused theGRADEapproach to interpret findings (Schünemann
2011), and we used the GRADE profiler to import data from
RevMan5.3 to create ’Summary of findings’ tables (GRADEPRO;
Review Manager). These tables provide outcome-specific infor-
mation concerning the overall quality of evidence from each in-
cluded study in the comparison, the magnitude of effect of the
interventions examined, and the sum of available data on all out-
comes we rated as important to patient-care and decision-making.
We aimed to select the following main outcomes for inclusion in
the ’Summary of findings’ tables:
1. PTSD symptoms
2. Quality of life or well-being
3. Symptoms of co-morbid psychosis
4. Depressive symptoms
5. Anxiety symptoms
6. Adverse events
7. Health economics
Search methods for identification of studies
Electronic searches
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1. Cochrane Schizophrenia Group’s Trials Register
On January 29, 2015 and March 10, 2016, the information spe-
cialist (TSC) searched the Cochrane Schizophrenia Group’s Trials
Register using the following search strategies:
(*trauma* or *ptsd*):ti,ab,kw of REFERENCE or (*trauma* or
*ptsd*):sco of STUDY
The Cochrane Schizophrenia Group’s Register of Trials is com-
piled by systematic searches of major resources (including AMED,
BIOSIS, CINAHL, Embase, MEDLINE, PsycINFO, PubMed,
and registries of clinical trials) and their monthly updates, hand-
searches, grey literature, and conference proceedings (see Group
Module). There are no language, date, document type, or publi-
cation status limitations for inclusion of records into the register.
Searching other resources
1. Reference searching
We inspected the references of all included studies for further
relevant studies.
2. Personal contact
We contacted the first and/or corresponding author of each
screened study for information regarding unpublished or ongoing
trials. We noted the outcome of these contacts in the included or
excluded studies tables.
Data collection and analysis
Selection of studies
Review authors DS and MF independently examined citations
from the searches and identified relevant abstracts. review authors
IN independently re-inspected a random 20% sample to ensure
reliability. Where disputes or uncertainty arose, we acquired the
full report for more detailed scrutiny. DS and MF obtained and
inspected full reports of the abstracts meeting the review criteria
independently. Again, IN re-inspected a random 20% of these
full reports in order to ensure reliable selection. Where it was not
possible to resolve disagreement by discussion, we made contact
with the authors of the study for clarification.
Data extraction and management
1. Extraction
Review authors DS andMF extracted data from all included stud-
ies. Again, we discussed any disagreement and documented deci-
sions. If necessary, authors of studies were contacted for clarifica-
tion and for obtaining further unpublished or subgroup data. IN
helped clarify issues for any remaining problems and these final
decisions were documented. We planned to extract data presented
in graphs and figures only, but included these data only if two re-
view authors independently obtained the same result. In the event,
we did not need to extract data from graphs and/or figures. We
contacted authors through an open-ended request in order to ob-
tain missing information or for clarification whenever necessary.
If studies were multi-centre, where possible, we planned to extract
data relevant to each component centre independently.
2. Management
2.1 Forms
We extracted data onto simple, standard forms.
2.2 Scale-derived data
We included continuous data from rating scales only if:
1. the psychometric properties of the measuring instrument
had been described in a peer-reviewed journal (Marshall 2000);
and
2. the measuring instrument had not been written or modified
by one of the trialists for that particular trial. Partial use of a
validated instrument would be included only if complete
subscale results were available for interpretation.
Ideally, the measuring instrument should either be a self-report
or a report completed by an independent rater or relative (not
the therapist). We realised that this is often not reported clearly;
we noted if this was the case or not in the Description of studies
section.
2.3 Endpoint versus change data
There are advantages of both endpoint and change data. Change
data can remove a component of between-person variability from
the analysis, however calculation of change needs two assessments
(baseline and endpoint), which can be difficult in unstable and
difficult to measure conditions such as schizophrenia. We decided
primarily to use endpoint data as much as possible, and only used
change data if the former were not available. For continuous out-
comes, we calculated the mean difference (MD) and 95% confi-
dence intervals (CI) where all outcomes were measured using the
same scale or there was only one trial. We also anticipated that
different studies might use different instruments (e.g. different
outcome measures or psychological tests) to assess the outcomes.
In this case, the scale of measurement would differ from study to
study and we decided it would only be meaningful to calculate the
standardised mean difference (SMD; i.e. by dividing the MD in
each study by that study’s standard deviation (SD)). We planned
to use a SMD value that was comparable across studies in the
analysis (Borenstein 2011), in such circumstances.
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2.4 Skewed data
Continuous data on clinical and social outcomes are often not
normally distributed. To avoid the pitfall of applying parametric
tests to non-parametric data, we applied the following standards
to all data before inclusion.
1. SDs and means are reported in the paper or obtainable
from the authors.
2. When a scale starts from the finite number zero, we
planned to subtract the lowest possible value from the mean, and
divide this by the SD. If this value is lower than 1, it strongly
suggests a skew and the study would be excluded. If this ratio is
higher than one but below two, there is suggestion of skew. We
entered the study and tested whether its inclusion or exclusion
would change the results substantially; in the event of significant
differences in the results, we performed analyses grouping the
unskewed and skewed data separately. Finally, if the ratio is larger
than 2 the study would have been included, because skew is less
likely (Altman 1996; Deeks 2011).
3. If a scale starts from a positive value (such as the Positive
and Negative Syndrome Scale (PANSS; Kay 1986), which can
have values from 30 to 210), we planned to modify the
calculation described above to take the scale starting point into
account. In these cases skew is present if 2 SD > (S-S min),
where S is the mean score and ’S min’ is the minimum score.
Endpoint scores on scales often have a finite start and end point
and these rules can be applied. Skewed data pose less of a problem
when looking at means if the sample size is large (> 200) (Moore
2010) and we planned to include these data into the syntheses.We
planned to present skewed endpoint data from studies of less than
200 participants in ’other tables’ within the data analysis section
rather than enter such data into statistical analyses together with
the unskewed data.
When continuous data are presented on a scale that includes a
possibility of negative value (such as change data), it is difficult to
tell whether data are skewed or not. We planned to present and
enter change data into statistical analyses.
2.5 Common measures
To facilitate comparison between trials, we intended to convert
variables that can be reported in different metrics, such as days in
hospital (mean days per year, per week or permonth) to a common
metric (e.g. mean days per month).
2.6 Conversion of continuous data to binary data
Where possible, we intended to convert outcome measures to di-
chotomous data. This can be done by identifying cut-off points
on rating scales and dividing participants accordingly into ’clin-
ically improved’ or ’not clinically improved’. In general, we as-
sumed that if there was a 50% reduction in a scale-derived score
such as the Brief Psychiatric Rating Scale (BPRS; Overall 1962),
or the Positive and Negative Syndrome Scale (PANSS; Kay 1986),
this could be considered as a clinically significant response (Leucht
2005a; Leucht 2005b). If data based on these thresholds were not
available, we planned to use the primary cut-off presented by the
original authors.
2.7 Direction of graphs
Where possible, we entered data in such a way that the area to
the left of the line of no effect indicates a favourable outcome
for trauma-focused psychological interventions. Where keeping
to this made it impossible to avoid outcome titles with clumsy
double-negatives (e.g. ’Not un-improved’) we reported data where
the left of the line indicated an unfavourable outcome. This would
have been noted in the relevant graphs.
Assessment of risk of bias in included studies
Review authors DS and MF worked independently to assess risk
of bias by using criteria described in the Cochrane Handbook for
Systemic Reviews of Interventions to assess trial quality (Higgins
2011). This set of criteria is based on evidence of associations
between overestimate of effect and high risk of bias of the article,
such as sequence generation, allocation concealment, blinding,
incomplete outcome data and selective reporting.
If the raters disagreed, the final rating was made by consensus,
with the involvement of other members of the review group (TM
and IN). Where inadequate details of randomisation and other
characteristics of trials were provided, we contacted the authors
of the studies to obtain further information. We also planned to
report non-concurrence in quality assessment, but if disputes arose
regarding the category to which a trial was to be allocated, again,
we would have resolved these by discussion.
We noted the level of risk of bias in both the text of the review
and in the ’Summary of findings’ tables.
Measures of treatment effect
1. Binary data
For binary outcomeswe planned to calculate a standard estimation
of the risk ratio (RR) and its 95% CI. It has been shown that RR
is more intuitive than odds ratios (Boissel 1999), and that odds
ratios tend to be interpreted as RR by clinicians (Deeks 2000).
The number needed to treat for an additional beneficial outcome
(NNTB)/number needed to treat for an additional harmful out-
come (NNTH) statistic with its CIs is intuitively attractive to
clinicians but is problematic both in its accurate calculation in
meta-analyses and interpretation (Hutton 2009). For binary data
presented in the ’Summary of findings’ tables, where possible, we
planned to calculate illustrative comparative risks.
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2. Continuous data
For continuous outcomes, we calculated the mean difference
(MD) and its 95%CIwhere all outcomes weremeasured using the
same scale or where there was only one trial. If different scales had
been used, we planned to calculate the standardised mean differ-
ence (SMD) and 95% CI. We preferred not to calculate effect size
measures (SMD).However, if scales of very considerable similarity
had been used, we would have considered that there was a small
difference in measurement, and proceeded to calculate effect size
and transform the effect back to the units of one or more of the
specific instruments.
Unit of analysis issues
1. Cluster trials
Studies increasingly employ ’cluster randomisation’ (such as ran-
domisation by clinician or practice) but analysis and pooling of
clustered data poses problems. Firstly, authors often fail to account
for intra-class correlation in clustered studies, leading to a ’unit of
analysis’ error whereby P values are spuriously low (Divine 1992),
CIs are unduly narrow and statistical significance overestimated.
This causes type I errors (Bland 1997; Gulliford 1999).
Where clustering had not been accounted for in primary studies,
we planned to present data in a table, with a (*) symbol to indicate
the presence of a probable unit of analysis error. In subsequent
versions of this review, if we include cluster-randomised trials,
we will contact the first or corresponding authors of studies to
obtain intra-class correlation coefficients (ICCs) for their clustered
data and will adjust for this by using accepted methods (Gulliford
1999). If clustering has been incorporated into the analysis of
primary studies, we will present these data as if from a non-cluster
randomised study, but adjust for the clustering effect.
We sought statistical advice and have been advised that the binary
data as presented in a report should be divided by a ’design ef-
fect’. This is calculated using the mean number of participants per
cluster (m) and the ICC [Design effect = 1+(m-1)*ICC] (Donner
2002). If the ICC was not reported, we would assume it to be
0.1 (Ukoumunne 1999). If cluster studies have been appropriately
analysed taking into account ICCs and relevant data documented
in the report, synthesis with other studies will be possible using
the generic inverse variance technique.
2. Cross-over trials
A major concern of cross-over trials is the carry-over effect. It oc-
curs if an effect (e.g. pharmacological, physiological or psycho-
logical) of the treatment in the first phase is carried over to the
second phase. As a consequence, the participants can differ sys-
tematically from their initial state on entry to the second phase,
despite a wash-out phase. For the same reason cross-over trials are
not appropriate if the condition of interest is unstable (Elbourne
2002). As both effects are very likely in severe mental illness, we
planned only to use data from the first phase of cross-over studies
if included in the review.
3. Studies with multiple treatment groups
We included a study that involved more than two treatment arms:
van den Berg 2015 investigated two types of trauma-focused psy-
chological interventions and compared them as a distinctive treat-
ment condition respectively against the waiting-list control con-
dition. We have presented the data of all three treatment arms in
comparisons (see Summary of main results). Had the additional
treatment arms not been relevant, we would not have used these
data.
Dealing with missing data
1. Overall loss of credibility
At some degree of loss of follow-up, the data must lose credibility
(Xia 2009). We chose that, for any particular outcome, should
more than 50% of the data be unaccounted for, we would not
reproduce the data or use them within analyses. If, however, more
than 50% of those in one arm of a study were lost, but the total
loss across arms was less than 50%, we addressed this within the
’Summary of findings’ tables by down-rating quality. This was the
case with one included study (Mueser 2008), which had a loss of
follow-up rate of 71% (i.e. five out of seven participants allocated
to the treatment as usual (TAU) control arm) at six-month follow-
up time point, although the overall loss of follow-up combining
both active treatment and control arms was 53% (i.e. only three
out of 10 participants allocated to the active treatment arm were
lost).
2. Binary
In the case where attrition for a binary outcome was between
0% and 50% and where these data were not clearly described,
we planned to present data on a ’once-randomised-always-analyse’
basis (an intention-to-treat (ITT) analysis). We planned to un-
dertake sensitivity analyses by imputing outcomes for the missing
participants with the most optimistic scenario and with the most
pessimistic scenario and then compare the results of these two
analyses. We also planned to undertake sensitivity analyses to test
how prone the primary outcomes were to change when only data
from people who completed the study (i.e. available-case analysis)
were compared to the ITT analysis using the above assumptions.
For the current review, we did not encounter this level of missing
binary outcome data and therefore did not undertake the afore-
mentioned sensitivity analyses.
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3. Continuous
3.1 Attrition
In the case when attrition for a continuous outcome was between
0 and 50%, and only data from people who completed the study
to that point were reported, we planned to reproduce these.
3.2 Standard deviations
If SDs were not reported, as in one included study (van den Berg
2015), we contacted the trial authors who provided us with the
raw group means and SDs of all reported outcomes, which we
presented and used in the review. If these were not available, where
there were missing measures of variance for continuous data, but
an exact standard error (SE) and CIs available for group means,
and either P value or ’t’ value available for differences in mean, we
could have calculated them according to the rules described in the
Cochrane Handbook for Systemic reviews of Interventions (Higgins
2011). When only the SE is reported, SDs are calculated by the
formula SD = SE * square root (n). Chapters 7.7.3 and 16.1.3 of
theCochrane Handbook for Systemic reviews of Interventions present
detailed formulae for estimating SDs from P values, t or F values,
CIs, ranges or other statistics. If these formulae did not apply, we
would have calculated the SDs according to a validated imputation
method that is based on the SDs of the other included studies
(Furukawa 2006). Although some of these imputation strategies
can introduce error, the alternative would be to exclude a given
study’s outcome and thus to lose information.We nevertheless also
planned to examine the validity of the imputations in a sensitivity
analysis excluding imputed values.
3.3 Assumptions about participants who left the trials early
or were lost to follow-up
Various methods are available to account for participants who left
the trials early or were lost to follow-up. Some trials just present the
results of study completers (this was the case with three included
studies: Mueser 2008; Mueser 2015; Steel 2010), others use the
method of last observation carried forward (LOCF) or more so-
phisticated approaches, such as multiple imputation or mixed-ef-
fects models for repeated measurements (MMRM) (Leon 2006).
As all methods of imputation to deal with missing data introduce
uncertainty about the reliability of the results (Leucht 2007), we
obtained the completers’ outcome data from the authors which
we presented and used in the review. Moreover, we also addressed
this issue in the ’incomplete outcome data’ item of the ’Risk of
bias’ tool.
Assessment of heterogeneity
1. Clinical heterogeneity
We considered all included studies initially, without seeing com-
parison data, to judge clinical heterogeneity. We simply inspected
all studies for clearly outlying people or situations that we had
not predicted would arise. If such situations or participant groups
arose, these would have been fully discussed by all review authors.
2. Methodological heterogeneity
We considered all included studies initially, without seeing com-
parison data, to judge methodological heterogeneity. Again, we
simply inspected all studies for clearly outlying methods that we
had not predicted would arise. When such methodological out-
liers arose, the review authors discussed these fully.
3. Statistical heterogeneity
3.1 Visual inspection
We inspected graphs visually to investigate the possibility of sta-
tistical heterogeneity.
3.2 Employing the I2 statistic
We investigated heterogeneity between studies by considering the
I2 method alongside the Chi2 P value. The I2 provides an estimate
of the percentage of inconsistency thought to be due to chance
(Higgins 2003). The importance of the observed value of I2 de-
pends on firstly, magnitude and direction of effects and secondly,
the strength of evidence for heterogeneity (e.g. P value from Chi2
test, or a CI for I2). We interpreted an I2 estimate greater than or
equal to around 50%accompanied by a statistically significantChi
2 statistic as evidence of substantial levels of heterogeneity (Section
9.5.2; Deeks 2011).When substantial levels of heterogeneity were
found in the primary outcome, we explored reasons for hetero-
geneity (Subgroup analysis and investigation of heterogeneity).
Assessment of reporting biases
1. Protocol versus full study
Reporting biases arise when the dissemination of research findings
is influenced by the nature and direction of results. These are
described in section 10.1 of the Cochrane Handbook for Systemic
reviews of Interventions (Sterne 2011). We tried to locate protocols
of included randomised trials by both searching the databases and
by contacting authors of registered trials. Whenever the protocol
was available, we compared outcomes in the protocol and in the
published report. If the protocol was not available, we compared
outcomes listed in the methods section of the trial report with the
results reported.
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2. Funnel plot
Reporting biases arise when the dissemination of research findings
is influenced by the nature and direction of results (Egger 1997).
These are again described in Section 10 of theCochrane Handbook
for Systemic reviews of Interventions (Sterne 2011). We are aware
that funnel plots may be useful in investigating reporting biases
but have limited power to detect small-study effects. We therefore
did not use funnel plots for outcomes where there were 10 or fewer
studies, or where all studies were of similar sizes. In other cases,
where funnel plots were possible, we planned to seek statistical
advice in their interpretation.
Data synthesis
We understand that there is no closed argument for preference
for the use of fixed-effect or random-effects models. The random-
effects method incorporates an assumption that the different stud-
ies are estimating different, yet related, intervention effects. This
often seems to be true to us and the random-effects model takes
into account differences between studies, even if there is no sta-
tistically significant heterogeneity. There is, however, a disadvan-
tage to the random-effects model. It puts added weight onto small
studies which often are the most biased ones. Depending on the
direction of effect, these studies can either inflate or deflate the
effect size. As there were only few studies (i.e. four studies in to-
tal, and a maximum of three included in some analyses), random-
effects model analyses may be inadequate to estimate accurately
the width of the distribution of intervention effects (Deeks 2011;
Kontopantelis 2013). We chose to use the random-effects model
for analyses involving more than one study, and check and note
if the analysis results were different if using a fixed-effect model.
The reader is, however, able to choose to inspect the data using
the fixed-effect model.
Subgroup analysis and investigation of heterogeneity
1. Subgroup analyses
1.1 Primary outcomes
We proposed to perform subgroup analyses by age (i.e. adults ver-
sus adolescents < 18 years of age) and by types of trauma (i.e. con-
ventional trauma, such as road traffic accidents, physical or sexual
assaults versus SMI symptom-related trauma, such as persecutory
delusions). We planned to undertake these comparisons only for
the primary outcomes to minimise the risk of multiple compar-
isons.
1.2 Clinical state, stage or problem
We proposed to undertake this review and provide an overview
of the effects of psychological interventions for PTSD in people
with SMI in general. In addition, however, we planned to report
data on subgroups of people with similar clinical presentations and
demographics.
2. Investigation of heterogeneity
If inconsistency was high, this would have been reported. Firstly,
we planned to investigate whether data had been entered correctly.
Secondly, if data were correct, we would proceed to inspect the
graph visually and remove outlying studies successively to see if
homogeneity was restored. For this review, we decided that, should
this occur with data contributing to the summary finding of no
more than around 10% of the total weighting, the data would
have been presented. If not, data would not be pooled and issues
would be discussed. We know of no research that supports this
10% cut-off, but are investigating use of prediction intervals as an
alternative to this unsatisfactory state.
When unanticipated clinical or methodological heterogeneity
were obvious, we planned to simply state hypotheses regarding
these for future reviews or versions of this review. We had not pre-
planned any analyses relating to these.
Sensitivity analysis
1. Implication of randomisation
We planned to include trials in a sensitivity analysis if they were
described in some way that implied randomisation. For the pri-
mary outcomes, we planned to include these studies and, if there
was no substantive difference when the implied randomised stud-
ies were added to those with better description of randomisation,
then all data would have been employed from these studies.
2. Assumptions for lost binary data
If assumptions had to be made regarding people lost to follow-
up (see Dealing with missing data), we planned to compare the
findings of the primary outcomes when we used our assumptions
and when we used only the data from people who completed
the study to that point. If there was a substantial difference, we
would have reported the results and discuss them, but would have
continued to employ our assumption(s).
If assumptions had to bemade regarding missing SDs (see Dealing
with missing data), we planned to compare the findings of the
primary outcomes when we used our assumptions and when we
used data only from people who completed the study to that point.
We planned to undertake a sensitivity analysis to test how prone
results were to change when completer-only data were compared
to the imputed data using the above assumptions. If these analyses
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yielded similar results in terms of the effects of the treatment, we
would have presented the results of the available-case analyses. If
there was a substantial difference, we would have reported and
discussed the difference and presented all results in the ’Summary
of findings’ tables.
3. Risk of bias
We intended to analyse the effects of excluding trials that were
judged to be at high risk of bias across one or more of the domains
of randomisation (i.e. implied as randomised with no further de-
tails available), allocation concealment, blinding and outcome re-
porting for the meta-analysis of the primary outcome. If the ex-
clusion of trials at high risk of bias did not substantially alter the
direction of effect or the precision of the effect estimates, then we
would have included data from these trials in the analysis.
4. Imputed values
If we had included cluster-randomised trials, if necessary, we
planned to undertake a sensitivity analysis to assess the effects of
including data from trials where we had used imputed values for
ICC in calculating the design effect in cluster-randomised trials.
If substantial differences were noted in the direction or precision
of effect estimates in any of the sensitivity analyses listed above,
we would not have pooled data from the excluded trials with the
other trials contributing to the outcome, but would have presented
them separately.
5. Fixed-effect and random-effects models
As aforementioned (Data synthesis), we synthesised data using a
random-effects model primarily and further compared the results
obtained from using both random-effects and fixed-effect models
to seek potential bias and heterogeneity (Kontopantelis 2013).
R E S U L T S
Description of studies
See Characteristics of included studies and Characteristics of
excluded studies for detailed description of each screened study.
Results of the search
The search results from the Cochrane Schizophrenia Group Trial
Register yielded 35 unique titles and abstracts. After examination,
two duplicates were removed and two additional references which
belong to two studies were identified by contacting trial authors
and updated publication of registered trials (31st March 2015).
Seventeen full-text articles or trial registration details of eight stud-
ies were assessed for inclusion or exclusion. For trials that included
people with severe mental illness (SMI) as participants with others
who had a non-SMI diagnosis as defined by this review as their
primary diagnosis, we contacted the trial authors by email for spe-
cific data in relation to the SMI participants. We also contacted
trial authors to inquire if they had unpublished or completed study
outcomes relevant for this review, again by email correspondence.
Trial authors’ responses are summarised in the Characteristics of
included studies and Characteristics of excluded studies sections.
The results of the search is summarised in Figure 1.
16Psychological interventions for post-traumatic stress disorder (PTSD) in people with severe mental illness (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Fo
r P
r
vie
 O
nly
Figure 1. Study flow diagram.
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Included studies
With additional subgroup data specific to participants with a psy-
chotic disorder (Mueser 2008; Mueser 2015) and unpublished
data obtained from trial authors (Steel 2010), four studies (Mueser
2015; Mueser 2008; Steel 2010; van den Berg 2015) were in-
cluded that met all the inclusion criteria and provided data specific
to individuals with co-morbid psychotic disorder and post-trau-
matic stress disorder (PTSD) (n = 300). See also Characteristics
of included studies for description of the four included studies
(including eight papers and/or trial registration detail).
1. Design
All included studies were described as ’randomised’. van den Berg
2015 reported using an independent randomisation bureau to ran-
domise the participants into the three treatment conditions us-
ing “stratified randomisation blocks per therapist with equal strata
sizes” (van den Berg 2015, p. e3). Altogether, 20 therapists were
trained in both active interventions trialled in the study (i.e. Pro-
longed Exposure (PE) and eye movement desensitisation and re-
processing (EMDR)), they delivered both treatments and it was
not possible to blind them to the participant-allocation. Mueser
2008 reported using a computer-based randomisation programme
to randomly allocate participants to the two arms in blocks of four
within each of the 12 strata (i.e. stratification was devised by four
treatment sites and by the three major diagnostic groups, i.e. ma-
jor mood disorder with or without borderline personality disorder
and schizophrenia or schizoaffective disorder). Another study by
Mueser (Mueser 2015) also used a computer programme operated
by an off-site data manager for randomisation which was strati-
fied by sites (i.e. five) and by primary diagnosis (i.e. three similar
to the aforementioned categories used in Mueser 2008). In both
USA-based studies, it was not possible to blind the therapists nor
the participants to the treatment-allocation (Mueser 2015;Mueser
2008). Steel 2010 did not describe the method used to randomly
allocate the participants, however, it was clear that neither the ther-
apist nor the participants were blinded to the treatment allocation.
2. Setting
van den Berg 2015’s three-arm randomised controlled trial (RCT)
was based in the Netherlands; Mueser 2008’s trial was based in
the State of New Hampshire, USA, while a more recent trial by
Mueser and colleagues (Mueser 2015), was based in the State of
New Jersey, USA. Steel 2010’s study was based in South East Eng-
land, UK. Both trials based in the USA (Mueser 2015; Mueser
2008), recruited individuals in community dwellings who had a
diagnosis of SMI and a co-morbid PTSD. The UK-based study
(Steel 2010), and the Netherlands study (van den Berg 2015), also
focused on community-dwelling patients. All patients received the
psychological treatment at out-patient clinics.
3. Participants
All participants in Steel 2010 (n = 61) had a diagnosis of
schizophrenia or schizoaffective disorder and current symptoms
consistent with a diagnosis of PTSD, both with reference to the
DSM-IV diagnostic criteria (APA, 2000). van den Berg 2015 re-
cruited 155 adults with a lifetime diagnosis of a psychotic disorder
or mood disorder with psychotic features according to the Mini-
International Neuropsychiatric Interview-Plus (Sheehan 1997;
Sheehan 1998) and a concurrent diagnosis of chronic PTSDmeet-
ing all the DSM-IV-tr criteria (APA, 2000). The two USA-based
studies recruited individuals meeting the State of NewHampshire
(n = 108) (Mueser 2008) or State of New Jersey (n = 201) (Mueser
2015) definition of ’severemental illness’ which included a range of
DSM-IV Axis-I disorders (including schizophreniform disorders,
schizoaffective disorders,major depressionor bipolar disorder) and
persistent impairment in the areas of work, school, or ability to
care for oneself, and a DSM-IV diagnosis of severe PTSD. Out of
the total 108 participants in Mueser 2008, 17 individuals (16%)
had co-morbid psychotic disorder and PTSD. And, 67 out of the
total 201 participants (33%) in Mueser 2015 met the inclusion
criteria of co-morbid SMI and PTSD as defined by this review.
All 300 participants across the four studies were adults aged 18
or above, as stipulated in the study eligibility criteria. Apart from
Steel 2010 (which was not yet published at the time of writing
this review but the lead trialist provided us with some unpublished
outcome data), the remaining three studies recruited community-
dwelling patients with an average age of early to mid 40s (Mueser
2008;Mueser 2015, van den Berg 2015). There were more female
than male patients in both USA studies, ranging from 61% of
the sample female patiens (Mueser 2008) to 71% (Mueser 2015).
van den Berg 2015’s trial included 71 male patients (46%) and 84
female patients (54%).
4. Nature of trauma and duration of trauma symptoms
Assessment for a current diagnosis of PTSD in all potentially eligi-
ble participants across all included studies (Mueser 2015; Mueser
2008; Steel 2010; van den Berg 2015) was conducted by using
the Clinician Administered PTSD Scale (CAPS by Blake 1995;
Weathers 2001). Mueser 2015 specified that their intervention fo-
cused on people with severe PTSD as defined by having a min-
imum CAPS total score of 65 (Weathers 2001). While van den
Berg 2015 specified a diagnosis of chronic PTSD as part of their
inclusion criteria for their participants; no minimum duration of
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PTSD symptoms was stipulated as part of the eligibility crite-
ria, although the baseline data of all participants (n = 155) re-
ported an average duration of PTSD of 21 years (SD = 13.5 years).
No details could be found in relation to the nature of traumatic
events participants experienced in two studies (Mueser 2015; Steel
2010). Nonetheless, in the remaining studies that reported the
nature of the trauma the participants experienced (Mueser 2008;
van den Berg 2015), it was reported that most participants expe-
rienced multiple childhood traumas, including sexual, emotional
and physical abuse. van den Berg 2015 further identified 28 par-
ticipants (18%) who developed PTSD due to traumatic psychosis
experiences.
5. Interventions
5.1 Intervention groups
In order to compare data in a meaningful way, we had made an
a priori decision to group different psychological interventions
based upon their theoretical basis into four categories when de-
vising our review protocol (see Types of interventions). These
four categories of trauma-focused interventions were: individual
trauma-focused cognitive behavioural therapy (TF-CBT) includ-
ing exposure-based therapy; group TF-CBT; EMDR; and any
other psychological intervention with an explicit aim to treat
PTSD symptoms and related distress.The interventions trialled in
the included studies are described below.
5.1.1 Individual trauma-focused cognitive behavioural ther-
apy (TF-CBT)
All four included studies evaluated TF-CBT that was delivered
to patients on an individual basis. Mueser 2015 reported devising
and trialling a 12- to 16-week CBT programme that was devel-
oped based on cognitive models of PTSD (Ehlers 2005; Horowitz
1979): the initial three sessions were dedicated to teaching breath-
ing retraining for anxiety and psychoeducation about PTSD;while
the remaining nine to 13 sessions focused on cognitive restruc-
turing. Treatment exposure was a priori defined as completion of
at least six sessions. An earlier study by Mueser 2008 also trialled
a 12- to 16-session CBT for PTSD programme, with the initial
few sessions focusing on psychoeducation and breathing retrain-
ing and the remaining sessions split into two parts of cognitive re-
structuring. Again, participants were required to complete at least
six sessions including a minimum of three sessions of cognitive
restructuring, to satisfy the definition of treatment exposure. The
UK-based study by Steel 2010 adopted the 16-sessions CBT pro-
gramme developed byMueser 2008 in which the 12-to 16-session
CBT programme was delivered to patients individually over a six-
month duration. van den Berg 2015 devised and trialled eight
sessions prolonged exposure (PE) therapy run within a 10-week
time frame, which was developed based upon a protocol by Foa et
al (Foa 2007). Whilst the first of the eight 90-minute PE sessions
was used to develop a case conceptualisation between the thera-
pist and the individual patient, the remaining sessions focused on
imaginal and in vivo exposure targeting a list of avoided trauma-
related stimuli.
5.1.2 Group TF-CBT
No study reported on group-based interventions.
5.1.3 Eyemovement desensitisation and reprocessing (EMDR)
An eight weekly 90-minute EMDR therapy delivered to patients
individually over a 10-week period was also trialled in van den
Berg 2015. The study used the Dutch EMDR therapy protocol
(de Jongh 2003), which was translated and adapted from the stan-
dard eight-phase protocol by Shapiro (Shapiro 2001). Bilateral
eye movements were applied as the dual-attention stimuli when
traumatic memories were processed from the second through to
the eighth (i.e. last) session, whilst the first session was used to
develop a case conceptualisation including identifying a hierarchy
of relevant traumatic experiences for the individual patients.
5.1.4 Any other trauma-focused psychological intervention
that does not fit the above categories of modality and format
In addition to the TF-CBT programme, Mueser 2015 also tri-
alled a brief PTSD psychoeducation programme, adapted from
an earlier therapy the researchers developed to educate persons
with SMI about PTSD (Pratt 2005). The brief psychoeducation
programme included three sessions, the first of which covered the
same breathing retraining and education components as the TF-
CBT programme, which was tested in the other arm of the study.
The remaining two sessions focused on education on anxiety man-
agement and discussion about the causes and nature of PTSD.
Treatment exposure was defined a priori as completion of at least
two sessions.
5.2 Comparison groups
Comparisons most commonly used were ’Treatment as Usual
(TAU)’ or ’standard treatment’ which usually included out-patient
follow-up and case management or care co-ordination, pharmaco-
logical treatment and access to a range of supportive psychothera-
pies excluding any trauma-focused therapies (Mueser 2008; Steel
2010). van den Berg 2015 used a ’wait list’ (WL) control group as
comparison to the PE and EMDR groups, participants in theWL
group received the usual treatment during the 6-month follow-up
period and was then offered either PE or EMDR based on their
own choice after the follow-up period. Mueser 2015 used the brief
PTSD psychoeducation programme (as detailed in Section 5.1.4)
as an active comparison against the TF-CBT programme.
6. Outcomes
6.1 Outcome scales
Primary outcomes of the review were PTSD symptom severity and
quality of life or well-being of the individuals with co-morbid SMI
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and PTSD (see Primary outcomes for further details). Secondary
outcomes included patients’ psychotic symptoms, depressive and
anxiety symptoms, adverse events, leaving the study early, satisfac-
tion or perceived acceptability of treatment, and health economic
outcomes (see Secondary outcomes). Most of these outcomes were
reported by the four included studies, using various scales as de-
scribed below.
6.1.1 PTSD symptom severity
All four included studies (Mueser 2015;Mueser 2008; Steel 2010;
van den Berg 2015) reported clinician-rated PTSD symptom
severity and loss of PTSD diagnosis (i.e. remission from PTSD
with sub-threshold PTSD symptoms) and/or recovery fromPTSD
(i.e. asymptomatic of PTSD) as the primary outcome of their
study aims. The Clinician Administered PTSD Scale (CAPS by
Blake 1995; Weathers 2001) was used as the study’s primary out-
come measure in all four studies, with Mueser 2015 specifying
using the CAPS-schizophrenia version (Gearon 2004). CAPS is a
widely used, reliable and valid semi-structured interview for the
assessment of PTSD symptoms (Gearon 2004; Weathers 2001).
For each PTSD symptom, a frequency and intensity rating is pro-
vided, with overall severity scores computed by summing the fre-
quency and intensity scores for all of the PTSD symptoms, i.e.
CAPS-total (Blake 1995; Weathers 2001). The higher the CAPs-
total scores, the more severe the PTSD symptoms.
In addition, the cut-off of CAPS-total score (i.e. less than 40)
(Weathers 2001) was used by three studies (Mueser 2008; Mueser
2015; van denBerg 2015) to determine the number of participants
achieving remission fromPTSDor sub-threshold PTSD symptom
severity (i.e. loss of diagnosis of PTSD) following treatment and at
follow-up. Furthermore, van den Berg 2015 used the CAPS-total
cut-off of less than 20 (Weathers 2001) as a binary measure to
indicate recovery or full remission from PTSD (i.e. asymptomatic
or few symptoms of PTSD). Mueser 2015 focused on individuals
with SMI and severe PTSD as defined by a minimum CAPS-
total score of 65 (Weathers 2001) on entry to the trial, after the
intervention and at follow-up time points; this CAPS-total cut-
off point of 65 was used again as binary outcome for remission
from (or loss of diagnosis of ) severe PTSD.
A number of validated outcome measures were used by the in-
cluded studies to report self-rated PTSD symptoms. These in-
cluded: the Posttraumatic Cognitions Inventory (PTCI by Foa
1999) - a subjective measure for PTSD patients to report trauma-
related cognitions especially negative beliefs about self, others and
the world, with higher scores corresponding to greater endorse-
ment of negative beliefs - was used in all studies (Mueser 2015;
Mueser 2008; Steel 2010; van den Berg 2015); the Posttraumatic
Stress Symptom Scale Self-Report (PSS-SR by Foa 1993) was also
used by van den Berg 2015 to assess patients’ self-reported fre-
quency of PTSD symptoms (higher scores indicate poorer symp-
tom severity).
6.1.2 Quality of life or well-being
General quality of life (across different life domains) was assessed
and considered as one of the secondary outcomes in two studies
(Mueser 2015; Steel 2010) using theBriefQuality of Life Interview
(QOLI by Lehman 1995) and the Quality of Life Scale (QoLS by
Heinrichs 1984), respectively. Furthermore, overall functioning
was evaluated with the Global Assessment of Function scale (GAF
by Jones 1995) in both Mueser 2015 and Steel 2010. Mueser
2015 reported further on participants’ social functioning using
the CAPS-impact on social functioning subscale (Blake 1995).
Participants’ self-reported mental health and physical functioning
were assessed with the Short Form-12 Mental Component and
Physical Component respectively (SF12 byWare 1994) inMueser
2008.
6.1.3 Symptoms of co-morbid psychosis
Overall and specific psychotic symptoms were assessed as sec-
ondary outcomes in three included studies (Mueser 2015; Mueser
2008; Steel 2010). Two studies used the Positive and Negative
Syndrome Scale (PANSS by Kay 1986) to assess psychiatric symp-
toms:Mueser 2015 reported the PANSS total for overall psychotic
symptoms severity, the PANSS-positive subscale total for positive
symptoms and PANSS-negative subscale total for negative symp-
toms whilst Steel 2010 reported only the PANSS-positive and -
negative subscale totals. The Brief Psychiatric Rating Scale (BPRS
by Lukoff 1986) was used by Mueser 2008 to assess overall psy-
chiatric symptoms.
Furthermore, Steel 2010 also assessed specific psychotic symp-
toms, namely auditory hallucinations and delusions, using the
Psychotic Symptom Rating Scale (PSYRATS by Haddock 1999)
hallucinations and delusions subscale totals, respectively.
6.1.4 Depressive symptoms
Self-reported depressive symptoms were rated with the Beck De-
pression Inventory-II (BDI-II by Beck 1990) in three included
studies as one of the secondary outcomes (Mueser 2015; Mueser
2008; Steel 2010).
6.1.5 Anxiety symptoms
Three studies (Mueser 2015; Mueser 2008; Steel 2010) reported
anxiety symptoms as secondary outcomes and they all used the
Beck Anxiety Inventory (BAI by Beck 1996).
6.1.6 Adverse events
van den Berg 2015 reported incidents of severe adverse events,
however the nature of the adverse events was not made explicit
apart from that they were reported as not related to the interven-
tions trialled. Adverse events, if any, were not reported by the other
studies.
6.1.7 Leaving the study early
All included studies reported a priori definition of treatment ex-
posure (i.e. minimal sessions of treatment attended) and reported
participants’ dropout/attrition rate and loss to follow-up (Mueser
2015; Mueser 2008; Steel 2010; van den Berg 2015).
6.2 Redundant data
6.2.1 Satisfaction or perceived acceptability of treatment
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In Steel 2010, participants’ perceived acceptability of the TF-CBT
was assessed by service user-led interview which implies qualitative
data. However, as this study has not published to date, no data are
yet available.
6.2.2 Understanding of PTSD
Participants’ understanding of PTSD was measured by the PTSD
Knowledge Test (Pratt 2005) in both studies led by Mueser
(Mueser 2008; Mueser 2015). However, we had not planned to
consider PTSD knowledge on its own without subsequent data on
any impact of such on PTSD symptoms and/or related distress.
6.3 Missing data
None of the included studies reported health economic outcomes.
7. Follow-up
All studies reported follow-up at post treatment time point while
the intervention duration varied across studies, from10weeks (van
den Berg 2015) to six months (Mueser 2015; Mueser 2008; Steel
2010). Mueser 2015 and van den Berg 2015 collected follow-up
outcomes measures up to 12 months post-intervention, although
data reporting by van den Berg 2015 was limited to six-month
follow-up at the time of data extraction for this review. Mueser
2008 and Steel 2010 followed up their participants for up to six
months post-intervention.
Excluded studies
Studies excluded from the review are described in Characteristics
of excluded studies section. These included nine full-text papers
of four studies, which were examined but excluded at the end of
the full-text screening stage, due to the study not using a ran-
domised-controlled design (de Bont 2013), or the study partic-
ipants not meeting the diagnostic threshold of PTSD (Jackson
2006; ISRCTN43816889; NCT00307216). de Bont 2013 was a
feasibility study using a within-group controlled design to test the
feasibility and safety of EMDR and prolonged exposure in people
with co-morbid psychosis and PTSD. Jackson 2006 investigated
the effectiveness of a form of cognitive therapy, which was called
the ’recovery intervention’, in promoting personal adjustment to
psychosis and in reducing depression, trauma and other charac-
teristic negative consequences of psychosis; participants were not
assessed for having PTSD or not. ISRCTN43816889 tested the
efficacy and safety of EMDR in patients with a psychotic illness
but without a co-morbid PTSD. A manual-based individual ther-
apy programme called ’The Gradual Recovery Intervention Pro-
grame’ (GRIP) investigated by NCT00307216 also focused on
individuals recovering from their first episodes of psychosis; no
PSTD diagnosis was made.
Please note that Figure 1 - Study flow diagram relates to exclusion
of full-text papers.
Studies awaiting assessment
No studies await assessment.
Ongoing Studies
We are not aware of any ongoing studies.
Risk of bias in included studies
Our overall impression of risk of bias in the included studies is
represented in Figure 2 and Figure 3, whilst assessment of risk
of bias of each included study is reported in Characteristics of
included studies. Overall, the methodological quality of all the
included studies is good, with clear reporting of the trial design
and conduct (except Steel 2010 which was not yet published albeit
unpublished outcome data were provided for this review). This
suggests that the results can be considered to be at low to medium
risk of bias, subject to the available data.
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Figure 2. ,Risk of bias’ summary: review authors’ judgements about each risk of bias item for each included
study.
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Figure 3. ’Risk of bias’ graph: review authors’ judgements about each risk of bias item presented as
percentages across all included studies.
Allocation
All included studies were randomised controlled trials (RCTs).
Apart from Steel 2010, which was not yet published at the time
of writing this review (i.e.July 2016 and no data were obtained
from the trialist regarding allocation) and assessed as being at un-
clear risk of bias, all studies reported the randomisation method
used, including the method used to generate the randomisation
sequence and strategies to conceal allocation to outcome asses-
sors and participants. Hence, three studies (Mueser 2008; Mueser
2015; van den Berg 2015) were rated as being at low risk of bias.
Blinding
Three studies used waiting list or usual care as the comparison
(i.e. Mueser 2008; Steel 2010; van den Berg 2015), making it im-
possible to blind the participants. Due to the design of the trials
involving therapists delivering the trauma-focused psychological
interventions and/or active control (i.e. brief PTSD-psychoedu-
cation in Mueser 2015), it was not possible to blind the thera-
pists either. Nonetheless, three studies reported clearly their use
of blinded assessors for data collection to minimise detection bias
(Mueser 2008; Mueser 2015; van den Berg 2015). van den Berg
2015 further described strategies to handle the few unblinding in-
cidents enlisting another independent assessor to re-conduct the
assessment, hence this study was rated as at low risk of bias. Both
USA studies also reported training and monitoring of blinded as-
sessors, hence we also rated them as at low risk (Mueser 2008;
Mueser 2015). Due to inadequate detail, we rated Steel 2010 as
at unclear risk.
Incomplete outcome data
All studies reported using intention-to-treat (ITT)methodof anal-
ysis, except Steel 2010 which is due to limited data available at
the time of writing this review. There was also clear reporting of
the number of participants completing the treatment exposure (as
required as defined a priori) across all studies. However, in two
of the studies, these data were difficult to disentangle or were in-
consistent. We therefore rated two studies as at low risk of bias
(Mueser 2008; van den Berg 2015) and two at unclear risk of bias
(Mueser 2015; Steel 2010).
Selective reporting
For all four included studies, we identified either a published trial
protocol (i.e. de Bont 2013 for van den Berg 2015) and/or a
detailed trial registration (Mueser 2008;Mueser 2015; Steel 2010).
Three studies seemed to have reported all outcomes as specified in
their study protocol and/or trial registration records (Mueser 2008;
Mueser 2015; van den Berg 2015), although van den Berg 2015,
which had recently published their six-month follow-up primary
outcome results in the previous few months (i.e. e-publication in
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January 2015), has yet to report its 12-month follow-up results
and the secondary to quaternary outcomes in due course. We
therefore rated Mueser 2008 and Mueser 2015 as at low risk of
bias whilst we rated van den Berg 2015 as at unclear risk of bias at
this time. We were provided with unpublished results from Steel
2010, however, since this study was not published at the time of
writing this review, we rated it as at unclear risk of bias.
Other potential sources of bias
All included studies provided information on funding sources and
any potential conflict of interests. We identified no other potential
sources of bias.
Effects of interventions
See: Summary of findings for the main comparison Individual
TF-CBT compared to waiting list/usual care for PTSD and
severe mental illness; Summary of findings 2 EMDR compared
to waiting list/usual care for PTSD and severe mental illness;
Summary of findings 3 Individual TF-CBT compared to EMDR
for PTSD and severe mental illness; Summary of findings 4
Individual TF-CBT compared to Brief PTSD psychoeducation
for PTSD and severe mental illness
There are four comparisons, and results of data analyses are
summarised below. See also Summary of findings for the main
comparison; Summary of findings 2; Summary of findings 3;
Summary of findings 4. Of note, as most of the continuous
outcome data were found to be skewed (i.e. un-symmetrically
distributed), we conducted analyses grouping unskewed data
and skewed data separately (as outlined in Data extraction and
management). In the .Summary of findings’ tables, we reported the
pre-specified outcomes of interest (Types of outcome measures)
whenever data were available, and priority was given to the anal-
yses drawn using unskewed continuous data. In the event of no
available analyses using unskewed data, we reported the analyses
pooling skewed data and downgraded the quality of evidence.
Comparison 1: Individual trauma-focused cognitive
behavioural therapy (TF-CBT) versus waiting list/usual care
Three studies including 178 participants in total contributed to
this comparison (Mueser 2008; Steel 2010; van den Berg 2015).
See also Summary of findings for the main comparison.
1.1 PTSD symptoms severity: 1a. Clinician-rated PTSD
symptom severity - average endpoint CAPS total score (high
= poor)
Three studies considered this outcome with a total of 178 indi-
viduals.
Short-term unskewed data from one study found no differences in
symptom severity between groups (1RCT, n = 13,mean difference
(MD) 13.15, 95% confidence interval (CI) -4.09 to 30.39; low-
quailty evidence, Analysis 1.1).
1.2 PTSD symptoms severity: 1b. Clinician-rated PTSD
symptom severity - average endpoint CAPS total score (high
= poor) - skewed data
Short-term skewed data from two studies reported data that
showed no significant differences between TF-CBT and waiting-
list control groups although there was high heterogeneity (2 RCTs,
n = 147, MD -7.44, 95% CI -29.15 to 14.27, I2 = 87%, Analysis
1.2 ).
Three studies reported medium-term skewed data. No effect be-
tween groups was found (3 RCTs, n = 155, MD -3.92, 95% CI -
19.25 to 11.40, Analysis 1.2). There was high heterogeneity (I2 =
63%),
1.3 PTSD symptoms severity: 2. Self-reported trauma-related
cognitions - average endpoint Posttraumatic Cognitions
Inventory (PTCI) total score (high = poor)
Three studies reported short-term outcome data, results were
equivocal across groups (3 RCTs, n = 136, MD -5.45, 95% CI -
33.61 to 22.70; I2 = 76%) with high heterogeneity detected, how-
ever, medium-term data from three studies showed an effect for
TF-CBT (3 RCTs, n = 133, MD -15.25, 95%CI -29.48 to -1.02).
Analysis 1.3.
1.4 PTSD symptoms severity: 3. Self-reported frequency of
PTSD symptoms - average endpoint PSS-SR total score (high
= poor) - skewed data
Only one study provided datawhichwere skewed on this outcome.
Both short-term (1 RCT, n = 86, MD -9.51, 95% CI -13.84 to -
5.18) and medium-term at nine months (1 RCT, n = 85, MD -
7.52, 95% CI -12.06 to -2.98) data show an effect for TF-CBT.
Analysis 1.4.
1.5 PTSD symptoms severity: 4. Remission from PTSD:
Symptoms below diagnostic threshold - CAPS total score <
40
Two studies reported remission from PTSD as measured by below
CAPS cut-off score (i.e. <40). Both short-term and medium-term
data favoured the TF-CBT group (short term: 2 RCTs, n = 113,
risk ratio (RR) 1.99, 95% CI 1.20 to 3.30; medium term: 2 RCTs,
n = 109, RR 1.44 95% CI 0.57 to 3.63; Analysis 1.5).
1.6 PTSD symptoms severity: 5. Recovery from PTSD:
Asymptomatic or few symptoms - CAPS total score < 20
Only one study provided data on this outcome; recovery was de-
fined as a CAPS total score below 20. The short-term results
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showed thatmore participants in the TF-CBT group had achieved
full recovery fromPTSDwhen comparedwith those in the waiting
list group and the results were statistically significant (1 RCT, n
= 100, RR 4.43, 95% CI 1.37 to 14.37). The medium-term data
also favour the TF-CBT group with statistical significant results
(1 RCT, n = 100, RR 4.14, 95% CI 1.27 to 13.51; Analysis 1.6).
1.7 Quality of life: 1. General quality of life - average
endpoint QLS total score (high = good)
Only one study provided data (unskewed) on this outcome. Both
the short-term (1 RCT, n = 38, MD -3.00, 95% CI -8.26 to 2.26)
and medium-term results (1 RCT, n =39, MD -0.60, 95% CI -
4.47 to 3.27) were equivocal across groups; low-quality evidence,
Analysis 1.7.
1.8 Quality of life: 2. Overall functioning - average endpoint
GAF total score (high = good)
Again, only one study reported data (unskewed) on this outcome.
Neither the short-term (1 RCT, n = 44, MD 0.80, 95% CI -4.61
to 6.21); nor themedium-term (1RCT, n = 46,MD2.70, 95%CI
-3.32 to 8.72) results showed any significant differences between
groups; Analysis 1.8.
1.9 Quality of life: 3. Mental health functioning - average
endpoint SF-12 mental component total score (high = good)
Short-term unskewed data from one study (1 RCT, n = 11, MD
-9.89, 95% CI -23.35 to 3.57) showed no effect. Medium-term
data were also equivocal across the TF-CBT and usual care groups
(1 RCT, n = 9, MD 1.96 95% CI -28.15 to 32.07); Analysis 1.9.
1.10 Quality of life: 4. Physical functioning - average
endpoint SF-12 physical component total score (high = good)
Again, only one study provided data (unskewed) for this outcome.
We found no effect from data across short-term (1 RCT, n = 11,
MD 1.32, 95% CI -16.35 to 18.99), and at medium-term follow-
up (1 RCT, n = 9, MD -2.52, 95% CI -25.64 to 20.60). Analysis
1.10.
1.11 Symptoms of co-morbid psychosis: 1. Overall mental
state - average endpoint BPRS total score (high = poor)
One study reported this outcome using the total BPRS scores; all
data were unskewed. Results in the short term (1 RCT, n = 13,
MD 1.00, 95% CI -9.96 to 11.96), and medium term (1 RCT,
n = 9, MD -6.93 95% CI -34.17 to 20.31, low-quality evidence)
were equivocal across groups. Analysis 1.11.
1.12 Symptoms of co-morbid psychosis: 2. Positive
symptoms - average endpoint PANSS positive subscale total
score (high = poor)
Unskewed data showed no significant differences between groups
at short term (1 RCT, n = 61, MD -2.00, 95% CI -5.07 to 1.07),
and at medium term (1 RCT, n = 61, MD -1.40, 95% CI -4.42
to 1.62). Analysis 1.12.
1.13 Symptoms of co-morbid psychosis: 3. Negative
symptoms - average endpoint PANSS negative subscale total
score (high = poor)
Again, only one study reported data on this outcome, all data were
unskewed. Short-term data across the two groups were equivocal
(1 RCT, n = 61, MD -1.40, 95% CI -4.19 to 1.39), as were the
medium-term data (1 RCT, n = 61, MD -1.10, 95% CI -3.38 to
1.18). Analysis 1.13.
1.14 Symptoms of co-morbid psychosis: 4. Hallucinations -
average endpoint PSYRATS-hallucinations subscale total
score (high = poor) - skewed data
Short-term skewed data showed no significant differences between
groups (1 RCT, n = 61, MD 2.80, 95% CI -3.88 to 9.48), nor the
medium-term skewed data (1 RCT, n = 61, MD -0.30, 95% CI -
7.48 to 6.88). Analysis 1.14.
1.15 Symptoms of co-morbid psychosis: 5. Delusions -
average endpoint PSYRATS-delusions subscale total score
(high = poor) - skewed data
Results between groups across short term (1 RCT, n = 61, MD -
0.70, 95% CI -4.73 to 3.33) and medium term (1 RCT, n = 61,
MD -2.30, 95% CI -6.22 to 1.62) were equivocal. Of note, all
data were skewed. Analysis 1.15.
1.16 Anxiety symptoms - average endpoint BAI total score
(high = poor)
One study reported unskewed data for this outcome. Both short-
term (1 RCT, n = 13, MD 4.20, 95% CI -7.52 to 15.92) and
medium-term (1 RCT, n = 9, MD 12.57, 95% CI -5.54 to 30.68,
very low-quality evidence) unskewed data showed no significant
differences between groups. Analysis 1.16
1.17 Anxiety symptoms - average endpoint BAI total score
(high = poor) - skewed data
Another study presented skewed data for this outcome, again no
effect between treatments was found at either short term (1 RCT,
n = 35, MD 2.00, 95% CI -7.02 to 11.02) or medium term (1
RCT, n = 40, (MD -3.00, 95% CI -12.36 to 6.36). Analysis 1.17.
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1.18 Depressive symptoms - average endpoint BDI-II total
score (high = poor) - skewed data
Only skeweddata from two studieswere available for this outcome.
No effect was found at short term (2 RCTs, n = 49, MD 1.31,
95% CI -5.81 to 8.44), or medium term (2 RCTs, n = 48, MD
3.26, 95% CI -3.66 to 10.18, very low-quality evidence). Analysis
1.18.
1.19 Adverse events - incidents of unspecified severe adverse
events
Only one study reported incidents of unspecified severe adverse
events, medium-term data were equivocal across TF-CBT and
waiting-list control groups (1RCT, n=100,RR0.44, 95%CI0.09
to 2.31, low-quality evidence). These adverse events were specified
as not related to the PTSD or psychotic symptoms. See Analysis
1.19.
1.20 Leaving the study early
Three studies with 178 participants in total provided attrition
data. No differences in numbers of participants leaving the study
early across groups were at short term (3 RCTs, n = 178, RR 0.74,
95% CI 0.38 to 1.44) or medium term (3 RCTs, n = 178, RR
0.80, 95% CI 0.46 to 1.40). Analysis 1.20.
2. Comparison 2: Eye movement desensitisation and
reprocessing (EMDR) versus waiting list
Only one studywith 102participants comparedEMDRwithwait-
ing-list control (van den Berg 2015), meta-analyses on outcomes
were therefore not possible using the data. We report the analyses
on all available outcome data below. See also Summary of findings
2 for main outcomes of interest.
2.1 PTSD symptoms severity: 1. Clinician-rated severity -
average endpoint CAPS total score (high = poor) - skewed
data
All available data were skewed. Both short-term data (1 RCT, n =
83, MD -15.32, 95% CI -25.99 to -4.65) and medium-term data
(1 RCT, n = 83, MD -12.31, 95% CI -22.72 to -1.90, very low-
quality evidence) showed favourable effect for EMDR. Analysis
2.1.
2.2 PTSD symptoms severity: 2. Self-reported trauma-related
cognitions - average endpoint PTCI total score (high = poor)
Data reporting this outcome were unskewed. Short-term data
favoured EMDR (1 RCT, n = 83, MD -23.27, 95% CI -38.50 to
-8.04) and these benefits seemed to be sustained at medium-term
follow-up (1 RCT, n = 83, MD -20.66, 95% CI -36.72 to -4.60).
Analysis 2.2 .
2.3 PTSD symptoms severity: 3. Self-reported frequency of
PTSD symptoms - average endpoint PSS-SR total score (high
= poor) - skewed data
The EMDRgroup fared better in self-reported frequency of PTSD
symptoms asmeasured by PSS-SR, across both short term (1 RCT,
n = 83, MD -8.60, 95% CI -13.03 to -4.17) and medium term
(1 RCT, n = 83, MD -7.37, 95% CI -12.17 to -2.57), although
data reported were skewed. Analysis 2.3.
2.4 PTSD symptoms severity: 4. Remission from PTSD:
Symptoms below diagnostic threshold - CAPS total score <
40
A favourable effect for EMDR compared to waiting list was found
in both the short-term data (1 RCT, n = 102, RR 2.17, 95% CI
1.30 to 3.61), and the medium-term data (1 RCT, n = 102, RR
1.77, 95% CI 1.10 to 2.85). Analysis 2.4.
2.5 PTSD symptoms severity: 4. Recovery from PTSD:
Asymptomatic or few symptoms - CAPS total score < 20
There were no significant differences in numbers of participants
achieved full recovery from PTSD across EMDR and waiting-list
groups, both at short term (1 RCT, n = 102, RR 2.56, 95% CI
0.74 to 8.92) and medium term (1 RCT, n = 102, RR 2.28, 95%
CI 0.64 to 8.10). Analysis 2.5.
2.6 Adverse events - incidents of unspecified severe adverse
events
No adverse events were recorded at short term. Events were
recorded at medium term, with equivocal numbers of adverse
events reported across groups in medium term (1 RCT, n = 102,
RR 0.21, 95%CI 0.02 to 1.85, low-quality evidence). Analysis 2.6.
2.7 Leaving the study early
Short-term data showed no significant differences in number of
participants lost to follow-up between groups (1 RCT, n = 102,
RR 1.18, 95% CI 0.52 to 2.68). Equivocal attrition data were also
reported at medium term (1 RCT, n = 102, RR 1.46, 95% CI
0.63 to 3.42). Analysis 2.7.
Head to head comparisons of specific category of
trauma-focused psychological therapies
Wemade the following two specific comparisons and reported on
primary outcomes only, as pre-specified in our protocol.
Comparison 3: TF-CBT (specifically prolonged exposure)
versus EMDR
One study with 108 participants (van den Berg 2015) compared
prolonged exposure (PE) therapy which was categorised as a type
of TF-CBT (as defined a priori in Types of interventions) with
EMDR.We report herewith the analyses on all the available review
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primary outcomes although meta-analyses were not possible. See
also Summary of findings 3.
3.1 PTSD symptoms severity: 1. Clinician-rated severity -
average endpoint CAPS total score (high = poor) - skewed
data
No significant differences was found between TF-CBT and
EMDR groups based on the short-term data (1 RCT, n = 91, MD
-2.94, 95% CI -13.13 to 7.25), as well as the medium-term data
(1 RCT, n = 88, MD -1.69, 95% CI -12.61 to 9.23, very low-
quality evidence). Of note, all available data were skewed. Analysis
3.1.
3.2 PTSD symptoms severity: 2. Self-reported trauma-related
cognitions - average endpoint PTCI total score (high = poor)
Results were equivocal between the PE and EMDR groups, both
in the short term (1 RCT, n = 91, MD -3.38, 95% CI -21.17 to
14.41) and in the medium term (1 RCT, n = 88, MD 2.05, 95%
CI -16.69 to 20.79), based on unskewed data. Analysis 3.2.
3.3 PTSD symptoms severity: 3. Self-reported frequency of
PTSD symptoms - average endpoint PSS-SR total score (high
= poor) - skewed data
There were no significant differences found between groups, both
at short term (1 RCT, n = 91, MD -0.91, 95% CI -5.18 to 3.36)
and at medium term (1 RCT, n = 88, MD -0.15, 95% CI -5.49
to 5.19). Of note, data reported were skewed. Analysis 3.3.
3.4 PTSD symptoms severity: 4. Remission from PTSD:
Symptoms below diagnostic threshold - CAPS total score <
40
Data showed equivocal results across the PE and EMDR groups,
at short term (1 RCT, n = 108, RR 0.94, 95% CI 0.69 to 1.30)
and at medium term (1 RCT, n = 108, RR 1.04, 95% CI 0.75 to
1.44). Analysis 3.4.
3.5 PTSD symptoms severity: 5. Recovery from PTSD:
Asymptomatic or few symptoms - CAPS total score < 20
Data showed equivocal results across groups, both at short term
(1 RCT, n = 108, RR 1.73, 95% CI 0.83 to 3.61) and at medium
term (1 RCT, n = 108, RR 1.82, 95% CI 0.83 to 3.97). Analysis
3.5.
Comparison 4: TF-CBT versus brief PTSD psychoeducation
One study compared TF-CBT with brief PTSD psychoeducation
(Mueser 2015). We report the analyses on available primary out-
comes below although meta-analyses were not possible. See also
Summary of findings 4.
4.1 PTSD symptoms severity: 1a. Clinician-rated severity -
average endpoint CAPS total score (high = poor)
Short-term unskewed data (1 RCT, n = 54, MD -1.45, 95% CI -
14.63 to 11.73) were equivocal across groups. The medium-term
unskewed data (1 RCT, n = 52, MD 0.23, 95% CI -14.66 to
15.12, low-quality evidence) Analysis 4.1.
4.2 PTSD symptoms severity: 1b. Clinician-rated severity -
average endpoint CAPS total score (high = poor) - skewed
data
Long-term skeweddata (1RCT, n= 48,MD-2.13, 95%CI -19.45
to 15.19) also showed no significant differences across groups.
Analysis 4.2.
4.3 PTSD symptoms severity: 2. Self-reported trauma-related
cognitions - average endpoint PTCI total score (high = poor)
Unskewed data across short term (1 RCT, n = 53, MD 1.64, 95%
CI -24.40 to 27.68), medium term (1 RCT, n = 51, MD 7.68,
95% CI -18.64 to 34.00) and long term (1 RCT, n = 49, MD
16.19, 95% CI -10.45 to 42.83) were equivocal across the two
treatment groups. Analysis 4.3.
4. 4 PTSD symptoms severity: 3. Remission from PTSD:
Symptoms below diagnostic threshold - CAPS total score <
40
The data showed no significant differences across groups at short-
term (1 RCT, n = 54, RR 1.04, 95% CI 0.47 to 2.30), at medium-
term (1 RCT, n = 52, RR 2.00, 95%CI 0.79 to 5.05), and at long-
term follow-up (1 RCT, n = 48, RR 1.14, 95% CI 0.49 to 2.65).
Analysis 4.4.
4.5 PTSD symptoms severity: 4. Remission from severe
PTSD: Loss of severe PTSD diagnosis - CAPS total scores <
65
The results were equivocal across the two treatment groups, at
short-term (1 RCT, n = 54, RR 1.21, 95% CI 0.64 to 2.26), at
medium-term (1 RCT, n = 52, RR 1.56, 95% CI 0.82 to 2.94),
and at long-term follow-up (1 RCT, n = 48, RR 1.30, 95% CI
0.71 to 2.37). Analysis 4.5.
4.6 Quality of life: 1. General quality of life - average
endpoint QoLI total score (high = good)
We found no significant differences between the two treatment
groups, at short term (1 RCT, n = 54, MD -0.58, 95% CI -1.35
to 0.19), at medium term (1 RCT, n = 52, MD -0.29, 95% CI -
1.03 to 0.45), and at long term (1 RCT, n = 49, MD 0.11, 95%
CI -0.74 to 0.96, low-quality evidence). Analysis 4.6.
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4.7 Quality of life: 2. Overall functioning - average endpoint
GAF total score (high = good)
No significant differences were found between groups based on
short-term data (1 RCT, n = 49, MD -0.86, 95% CI -6.48 to
4.76), medium-term data (1 RCT, n = 50, MD 0.60, 95% CI -
4.92 to 6.12); and long-term data (1 RCT, n = 48, MD 1.88, 95%
CI -4.93 to 8.69). All data reported were unskewed. See Analysis
4.7.
4.8 Quality of life: 3. Social functioning - average endpoint
CAPS social functioning subscale total score (high = poor) -
skewed data
We found no significant differences in this outcome across groups
(short term: 1 RCT, n = 54, MD -0.29, 95% CI -0.86 to 0.28;
medium term: 1 RCT, n = 52, MD -0.61, 95% CI -1.28 to 0.06;
long term: 1 RCT, n = 48, MD 0.19, 95% CI -0.46 to 0.84). Data
reported were skewed. Analysis 4.8.
Subgroup analyses
No subgroup analyses were conducted on the two pre-specified
factors (see Subgroup analysis and investigation of heterogeneity),
due to the following reasons.
1. Participants’ characteristic, i.e. by age - adults versus
adolescents
All included studies recruited adults aged 18 or above. No data
were available on adolescents.
2. Clinical characteristics, i.e. by types of trauma
Data on types of trauma experienced by study participants were
reported on sample and group levels, but not available on an indi-
vidual level, to allow for such a subgroup analysis. Furthermore,
in all four included studies, it was reported that participants with
co-morbid SMI and PTSD commonly experienced multiple trau-
mas, which were often a combination of childhood and adult trau-
matic events, with the nature of the trauma spanned across con-
ventional events (such as interpersonal violence) and SMI symp-
tom-related experience (e.g. persecutory delusion). These find-
ings raised queries over the feasibility and appropriateness of cat-
egorically delineating types of trauma experienced by individu-
als with such co-morbid conditions and complex presentations.
It also raised challenges in our attempt to estimate participants’
overall and specific responsiveness to trauma-focused psycholog-
ical treatment based on types of trauma experienced, even if the
individual-level data were available.
Sensitivity analysis
Apart from Comparison 1 (TF-CBT versus usual care/waiting
list), which included three studies, the other three comparisons
included only one study each which rendered sensitivity analysis
impossible.
Overall, all four studies included in the various analyses were of
good methodological quality (see Assessment of risk of bias in
included studies) and therefore even for Comparison 1, there was
no need to undertake a sensitivity analysis based on the following.
1. Implication of randomisation - all included studies were
clearly randomised controlled trials.
2. Assumptions for lost binary data - the quantity of
included study data lost to follow-up was small (i.e. no
studies reported over 50% of missing data).
3. Risk of bias - no included studies were judged to be of
high risk of bias.
4. Imputed values - we were provided with the raw data by
the trial authors of all four included studies, hence we had
not used imputed values for various analyses.
Lastly, regarding meta-analyses using fixed-effect and random-ef-
fects models - we had used primarily the random-effects model
for analyses when data from more than one study were included;
whereas the fixed-effectmodel was used in analyses when only data
from one study were included.
When preparing the ’Summary of findings’ tables summarising
the pre-specified outcomes together with their respective overall
rating of quality of evidence, we prioritised reporting the analyses
based on unskewed data (of continuous outcomemeasures). In the
absence of analyses based on unskewed data, we reported analyses
based on skewed data with the quality of evidence downgraded.
28Psychological interventions for post-traumatic stress disorder (PTSD) in people with severe mental illness (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Fo
 P
re
vie
w 
On
ly
A D D I T I O N A L S U M M A R Y O F F I N D I N G S [Explanation]
EM DR compared to wait ing list / usual care for PTSD and severe mental illness
Patient or population: Adults with co-morbid PTSD and SMI
Settings: Community
Intervention: EMDR
Comparison: Wait ing list
Outcomes Illustrative comparative risks* (95% CI) No of Participants
(studies)
Quality of the evidence
(GRADE)
Comments
Assumed risk Corresponding risk
Waiting list EM DR
PTSD symptom severity: 1.
Clinician- rated severity -
average endpoint CAPS to-
tal score (high = poor) -
M edium term - skewed data
The mean clinician-rated
PTSD symptom severity -
average endpoint caps to-
tal score (high = poor) -
medium term (7-9 months)
- skewed data in the inter-
vent ion groups was
12.31 lower
(22.72 to 1.90 lower)
83
(1 study)
⊕©©©
very low1,2,3
Only available data were
skewed.
Quality of life: 1. General
quality of life
- - - No data available.
Symptoms of co-morbid
psychosis: 1. Overall men-
tal state
- - - - No data available.
Anxiety symptoms - - - - No data available.
Depressive symptoms - - - - No data available.
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Adverse events - incidents
of unspecified severe ad-
verse events - medium term
Study population 102
(1 study)
⊕⊕©©
low3
85 per 1000 18 per 1000
(2 to 157)
M oderate
85 per 1000 18 per 1000
(2 to 157)
Health economics - - - - No data available.
* The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% conf idence interval) is
based on the assumed risk in the comparison group and the relative effect of the intervent ion (and its 95% CI).
CI: Conf idence interval.
GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our conf idence in the est imate of ef fect.
M oderate quality: Further research is likely to have an important impact on our conf idence in the est imate of ef fect and may change the est imate.
Low quality: Further research is very likely to have an important impact on our conf idence in the est imate of ef fect and is likely to change the est imate.
Very low quality: We are very uncertain about the est imate.
1 Only data available were skewed.
2 Continuous measure with a wide score range used which may not ref lect clinical signif icant change accurately.
3 Only one study provided data on this outcome.
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Individual TF-CBT compared to EM DR for PTSD and severe mental illness
Patient or population: Adults with co-morbid PTSD and SMI
Settings: Community
Intervention: TF-CBT
Comparison: EMDR
Outcomes Illustrative comparative risks* (95% CI) No of Participants
(studies)
Quality of the evidence
(GRADE)
Comments
Assumed risk Corresponding risk
EM DR TF-CBT
PTSD symptom severity: 1.
Clinician- rated severity -
average endpoint CAPS to-
tal score (high = poor) -
M edium term - skewed data
The mean clinician-rated
PTSD symptom severity -
average endpoint caps to-
tal score (high = poor) -
medium term (7-9 months)
- skewed data in the inter-
vent ion groups was
1.69 lower
(12.61 lower to 9.23 higher)
88
(1 study)
⊕©©©
very low1,2
Only data available were
skewed.
Quality of life: 1. General
quality of life
- - - - No data available.
Symptoms of co-morbid
psychosis: 1. Overall men-
tal state
- - - - No data available.
Anxiety symptoms - - - - No data available.
Depressive symptoms - - - - No data available.
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Adverse events - inci-
dents of unspecified severe
events - medium term
- - - - Secondary review out-
comes not analysed in this
comparison.
Health economics - - - - No data available.
* The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% conf idence interval) is
based on the assumed risk in the comparison group and the relative effect of the intervent ion (and its 95% CI).
CI: Conf idence interval.
GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our conf idence in the est imate of ef fect.
M oderate quality: Further research is likely to have an important impact on our conf idence in the est imate of ef fect and may change the est imate.
Low quality: Further research is very likely to have an important impact on our conf idence in the est imate of ef fect and is likely to change the est imate.
Very low quality: We are very uncertain about the est imate.
1 Only one study provided data which were skewed.
2 Continuous outcome measure with a wide score range was used, score changes may not ref lect meaningful clinical changes.
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Individual TF-CBT compared to Brief PTSD psychoeducation for PTSD and severe mental illness
Patient or population: Adults with co-morbid PTSD and SMI
Settings: Community
Intervention: Individual TF-CBT versus brief PTSD psychoeducat ion
Comparison: Brief PTSD psychoeducat ion
Outcomes Illustrative comparative risks* (95% CI) No of Participants
(studies)
Quality of the evidence
(GRADE)
Comments
Assumed risk Corresponding risk
Brief PTSD psychoeduca-
tion
Individual TF-CBT versus
brief PTSD psychoeduca-
tion
PTSD symptom severity:
1. Clinician- rated PTSD
severity - average endpoint
CAPS total score (high =
poor) - M edium term
The mean clinician-rated
PTSD symptom severity -
average endpoint caps to-
tal score (high = poor)
- medium term (10-12
months) - unskewed data in
the intervent ion groups was
0.23 higher
(14.66 lower to 15.12
higher)
52
(1 study)
⊕⊕©©
low1,2
Quality of life: 1. General
quality of life - average
endpoint QoLI total score
(high = good) - Long term
The mean quality of lif e:
(a) general quality of lif e -
average endpoint QoLI to-
tal score (high = good) -
long term (16-18 months) -
unskewed data in the inter-
vent ion groups was
0.11 higher
(0.74 lower to 0.96 higher)
49
(1 study)
⊕⊕©©
low1,2
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Symptoms of co-morbid
psychosis: 1. Overall men-
tal state
- - - - Secondary review out-
comes not analysed in this
comparison.
Anxiety symptoms - - - Secondary review out-
comes not analysed in this
comparison.
Depressive symptoms - - - Secondary review out-
comes not analysed in this
comparison.
Adverse events - incidents
of unspecified severe ad-
verse events
- - - - No data available.
Health economics - - - - No data available.
* The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% conf idence interval) is
based on the assumed risk in the comparison group and the relative effect of the intervent ion (and its 95% CI).
CI: Conf idence interval.
GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our conf idence in the est imate of ef fect.
M oderate quality: Further research is likely to have an important impact on our conf idence in the est imate of ef fect and may change the est imate.
Low quality: Further research is very likely to have an important impact on our conf idence in the est imate of ef fect and is likely to change the est imate.
Very low quality: We are very uncertain about the est imate.
1 Only data f rom one study with small subgroup sample available.
2 Continuous measure used which may not ref lect clinical signif icant change accurately.
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D I S C U S S I O N
Four randomised controlled trials (RCTs) involving 300 partic-
ipants were included in this review to investigate the effective-
ness of trauma-focused psychological therapies for individualswith
both severe mental illness (SMI) and post-traumatic stress disor-
der (PTSD). We conducted four comparisons to assess the effec-
tiveness of three specific modalities of PTSD psychological inter-
ventions, namely: trauma-focused cognitive behavioural therapy
(TF-CBT) (including prolonged exposure); eye movement desen-
sitisation and reprocessing (EMDR); and brief PTSD psychoedu-
cation. We have created a “Summary of Findings” table for each of
the comparisons (Summary of findings for the main comparison;
Summary of findings 2; Summary of findings 3; Summary of
findings 4) and the main results are discussed below.
Summary of main results
Trauma-focused cognitive behavioural therapy (TF-CBT)
We included four studies (Mueser 2008;Mueser 2015; Steel 2010;
van den Berg 2015) reporting on three specific TF-CBT pro-
grammes in this review. The three TF-CBT programmes ranged
from a ’prolonged exposure’ intervention delivered over eight ses-
sions within a 10-week duration (van den Berg 2015), a 12-to
16-week CBT programme emphasising on cognitive restructur-
ing (Mueser 2015), and a similar 12- to 16-week CBT for PTSD
programme with the initial few sessions focusing on psychoeduca-
tion and breathing retraining (Mueser 2008 and Steel 2010 whose
study adopted the Mueser 2008 CBT treatment manual).
Three studies provided data for comparing individual TF-CBT
against non-active control condition, i.e. usual care or waiting-
list control (Mueser 2008; Steel 2010; van den Berg 2015). Some
continuous outcome data were found to be skewed, and hence
meta-analyses groupingunskewed and skeweddata separatelywere
conducted on continuous outcome measures whenever both types
of data were present. In terms of clinician-rated PTSD symptom
severity as measured by Clinician Administered PTSD Symptom
Scale (CAPS) total score, only one study including 13 individ-
uals with co-morbid PTSD and SMI ( Mueser 2008) reported
short-term unskewed data, and these limited results were equiv-
ocal across the two groups. Further available data from the other
two studies were skewed, but also showed no effect between treat-
ment groups at either short or medium term. Data on self-re-
ported PTSD symptom severity as measured by Posttraumatic
Cognitions Inventory (PTCI) total scores were unskewed: short-
term andmedium-term outcomes were equivocal across groups al-
though follow-up data at medium term from three studies showed
a favourable effect for TF-CBT. Meta-analyses pooling binary data
from two included studies (Mueser 2008; van den Berg 2015) that
reported the number of participants scoring below 40 on CAPS,
provided some preliminary and low-quality evidence (2 RCTs, n
= 113) that TF-CBT is more effective than usual care/waiting list
in reducing participants’ PTSD symptoms to the sub-threshold
level leading to remission from PTSD (or loss of PTSD diagnosis)
in both short and medium terms. Only one study (van den Berg
2015), reported full recovery from PTSD using a CAPS cut-off
score of < 20, and there was some limited and very low-quality ev-
idence favouring TF-CBT in promoting full recovery from PTSD
at medium term (1 RCT, n = 100). Only one study provided data
for the remaining primary outcomes focusing on quality of life,
and secondary outcomes, hence meta-analysis was not possible.
In terms of secondary outcomes, it was not clear from the avail-
able data if TF-CBT had any advantages than waiting list or usual
care, over a range of general psychiatric symptoms, specific psy-
chotic symptoms, affect or anxiety manifestation. Only one study
(van den Berg 2015) reported incidents of unspecified severe ad-
verse events; no significant differences were found between TF-
CBT and waiting-list groups. In terms of tolerability of interven-
tions, overall loss to follow-up was equivocal across TF-CBT and
usual care/waiting-list groups, as shown by low-quality evidence
(3 RCTs, n = 178) throughout the short- to medium-term follow-
up.
Only one study compared prolonged exposure therapy against
EMDR with 108 individuals with a chronic psychotic disorder
and PTSD (van den Berg 2015). Whilst it was not possible to un-
dertake meta-analyses, the study data indicated that outcomes of
patients receiving TF-CBT or EMDR did not differ significantly
across a range of outcomes focusing on PTSD symptoms.
Another study compared TF-CBT against brief PTSD psychoed-
ucation (Mueser 2015). The results showed no significant differ-
ences between the two PTSD psychological therapies in terms of
their impacts on patients’ PTSD symptoms severity, quality of life
and related functioning.
Eye movement desensitisation and reprocessing (EMDR)
We identified one study that compared EMDR against a wait-
ing list as well as against TF-CBT (van den Berg 2015). Meta-
analyses were not feasible. Comparing EMDR with waiting list (1
RCT, n = 83), there was some very low-quality evidence indicating
that EMDR was much more effective in reducing PTSD symp-
toms whether they were measured with clinician-rated tools or
self-reported cognitions and frequency assessment (of note, con-
tinuous outcome data available were skewed). A statistically sig-
nificant higher number of participants receiving EMDR achieved
remission from PTSD (i.e. loss of PTSD diagnosis as defined by
a CAPS total score < 40) at short and medium term, respectively,
although there was no significant differences in terms of numbers
of participants achieving full recovery from PTSD (i.e. CAPS <
20) across EMDR and waiting list. The remaining data indicated
equivocal results across EMDR and waiting-list groups in terms
of loss to follow-up and unspecified severe adverse events.
The same study also compared EMDR with TF-CBT (van den
Berg 2015) and its results suggested both interventionswere equiv-
35Psychological interventions for post-traumatic stress disorder (PTSD) in people with severe mental illness (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Fo
r P
r
vie
w 
O
ly
ocal in their effectiveness in reducing PTSD symptom severity, as
aforementioned. No data were available on other outcomes.
Brief PTSD Psychoeducation
A three-session PTSD psychoeducation programme (Pratt 2005)
was identified as an alternative modality of trauma-focused psy-
chological intervention by this review. Only one trial (1 RCT, n =
67) compared TF-CBT head to head with brief PTSD psychoe-
ducation as an active control (Mueser 2015). There was no clear
evidence that brief PTSD psychoeducation was either better or
worse than TF-CBT across a range of PTSD symptom severity
and quality of life outcomes.
Overall completeness and applicability of
evidence
Completeness
Our search identified 35 unique titles and abstracts initially. We
inspected all of them and contacted a number of authors known to
have conducted trials in this field for further unpublished and/or
ongoing study data. We also consulted a number of trial authors
to establish if their studies targeted people with PTSD or not as
sometimes the PTSD diagnostic thresholds used were not clearly
described. Many studies implied specially developed psychologi-
cal therapies focusing on trauma and/or trauma-related experience
and sequelae in association with psychotic illness experience and/
or other life events (e.g. Jackson 2006; NCT00307216) without
establishing if the participants met the diagnostic threshold for
PTSD or not. With assistance from the trial authors who provided
uswith unpublished and/or psychosis data, wewere able to include
four studies investigating the effects of trauma-focused psycholog-
ical therapies for people with co-morbid psychosis and PTSD -
one newly published online in the beginning of 2015 (van den
Berg 2015); one unpublished (Steel 2010); and two studies which
originally reported data of participants with psychosis together
with others diagnosed with non-psychotic disorder as their pri-
mary diagnosis (Mueser 2008; Mueser 2015). Nonetheless, these
translate into three studies which were included in the comparison
of TF-CBT with usual care/waiting list; and only one study for
each of the other comparisons: EMDR with waiting list; TF-CBT
with EMDR; and TF-CBT with psychoeducation.
Our pre-specified review primary outcome focusing on PTSD
symptoms (severity) was reported by the four included studies us-
ing well-established PTSD symptom severity measures, such as
CAPS (Blake 1995) and PTCI (Foa 1999). However, we detected
skewness inmany outcome data reported by continuous measures,
which limited the scope of analyses. To avoid the pitfall of apply-
ing parametric tests to non-parametric data, we performed anal-
yses grouping the unskewed and skewed data separately and re-
ported these analyses accordingly. We reported the analyses based
on unskewed data primarily in the ’Summary of findings’ tables,
but in the event of no such analyses were available, we reported
the analyses drawing on skewed data and downgraded the evi-
dence. When the data were reported as binary outcomes (such as
remission or recovery from PTSD as defined by various cut-off of
CAPS scores), we reported the risk ratios. The other primary out-
come focusing on quality of life/well-being had relatively much
less data available; and often limited data from solely one study
rendered meta-analysis impossible. This problem also applied to
the secondary outcomes including psychotic symptoms and other
common concurrent symptoms such as depression and anxiety,
whereas continuous outcome data (and often skewed) from one
study only were available, limiting the scope and extent of anal-
yses. Unfortunately, there was a distinct lack of data on health
economic outcomes.
Lastly, as this review includes a couple of newly emerging trials
(Steel 2010; van den Berg 2015), we expect further follow-up data
will become available in due course.
Inclusion of trials for this systematic review entailed that study par-
ticipants reach diagnostic thresholds for both SMI and for PTSD,
however it is likely that many of those with SMI have troublesome
symptoms relating to trauma without reaching the threshold for
a PTSD diagnosis. The automatic exclusion of studies evaluating
the effectiveness of psychological interventions for this population
is a limitation of this current review. Another possible limitation is
that only trauma-focused therapies were evaluated. It is theoreti-
cally possible that other psychological therapies have some efficacy
for post-traumatic symptoms even if not specified as such.
Applicability
This review identified four RCTs investigating the effectiveness,
acceptability and safety of PTSD psychological treatment, in par-
ticular TF-CBT and EMDR, for individuals with co-morbid SMI
and PTSD, a population commonly excluded from studies focus-
ing on the general population with PTSD (Bisson 2013;Morrison
2003; NICE 2014). The average profile of the study participants
reflects the complexity (such as multiple trauma ranging from
childhood to adulthood traumatic experiences) and history of
long-standing illness-presentation (such as a life-long diagnosis
of psychotic disorder in van den Berg 2015 and severe PTSD in
Mueser 2015) of the co-morbid population. All the included stud-
ies recruited participants from the community care settings target-
ing those receiving routine mental health service, with the PTSD
psychological therapies delivered in an outpatient clinic setting.
These review findings suggest that individual TF-CBT including
prolonged exposure and EMDR, can potentially be a feasible and
safe evidence-based treatment for the co-morbid group, as for the
general population as recommended by several systematic reviews
and treatment guidelines (ACPMH 2013; Bisson 2013; NICE
2005; NICE 2013).
There are only data from one study for comparing EMDR with
waiting list and the head-to-head comparisons of trauma-focused
36Psychological interventions for post-traumatic stress disorder (PTSD) in people with severe mental illness (Review)
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therapies. This has precludedmeta-analyses. While results showed
that EMDR was superior than waiting list in reducing PTSD
symptom severity, the analyses of the primary outcomes were
largely equivocal across TF-CBT versus EMDR, and, TF-CBT
versus brief psychoeducation. These analyses with limited data
should be interpreted with caution, preliminary evidence of com-
parative effectiveness of TF-CBT, EMDR and brief psychoeduca-
tion is still outstanding.
Meanwhile, we identified further factors whichmay affect the gen-
eralisability of the preliminary findings to routine clinical settings.
All included studies reported provision of training and ongoing
supervision for therapists who were highly skilled in delivering
the treatment manuals with specific considerations to the partici-
pants’ complex presentations. Examples included an initial phase
of breathing retraining and psychoeducation in the studies con-
ducted in the USA and the UK (Mueser 2008; Mueser 2015; Steel
2010), and assessment for treatment adherence to the protocol
(Mueser 2015; van den Berg 2015). In addition, all participants
who received an intervention also received usual care, which fre-
quently included receipt of multiple services (such as community
outreach services, case/care management, psychiatric out-patient
follow-up and medication treatment), and so it is not possible to
determine from this review the effectiveness of trauma-focused
psychological interventions for this co-morbid patient group, in
the absence of support from a multi-disciplinary mental health
service. All the included studies were conducted in the USA and
Europe, therefore the results may have limited generalisability to
the countries where the systems for delivering mental health care
are substantially different.
Quality of the evidence
Apart from Comparison 1 (comparing TF-CBT with usual care/
waiting list) which included three studies, the other three com-
parisons included only one study respectively, rendering limited
data available and precluding meta-analysis of a number of out-
comes. Analyses, with data from a small number of studies and/
or participants, should be interpreted with caution, as quite likely,
such results are under-powered. Also, it is worth noting that con-
tinuous outcome measures were used to report a good proportion
of outcomes which may make interpretation of the differences in
score points into clinically meaningful or significant changes diffi-
cult (e.g. mean difference between groups, or differences of scores
across time points versus recovery). Furthermore,much of the con-
tinuous data available for the analyses were found to be skewed,
with the study sample size relatively small (n < 200) (Moore 2010),
further limiting the scope and extent of analyses on outcomes even
when data frommore than one study were available.We had taken
the approach to pooling skewed and unskewed continuous data
separately into meta-analyses, reporting the analysis results sepa-
rately and prioritising those based on unskewed data. However, in
doing so to avoid the pitfall in combining parametric and non-
parametric data together and applying parametric tests on such
data, we might have further diffused the already relatively limited
data. Hence, the quality of evidence was often rated as low; and on
occasions where only analyses based on skewed data were reported
in the ’Summary of findings’ tables, we had further downgraded
the quality of evidence. In view of these problems with the data
available, we suggest further updated reviews may consider priori-
tising the reporting of binary outcomes, such as remission from
PTSD.
Potential biases in the review process
We believe the process of searching for studies was thorough. We
followed the review protocol strictly in the process of selecting
studies for inclusion, data extraction and analysis. In addition, we
also contacted a number of trial authors to seek unpublished and
subgroup data specific to patients with co-morbid psychosis and
PTSD. We were pleased to have received assistance from many
authors who provided further data and clarification on their study
design, outcome data and treatment content. Despite the small
number of trials included in this review, we were pleased to have
been able to include some newly emerging studies. We fully ac-
knowledge the potential conflict of interests which might arise as
one of our review authors (JS) was a trial therapist in one of the
included trials (Steel 2010); we took steps throughout the review
process to remove JS from the screening of search results, data
extraction, ’Risk of bias’ assessment and data input procedures in-
volving this study.
Agreements and disagreements with other
studies or reviews
NICE published a systematic review on the effectiveness of psy-
chological interventions for trauma in people with psychosis, in-
tegral to its guideline recommendations on treatment provision
for psychosis and schizophrenia (NICE 2014). Only one study
was included in the NICE review whose search was undertaken
in June 2013: Jackson 2006 devised a specific form of cognitive
therapy called “cognitive recovery therapy” and investigated its ef-
fectiveness in reducing post-psychotic trauma symptoms, with the
primary outcomes of treatment identified as trauma symptoms,
depression, and self-esteem. We had to exclude this study from
our review as no PTSD diagnostic threshold was applied to the
participants although some might have reached such a threshold
if assessed. No other systematic reviews focusing on trauma-fo-
cused psychological interventions for the co-morbid population
were identified.
Overall, this review identified some limited preliminary, albeit
low-quality, evidence that supports the safety and feasibility of TF-
CBT for treating PTSD in individuals with psychosis. Existing sys-
tematic reviews on psychological therapies for PTSD (e.g. Bisson
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2013; Bradley 2005) and current clinical practice guidelines rec-
ommend TF-CBT (including exposure therapy) as an evidence-
based treatment for PTSD (ACPMH 2013; NICE 2005; NICE
2013). However, there is insufficient high-quality evidence to de-
termine the effectiveness of TF-CBT for people with co-morbid
SMI and PTSD. This review also identified the first study which
investigated the effectiveness and safety of EMDR for the co-mor-
bid population (van den Berg 2015). EMDR was found to be
more beneficial than usual care/waiting list and equivocal to TF-
CBT for individuals with PTSD and psychosis, whilst there were
no significant differences reported in adverse events, dropout or
loss to follow-up. The findings of this study suggest that EMDR
could potentially be applicable and feasible for people with SMI.
Finally, this review also compared brief PTSD psychoeducation
with TF-CBTusing psychosis data fromone study (Mueser 2015),
although PTSD psychoeducation is not commonly recommended
for PTSD in the general population.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
For people with co-morbid psychosis and post-traumatic
stress disorder (PTSD)
Existing reviews support the effectiveness of trauma-focused cog-
nitive behavioural therapy (TF-CBT) and eye movement desensi-
tisation and reprocessing (EMDR) for PTSD in the general popu-
lation. TF-CBT and EMDRmay bemore effective than usual care
in promoting recovery from PTSD in the medium term; however
the evidence for this is drawn from one or two trials in which all
participants also received support from multi-disciplinary mental
health services rather than trauma-focused psychological interven-
tions (TFPIs) alone. Due to the limited data available from the few
studies carried out to date, the review findings on TF-CBT and
EMDR, in terms of their effect on PTSD symptoms, psychotic
and other mood and anxiety symptoms remain inconclusive. Ev-
idence-based and availability of TFPIs should be made known to
the service users who should be supported to consider and access
treatment.
For clinicians
Clinicians should be alerted to the potentially increased risk of
co-morbidity of PTSD and SMI. Increased knowledge in work-
ing with the co-morbid illnesses should enhance clinicians’ un-
derstanding of the often complex presentations of symptoms and
needs of service users. This increased awareness may optimise the
timely and early assessment of PTSD among people with psy-
chosis. This review has provided some preliminary and limited
evidence for the feasibility and safety of TF-CBT and EMDR for
individuals with SMI and PTSD, although its effectiveness on
improving PTSD, psychotic and other symptoms remain unclear.
Clinicians should consider these treatments for mental health ser-
vice users on an individual basis, as an adjunct to support from a
multi-disciplinary mental health service.
For policy makers
Although this review provides some preliminary albeit low-qual-
ity evidence on the feasibility and safety of TF-CBT and EMDR,
targeting service users with SMI and PTSD, the results of treat-
ment effect on PTSD, psychotic and other symptoms are largely
equivocal. Due to a small number of studies of the effects of TF-
PIs for this co-morbid population, there were limited data, often
from only one study, available for the outcomes under investiga-
tion for each modality of therapy. Meta-analysis was precluded
on many outcomes, and the few analyses undertaken likely lack
power. Given that people with SMI require support from multi-
disciplinary mental health services, it would be unwise to rely
upon evidence from existing reviews of TF-CBT for the general
population to guide treatment of people with co-morbid SMI and
PTSD. Thus more research is needed of the effectiveness of TFPIs
for people with SMI and PTSD to establish the clinical and cost-
effectiveness of the intervention with this co-morbid client group.
Implications for research
In general, this review shows that there is a lack of studies explor-
ing PTSD psychological treatment for people with SMI, contrary
to their increased vulnerability to developing PTSD and the im-
plications of untreated PTSD in their general prognosis. Despite
the small number of trials included in this review, we were pleased
to have been able to include three emerging trials (Mueser 2015;
Steel 2010; van den Berg 2015), which reflect a significant increase
of research and clinical interests in this subject over the recent
years. The preliminary findings from the few pioneering trials,
need support from further studies including sample sizes powered
to detect clinically significant changes in PTSD symptoms and
quality of life/well-being in individuals with SMI and PTSD. We
expect to see further long-term follow-up data from the included
studies alongside other new studies in the coming years which will
help expand the evidence base of TFPIs for the co-morbid pop-
ulations. In addition to extending the follow -p duration to pro-
vide data on long-term effects of treatments, future studies should
also strive to explore health economic outcomes to inform cost-
effectiveness of treatment and policy development. As most of the
included studies focused on people with long-standing psychotic
disorders and chronic and/or severe PTSD (e.g. onset of PTSD =
17 years in van den Berg 2015; the average age of participants was
mid-40s in Mueser 2008, Mueser 2015, and van den Berg 2015),
such patient profiles raise some suggestions for future research.
More research efforts focusing on younger people with early-onset
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psychosis and/or more timely-diagnosed PTSD are needed. It is
pertinent to investigate whether the treatment effects identified
by this review (when the interventions were applied to a sample
with relatively chronic illnesses) will fare equally well for those
who have a more recent onset of psychosis and/or PTSD. It is also
worthwhile to investigate if the interventions apply effectively in
those with SMI and trauma symptoms which may not necessarily
meet the diagnostic threshold of PTSD.
While there remains much need for further studies to explore dif-
ferent modalities of PTSD treatment and the optimal adaptation
of well-established therapies to suit the complex needs of individ-
uals with SMI, more comparison studies of one type of psycho-
logical therapy against another will also enhance our understand-
ing of comparative effectiveness of different treatments so to pro-
mote treatment options and choices for service users and clinicians
(NICE 2011; Roth 2005). Future research should also focus on
establishing effective training of therapists using various treatment
protocols and large-scale implementation of the evidence-based
psychological treatment of PTSD for people with SMI, in order
to widen provision of treatment.
We suggest an outline design for future trials in Table 1.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Mueser 2008
Methods Allocation: randomised, using a computer-based randomisation programme
Blindness: single-blind (assessor blind).
Duration: 4 to 6 months.
Setting: community (New Hampshire and Vermont, USA).
Participants Diagnosis: schizophrenia or schizoaffective disorder (DSM-IV) and co-morbid or current
PTSD (assessed with SCID-I for DSM-IV). In addition, PTSD diagnoses and symptom
severity based on CAPS ( at least CAPS minimum total score of 65)
N = 108*.
Age: 25 - 57 years (mean ~ 43.47 years, SD 9.07 years)
Sex: 23 M, 85F *
Excluded: people with recent psychiatric hospitalisation or suicidal attempt within the
past three months; and current DSM-IV diagnosis of substance dependence
Interventions 1. CBT for PTSD programme + TAU: CBT programme: 12 to 16 sessions following
a structured format inclusive of handouts, worksheets, and homework assignments.
Sessions cover: treatment overview, psychoeducation, breathing retraining and cognitive
restructuring as from the sixth sessions. Programme design based on an earlier pilot study
focusing on CBT treatment of the co-morbid population (Rosenberg 2004).Treatment
exposure was defined a priori as completion of at least six sessions including a minimum
of three sessions of cognitive restructuring.N =54 (n = 10with PTSD and schizophrenia/
schizoaffective disorder)*
2. TAU: usual comprehensive treatment the participants had been receiving for their
mental illness, based at local community mental health centre prior to their enrolment in
the trial. TAU usually included pharmacological treatment and monitoring, case man-
agement, supportive counselling, and access to psychiatric rehabilitation programmes
such as vocational rehabilitation
N = 54 (n = 7 with PTSD and schizophrenia /schizoaffective disorder)*
Outcomes PTSD symptom severity: clinician-rated severity (CAPS), self-reported trauma-related
cognition (PTCI), remission from PTSD (CAPS)
Quality of life: self-reported mental health functioning (SF-12), self-reported physical
functioning (SF-12)
Symptoms of co-morbid psychosis: overall mental state (BPRS)
Depressive symptoms (BDI-II)
Anxiety symptoms (BAI)
Leaving the study early
Unable to use -
Understanding of PTSD: assessed with PKT (outcome not specified in the review pro-
tocol)
Therapeutic alliance between patient and case manager: rated with client version of WAI
(outcome not specified in the review protocol)
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Mueser 2008 (Continued)
Notes * We only used data from the 17 participants (5M, 12F) with co-morbid PTSD and
schizophrenia/schizoaffective disorder. Other participants were diagnosed with concur-
rent PTSD and a severe mental illness (major depression, bipolar disorder, schizophrenia
or schizoaffective disorder) and persistent impairment in the areas of work, school or
ability to care for oneself
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Randomisation method clearly stated, i.
e. computer-based randomisation pro-
grammewhich stratified the randomisation
by four recruitment sites and three board
diagnostic groups. In addition, to balance
the number of participants randomised to
the two treatment arms, randomisationwas
conducted in blocks of four within each of
the 12 strata
Allocation concealment (selection bias) Low risk All research staff and therapists provid-
ing the CBT programme were unaware of
assignments in advance; participants in-
formed of allocation by the project co-or-
dinator
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Given the study design, both therapists and
participants could not be blinded to the
treatment allocation
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Blinded assessors, who had no involvement
and knowledge of participants’ allocation,
were used to collect participants’ outcomes
at all time points. Regardless of their treat-
ment allocation, all participants provided
with follow-up appointments according to
the CBT treatment schedule
Incomplete outcome data (attrition bias)
All outcomes
Low risk No incomplete data.
Selective reporting (reporting bias) Low risk All outcomes, as stated in the protocol and
the papers, were consistently reported
Other bias Low risk None noted. Treatment fidelity of the CBT
programme was monitored with 15% of
all sessions randomly selected for fidelity
monitoring
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Mueser 2015
Methods Allocation: randomised, using a computer programme
Blindness: single-blind, using independent interviewers masked to treatment assignment
Duration: 12 to 16 week CBT programme, with + 6 and 12 month-follow-up
Setting: community (in states of New Jersey, USA)
Participants Diagnosis: schizophrenia or schizoaffective disorder (DSM-IV), and current severe PTSD
(CAPS minimum total score of 65)
N = 201*
Age: mean ~ 43.7 years, (SD 11 years)*
Sex: 63 M 138 F (26 M; 41 F)*
Excluded: patients with recent psychiatric hospitalisation or suicidal attempt or substance
dependence within the past three months
Interventions 1. CBT for PTSD programme + TAU: 12 to 16 sessions individual CBT programme spe-
cially designed and adapted to accommodate the unique challenges of people with SMI,
such as psychotic symptoms, cognitive impairment and high levels of stress vulnerability
(Mueser 2008; Mueser 2009). The CBT programme included three sessions teaching
breathing retraining for anxiety and education about trauma and PTSD, followed by
nine to 13 sessions of cognitive restructuring. Treatment exposure was a priori defined as
completion of at least six sessions. TAU included usual pharmacological treatment, case
management and access to a range of available services within the participants’ treatment
setting such as individual psychotherapy and vocational rehabilitation excluding inter-
vention specifically targeting PTSD. N = 104 (n = 32 with PTSD and schizophrenia or
schizoaffective disorder)*
2. Brief PTSD psychoeducation programme + TAU: A three-session brief treatment
programme for PTSD adapted from an earlier PTSD-psychoeducation programme de-
veloped by the trial team (Pratt 2005). This brief programme was designed to provide
the same breathing retraining and education components as the CBT programme, using
the same handouts and worksheets and a video to initiate discussion between the patient
and therapist about the causes and nature of PTSD. There was no content on cognitive
restructuring in the three-session programme. Treatment exposure was defined a priori
as completion of at least two sessions. TAU is same as aforementioned. N = 97 (n = 35
with PTSD and schizophrenia or schizoaffective disorder)*
Outcomes PTSD symptom severity: clinician-rated severity (CAPS), remission fromPTSD (CAPS)
, self-reported trauma-related cognition (PTCI)
Quality of life: overall quality of life (QOLI), overall functioning (GAF), social func-
tioning (CAPS-social functioning)
Unable to use -
Understanding of PTSD: assessed with average endpoint score of PKT (outcome not
specified in the review protocol)
Leaving the study early: no data available for the psychosis-specific sample
Notes *We could only use data from 67 participants (mean age ~ 43.4 years, SD 12 years) (26
M, 41 F) with co-morbid PTSD and schizophrenia or schizoaffective disorder out of
a total of 201 participants. Other participants were diagnosed with concurrent PTSD
and a severe mental illness as defined by the State of New Jersey, USA (i.e. DSM-IV
diagnosis of major depression, bipolar disorder, schizophrenia or schizoaffective disorder
and significant functional limitations in major life activities within the past three to six
47Psychological interventions for post-traumatic stress disorder (PTSD) in people with severe mental illness (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Fo
r P
r
vi
w 
On
ly
Mueser 2015 (Continued)
months because of the mental disorder and had been receiving supportive services for
more than two years)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Randomisation method was clearly stated,
i.e. operated by a computer randomisa-
tion programme operated by an off-site
datamanager which stratified the randomi-
sation by five recruitment sites and three
board diagnostic groups
Allocation concealment (selection bias) Low risk All research staff and therapists providing
treatments were not involved in the alloca-
tion and had no prior knowledge of treat-
ment allocation
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Both therapists and participants could not
be blinded to the treatment allocation given
the design of the study
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Blinded interviewers who were masked to
treatment allocation were used to collect
participants’ outcomes at all time points.
Regardless of their treatment allocation, all
participants were provided with follow-up
appointments according to the CBT treat-
ment schedule
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk The study stated using an ITT analysis and
a flow chart is provided to outline the sam-
pling frame as well as study participants’
progress through the study; however, num-
bers used at post-treatment analysis seem
to be inconsistent with the number of par-
ticipants having been exposed to the treat-
ment conditions. Also a small number of
participants appeared to be un-accounted
for (i.e. one in the brief PTSD arm; 3 in
CBT arm)
Selective reporting (reporting bias) Low risk All outcomes as stated in the protocol and
the papers were consistently reported
Other bias Low risk Clinical training and treatment adherence
monitoring were reported with 5% to 10%
of all sessions were rated for adherence in
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Mueser 2015 (Continued)
addition to weekly group supervision for
trial therapists
Steel 2010
Methods Allocation: randomised, undertaken via MHRN database
Blindness: single-blind (assessor blind)
Duration: 6 months (16 sessions of CBT for PTSD) with a + 6 month-follow-up
Setting: community (South East of England)
Participants Diagnosis: DSM-IV diagnosis of schizophrenia or schizoaffective disorder and current
DSM-IV diagnosis of PTSD
N = 61 (no baseline demographic data were made available for this review)
Excluded: patients with organic disorder, unable to read and write in English, or learning
disability
Interventions 1. CBT for PTSD programme + Standard Care: 16 session trauma focused CBT inter-
vention specifically designed and developed for people with psychosis by Mueser 2008
(see above for further details on treatment protocol). N = 30
2. TAU: standard psychiatric care in the UK is based on the care programme approach
to case management and typically includes antipsychotic medication, outpatient and
community follow-up, and access to community rehabilitative activities such as day
centres and drop-ins. N = 31
Outcomes PTSD symptom severity: clinician-rated severity (CAPS), self-reported trauma-related
cognition (PTCI)
Quality of life: general quality of life (QLS), overall functioning (GAF)
Symptomsof co-morbid psychosis: overallmental state (PANSS-total), positive andnega-
tive symptoms (PANSS-positive, PANSS-negative subscales), hallucinations (PSYRATS-
hallucination) delusions (PSRATS-delusion)
Depressive symptoms: (BDI-II)
Anxiety symptoms: (BAI)
Leaving the study early
Unable to use -
Acceptability of the intervention: was assessed through a service-user led interview which
appeared to be non-quantitative data. Not made available for this review
Notes Review author JS was therapist in this trial, therefore, was not involved in the data
extraction and assessment of risk of bias of this trial. At the time of writing this review,
this trial has not been published, after contacting the lead author of the trial, we used
unpublished data provided by the trialists for this review’s analyses
Risk of bias
Bias Authors’ judgement Support for judgement
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Steel 2010 (Continued)
Random sequence generation (selection
bias)
Unclear risk Randomisation undertaken via MHRN
database, but further detail such as how
allocation was generated (e.g. equal sized
strata, or permuted block) were not pro-
vided
Allocation concealment (selection bias) Unclear risk Insufficient detail provided.
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Due to the design of the study, both the
participants and the treatment therapists
were unable to be blinded. It was unclear
if blinded and independent assessors were
used for all data collection
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk A proportion of assessments were under-
taken unblinded, but detail of such un-
blinding incidents (e.g. reasons leading to
unblinding, time points at which these
occurred, the number of participants af-
fected) and specific measures for managing
unblinding, if any were applied, was not re-
ported
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk According to theCONSORTdiagram, not
all participants allocated to CBT arm re-
ceived the same number of treatment ses-
sions. Although an ITT analysis was used,
the data in Table 1 of their paper are diffi-
cult to disentangle
Selective reporting (reporting bias) Unclear risk As yet the data have not been published
openly, data reported on this study were
provided by the trialists for the current re-
view ahead of publication. Therefore, cur-
rently, it is not possible to judge the risk of
selective reporting bias
Other bias Unclear risk Although we were provided with unpub-
lished data for the purpose of this review,
detail required to estimate the risk of bias,
such as with regards to sequence genera-
tion, unblinding protocol, and fidelity fac-
tors regarding intervention, have not been
provided. Therefore the estimation of risk
of other bias at this time is difficult to assess
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van den Berg 2015
Methods Allocation: randomised, stratified randomisation blocks.
Blindness: single-blind (assessor blind)
Duration: 10 weeks (eight sessions of prolonged exposure (PE) or EMDR therapy) with
a + 6 month-follow-up
Setting: out-patient services in the Netherlands
Participants Diagnosis: a lifetime diagnosis of a psychotic disorder or mood disorder with psychotic
features according to the Mini-International Neuropsychiatric Interview-Plus (Sheehan
1997; Sheehan 1998), and DSM-IV-tr diagnosis (APA, 2000) of chronic PTSD as
assessed with CAPS (Blake 1995)
N = 155
Age: mean ~ 41.2 years, SD 10.5 years
Sex: 71 M, 84 F
History: duration of psychosis: mean ~ 17.7 years (SD 11.8 years), duration of PTSD:
mean ~ 21.0 years (SD 13.5 years)
Excluded: patients with an extremely high acute suicide risk, or who had changes in
antipsychotic or antidepressant medication regimen within two months before the as-
sessments, or with insufficient competence in the Dutch language; or with intellectual
impairment (as defined as an estimated IQ of 70 or less; or not being able to travel to
the outpatient service (including current involuntary hospitalisation)
Interventions 1. Prolonged exposure (PE) + TAU*: eight weekly 90-minute sessions offered within
a 10-week period. The PE intervention comprised development of a case formulation
including a hierarchy of former experiences, and then use of imaginal exposure, audio
recordings of sessions were made and listened to for homework, in vivo exposure was
also included. N = 53
2. EMDR + TAU*: eight weekly 90-minute sessions (offered within a 10-week period);
the standard eight phase protocol was used after being translated into Dutch (de Jongh
2003). N = 55
3. Waiting-list control + TAU*: in addition to usual care, participants were seen at the
outset following randomisation and then approximately six months later at which time
they could choose their treatment of choice. N = 47
Outcomes PTSD symptom severity: clinician-rated severity (CAPS), remission and recovery
from PTSD (CAPS), self-reported frequency PTSD symptoms (PSS-SR), self-reported
trauma-related cognition (PTCI)
Adverse events: number of severe adverse events
Leaving the study early
Notes *Treatment as usual comprised typically care provided by multidisciplinary assertive
outreach teams, usually consisting of antipsychotic medication and treatment and/or
non-trauma focused supportive counselling
Risk of bias
Bias Authors’ judgement Support for judgement
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van den Berg 2015 (Continued)
Random sequence generation (selection
bias)
Low risk Sequence generation was undertaken by an
independent randomisation bureau, using
stratified randomisation blocks with equal
strata sizes
Allocation concealment (selection bias) Low risk Treatment allocation was conducted by the
independent bureau
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Single-blind given the study design that
both participants and therapists were not
able to be blinded to treatment they re-
ceived or delivered
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Outcome assessments were undertaken by
independent assessors who were blind to
treatment allocation; trial authors reported
a small proportion of assessments were un-
blinded (27 occasions), however, measures
by means of implementing a further in-
dependent assessor were implemented that
minimised detection bias
Incomplete outcome data (attrition bias)
All outcomes
Low risk The study used an ITT analysis and a flow
chart is provided to outline the sampling
frame as well as the reasons for excluding
participants and a clear description of par-
ticipants’ journey through the study
Selective reporting (reporting bias) Unclear risk Only some selected outcome data focusing
onPTSDdiagnosis, PTSDsymptom sever-
ity and self-report of PTSD symptoms and
trauma-related cognition were reported in
the main paper (albeit they are the study
primary outcomes); many other outcomes
as stated in the protocol (such as paranoid
thinking, verbal hallucinations, delusions,
depression, social functioning, and cost-ef-
fectiveness data) which are reported as sec-
ondary, tertiary and quaternary objectives
of the trial, were not reported. We under-
stand other publications reporting on these
other outcomes and further follow-up data,
are planned. Nonetheless, we have to rate
the reporting bias, as best, unclear
Other bias Low risk None noted; treatment therapist training
and fidelity monitoring are reported with
10% of all treatment sessions which were
videotaped, randomly selected and rated
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van den Berg 2015 (Continued)
by trained and blinded raters. Treatment
adherence to protocols of both PE and
EMDR is reported as good and excellent
respectively
BAI: Beck Anxiety Inventory (Beck 1990)
BDI-II: Beck Depression Inventory-II (Beck 1996)
BPRS: Brief Psychiatric Rating Scale (Lukoff 1986)
CAPS: Clinician Administered PTSD Scale (Blake 1995)
CBT Cognitive Behavioural Therapy
DSM-IV: Diagnostic and Statistical Manual of Mental Disorders(4th edition)
EMDR: eye movement desensitisation and reprocessing
F: Female
GAF: Global Assessment of Functioning Scale (Jones 1995)
ITT: intention-to-treat
M: Male
N: total number
N: number
QOLI: Brief Quality of Life interview (Lehman 1995)
QOLS: Quality of Life Scale(Heinrichs 1984)
PANSS: Positive and Negative Syndrome Scale ( Kay 1986)
PKT - PTSD: knowledge Test (Pratt 2005)
PSYRATS: Psychotic Symptom Rating Scale (Haddock 1999)
PSS-SR: Posttraumatic Stress Symptom Scale Selt Report (Foa 1993)
PTCI: Posttraumatic Cognitions Inventory (Foa 1999)
PTSD: post-traumatic stress disorder
SCID: Structured Clinical Interview (First 1996)
SD: Standard deviation
SF-12: Short Form-12 (Ware 1994)
SMI: severe mental illness
TAU: treatment as usual
WAI: Working Alliance Inventory (Horvath 1989)
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
de Bont 2013 Allocation: not randomised but used a within-group controlled design
ISRCTN43816889 Allocation: randomised
Participants: individuals with a psychotic illness without co-morbid PTSD
Jackson 2006 Allocation: randomised
Participants: Individuals with first episode psychosis without co-morbid PTSD
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NCT00307216 Allocation: randomised
Participants: individuals recovering from their first episodes of psychosis but with no PTSD
PTSD - post-traumatic stress disorder
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D A T A A N D A N A L Y S E S
Comparison 1. TF-CBT versus WAITING LIST/TAU
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 PTSD symptom severity: 1.
Clinician-rated severity -
average endpoint CAPS total
score (high = poor)
1 13 Mean Difference (IV, Fixed, 95% CI) 13.15 [-4.09, 30.39]
1.1 short term 1 13 Mean Difference (IV, Fixed, 95% CI) 13.15 [-4.09, 30.39]
2 PTSD symptom severity: 1a.
Clinician-rated severity -
average endpoint CAPS total
score (high = poor) - skewed
data
3 Mean Difference (IV, Random, 95% CI) Subtotals only
2.1 short term - skewed data 2 147 Mean Difference (IV, Random, 95% CI) -7.44 [-29.15, 14.
27]
2.2 medium term - skewed
data
3 155 Mean Difference (IV, Random, 95% CI) -3.92 [-19.25, 11.
40]
3 PTSD symptom severity: 2.
Self-reported trauma-related
cognition - average endpoint
PTCI total score (high = poor)
3 Mean Difference (IV, Random, 95% CI) Subtotals only
3.1 short term 3 136 Mean Difference (IV, Random, 95% CI) -5.45 [-33.61, 22.
70]
3.2 medium term 3 133 Mean Difference (IV, Random, 95% CI) -15.25 [-29.48, -1.
02]
4 PTSD symptom severity: 3.
Self-reported frequency of
PTSD symptoms - average
endpoint PSS-SR total score
(high = poor) - skewed data
1 Mean Difference (IV, Fixed, 95% CI) Subtotals only
4.1 short term - skewed data 1 86 Mean Difference (IV, Fixed, 95% CI) -9.51 [-13.84, -5.18]
4.2 medium term - skewed
data
1 85 Mean Difference (IV, Fixed, 95% CI) -7.52 [-12.06, -2.98]
5 PTSD symptom severity:
4. Remission from PTSD:
Symptoms below diagnostic
threshold - CAPS total score <
40
2 Risk Ratio (M-H, Random, 95% CI) Subtotals only
5.1 short term 2 113 Risk Ratio (M-H, Random, 95% CI) 1.99 [1.20, 3.30]
5.2 medium term 2 109 Risk Ratio (M-H, Random, 95% CI) 1.44 [0.57, 3.63]
6 PTSD symptom severity:
5. Recovery from PTSD:
Asymptomatic or few
symptoms - CAPS total score <
20
1 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
6.1 short term 1 100 Risk Ratio (M-H, Fixed, 95% CI) 4.43 [1.37, 14.37]
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6.2 medium term 1 100 Risk Ratio (M-H, Fixed, 95% CI) 4.14 [1.27, 13.51]
7 Quality of life: 1. General quality
of life - average endpoint QLS
total score (high = good)
1 Mean Difference (IV, Fixed, 95% CI) Subtotals only
7.1 short term 1 38 Mean Difference (IV, Fixed, 95% CI) -3.0 [-8.26, 2.26]
7.2 medium term 1 39 Mean Difference (IV, Fixed, 95% CI) -0.60 [-4.47, 3.27]
8 Quality of life: 2. Overall
functioning - average endpoint
GAF total score (high = good)
1 Mean Difference (IV, Fixed, 95% CI) Subtotals only
8.1 short term 1 44 Mean Difference (IV, Fixed, 95% CI) 0.80 [-4.61, 6.21]
8.2 medium term 1 46 Mean Difference (IV, Fixed, 95% CI) 2.70 [-3.32, 8.72]
9 Quality of life: 3. Mental health
functioning - average endpoint
SF-12 mental component total
score (high = good)
1 Mean Difference (IV, Fixed, 95% CI) Subtotals only
9.1 short term 1 11 Mean Difference (IV, Fixed, 95% CI) -9.89 [-23.35, 3.57]
9.2 medium term 1 9 Mean Difference (IV, Fixed, 95% CI) 1.96 [-28.15, 32.07]
10 Quality of life: 4. Physical
functioning - average endpoint
SF-12 physical component
total score (high = good)
1 Mean Difference (IV, Fixed, 95% CI) Subtotals only
10.1 short term 1 11 Mean Difference (IV, Fixed, 95% CI) 1.32 [-16.35, 18.99]
10.2 medium term 1 9 Mean Difference (IV, Fixed, 95% CI) -2.52 [-25.64, 20.
60]
11 Symptoms of co-morbid
psychosis: 1. Overall mental
state - average endpoint BPRS
total score (high = poor)
1 Mean Difference (IV, Fixed, 95% CI) Subtotals only
11.1 short term 1 13 Mean Difference (IV, Fixed, 95% CI) 1.0 [-9.96, 11.96]
11.2 medium term 1 9 Mean Difference (IV, Fixed, 95% CI) -6.93 [-34.17, 20.
31]
12 Symptoms of co-morbid
psychosis: 2. Positive symptoms
- average endpoint PANSS
positive subscale total score
(high = poor)
1 Mean Difference (IV, Fixed, 95% CI) Subtotals only
12.1 short term 1 61 Mean Difference (IV, Fixed, 95% CI) -2.0 [-5.07, 1.07]
12.2 medium term 1 61 Mean Difference (IV, Fixed, 95% CI) -1.40 [-4.42, 1.62]
13 Symptoms of co-morbid
psychosis: 4. Negative
symptoms - average endpoint
PANSS negative subscale total
score (high = poor)
1 Mean Difference (IV, Fixed, 95% CI) Subtotals only
13.1 short term 1 61 Mean Difference (IV, Fixed, 95% CI) -1.40 [-4.19, 1.39]
13.2 medium term 1 61 Mean Difference (IV, Fixed, 95% CI) -1.10 [-3.38, 1.18]
14 Symptoms of co-morbid
psychosis: 3. Hallucinations
- average endpoint
PSYRATS-hallucinations
subscale total score (high =
poor) - skewed data
1 Mean Difference (IV, Fixed, 95% CI) Subtotals only
14.1 short term - skewed data 1 61 Mean Difference (IV, Fixed, 95% CI) 2.80 [-3.88, 9.48]
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14.2 medium term - skewed
data
1 61 Mean Difference (IV, Fixed, 95% CI) -0.30 [-7.48, 6.88]
15 Symptoms of co-morbid
psychosis: 5. Delusions
- average endpoint
PSYRATS-delusions subscale
total score (high = poor) -
skewed data
1 Mean Difference (IV, Fixed, 95% CI) Subtotals only
15.1 short term - skewed data 1 61 Mean Difference (IV, Fixed, 95% CI) -0.70 [-4.73, 3.33]
15.2 medium term - skewed
data
1 61 Mean Difference (IV, Fixed, 95% CI) -2.30 [-6.22, 1.62]
16 Anxiety symptoms: 1a. average
endpoint BAI total score (high
= poor)
1 Mean Difference (IV, Fixed, 95% CI) Subtotals only
16.1 Short term 1 13 Mean Difference (IV, Fixed, 95% CI) 4.20 [-7.52, 15.92]
16.2 Medium term 1 9 Mean Difference (IV, Fixed, 95% CI) 12.57 [-5.54, 30.68]
17 Anxiety symptoms: 1b. average
endpoint BAI total score (high
= poor) - skewed data
1 75 Mean Difference (IV, Fixed, 95% CI) -0.41 [-6.90, 6.09]
17.1 Short term - skewed data 1 35 Mean Difference (IV, Fixed, 95% CI) 2.0 [-7.02, 11.02]
17.2 medium term - skewed
data
1 40 Mean Difference (IV, Fixed, 95% CI) -1.00 [-12.36, 6.36]
18 Depressive symptoms: 1.
average endpoint BDI-II total
(high = poor) - skewed data
2 Mean Difference (IV, Random, 95% CI) Subtotals only
18.1 short term - skewed data 2 49 Mean Difference (IV, Random, 95% CI) 1.31 [-5.81, 8.44]
18.2 medium term - skewed
data
2 48 Mean Difference (IV, Random, 95% CI) 3.26 [-3.66, 10.18]
19 Adverse events - incidents of
unspecified severe adverse
events
1 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
19.1 Medium term 1 100 Risk Ratio (M-H, Fixed, 95% CI) 0.44 [0.09, 2.31]
20 Leaving the study early 3 Risk Ratio (M-H, Random, 95% CI) Subtotals only
20.1 short term 3 178 Risk Ratio (M-H, Random, 95% CI) 0.74 [0.38, 1.44]
20.2 medium term 3 178 Risk Ratio (M-H, Random, 95% CI) 0.80 [0.46, 1.40]
Comparison 2. EMDR versus WAITING LIST
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 PTSD symptom severity: 1.
Clinician-rated severity -
average endpoint CAPS total
score (high = poor) - skewed
data
1 Mean Difference (IV, Fixed, 95% CI) Subtotals only
1.1 Short term - skewed data 1 83 Mean Difference (IV, Fixed, 95% CI) -15.32 [-25.99, -4.
65]
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1.2 Medium term - skewed
data
1 83 Mean Difference (IV, Fixed, 95% CI) -12.31 [-22.72, -1.
90]
2 PTSD symptom severity: 2.
Self-reported trauma-related
cognition - average endpoint
PTCI total score (high = poor)
1 Mean Difference (IV, Fixed, 95% CI) Subtotals only
2.1 Short term 1 83 Mean Difference (IV, Fixed, 95% CI) -23.27 [-38.50, -8.
04]
2.2 Medium term 1 83 Mean Difference (IV, Fixed, 95% CI) -20.66 [-36.72, -4.
60]
3 PTSD symptom severity: 3.
Self-reported frequency of
PTSD symptoms - average
endpoint PSS-SR total score
(high = poor) - skewed data
1 Mean Difference (IV, Fixed, 95% CI) Subtotals only
3.1 Short term - skewed data 1 83 Mean Difference (IV, Fixed, 95% CI) -8.60 [-13.03, -4.17]
3.2 Medium term - skewed
data
1 83 Mean Difference (IV, Fixed, 95% CI) -7.37 [-12.17, -2.57]
4 PTSD symptom severity:
4. Remission from PTSD:
Symptoms below diagnostic
threshold - CAPS total score <
40
1 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
4.1 Short term 1 102 Risk Ratio (M-H, Fixed, 95% CI) 2.17 [1.30, 3.61]
4.2 Medium term 1 102 Risk Ratio (M-H, Fixed, 95% CI) 1.77 [1.10, 2.85]
5 PTSD symptom severity:
5. Recovery from PTSD:
Asymptomatic or few
symptoms - CAPS total score <
20
1 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
5.1 Short term 1 102 Risk Ratio (M-H, Fixed, 95% CI) 2.56 [0.74, 8.92]
5.2 Medium term 1 102 Risk Ratio (M-H, Fixed, 95% CI) 2.28 [0.64, 8.10]
6 Adverse events - incidents of
unspecified severe adverse
events
1 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
6.1 Short term 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
6.2 Medium term 1 102 Risk Ratio (M-H, Fixed, 95% CI) 0.21 [0.02, 1.85]
7 Leaving the study early 1 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
7.1 Short term 1 102 Risk Ratio (M-H, Fixed, 95% CI) 1.18 [0.52, 2.68]
7.2 Medium term 1 102 Risk Ratio (M-H, Fixed, 95% CI) 1.46 [0.63, 3.42]
Comparison 3. TF-CBT versus EMDR
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Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 PTSD symptom severity: 1.
Clinician-rated severity -
average endpoint CAPS total
score (high = poor) - skewed
data
1 Mean Difference (IV, Fixed, 95% CI) Subtotals only
1.1 Short term - skewed data 1 91 Mean Difference (IV, Fixed, 95% CI) -2.94 [-13.13, 7.25]
1.2 Medium term - skewed
data
1 88 Mean Difference (IV, Fixed, 95% CI) -1.69 [-12.61, 9.23]
2 PTSD symptom severity: 2.
Self-reported trauma-related
cognition - average endpoint
PTCI total score (high = poor)
1 Mean Difference (IV, Fixed, 95% CI) Subtotals only
2.1 Short term 1 91 Mean Difference (IV, Fixed, 95% CI) -3.38 [-21.17, 14.
41]
2.2 Medium term (7-9
months)
1 88 Mean Difference (IV, Fixed, 95% CI) 2.05 [-16.69, 20.79]
3 PTSD symptom severity: 3.
Self-reported frequency of
PTSD symptoms - average
endpoint PSS-SR total score
(high = poor) - skewed data
1 Mean Difference (IV, Fixed, 95% CI) Subtotals only
3.1 Short term - skewed data 1 91 Mean Difference (IV, Fixed, 95% CI) -0.91 [-5.18, 3.36]
3.2 Medium term - skewed
data
1 88 Mean Difference (IV, Fixed, 95% CI) -0.15 [-5.49, 5.19]
4 PTSD symptom severity:
4. Remission from PTSD:
Symptoms below diagnostic
threshold - CAPS total score <
40
1 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
4.1 Short term 1 108 Risk Ratio (M-H, Fixed, 95% CI) 0.94 [0.69, 1.30]
4.2 Medium term 1 108 Risk Ratio (M-H, Fixed, 95% CI) 1.04 [0.75, 1.44]
5 PTSD symptom severity:
5. Recovery from PTSD:
Asymptomatic or few
symptoms - CAPS total score <
20
1 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
5.1 Short term 1 108 Risk Ratio (M-H, Fixed, 95% CI) 1.73 [0.83, 3.61]
5.2 Medium term 1 108 Risk Ratio (M-H, Fixed, 95% CI) 1.82 [0.83, 3.97]
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Comparison 4. Individual TF-CBT versus brief PTSD psychoeducation
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 PTSD symptom severity: 1a.
Clinician-rated severity -
average endpoint CAPS total
score (high = poor)
1 106 Mean Difference (IV, Fixed, 95% CI) -0.71 [-10.58, 9.16]
1.1 Short term 1 54 Mean Difference (IV, Fixed, 95% CI) -1.45 [-14.63, 11.
73]
1.2 Medium term 1 52 Mean Difference (IV, Fixed, 95% CI) 0.23 [-14.66, 15.12]
2 PTSD symptom severity: 1b.
Clinician-rated severity -
average endpoint CAPS total
score (high = poor) - skewed
data
1 48 Mean Difference (IV, Fixed, 95% CI) -2.13 [-19.45, 15.
19]
2.1 Long term - skewed data 1 48 Mean Difference (IV, Fixed, 95% CI) -2.13 [-19.45, 15.
19]
3 PTSD symptom severity: 2.
Self-reported trauma-related
cognition - average endpoint
PTCI total score (high = poor)
1 Mean Difference (IV, Fixed, 95% CI) Subtotals only
3.1 Short term 1 53 Mean Difference (IV, Fixed, 95% CI) 1.64 [-24.40, 27.68]
3.2 Medium term 1 51 Mean Difference (IV, Fixed, 95% CI) 7.68 [-18.64, 34.00]
3.3 Long term 1 49 Mean Difference (IV, Fixed, 95% CI) 16.19 [-10.45, 42.
83]
4 PTSD symptom severity:
4. Remission from PTSD:
Symptoms below diagnostic
threshold - CAPS total score <
40
1 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
4.1 Short term 1 54 Risk Ratio (M-H, Fixed, 95% CI) 1.04 [0.47, 2.30]
4.2 Medium term 1 52 Risk Ratio (M-H, Fixed, 95% CI) 2.0 [0.79, 5.05]
4.3 Long term 1 48 Risk Ratio (M-H, Fixed, 95% CI) 1.14 [0.49, 2.65]
5 PTSD symptom severity: 5.
Remission from severe PTSD:
Loss of severe PTSD diagnosis
- CAPS total score < 65
1 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
5.1 Short term 1 54 Risk Ratio (M-H, Fixed, 95% CI) 1.21 [0.64, 2.26]
5.2 Medium term 1 52 Risk Ratio (M-H, Fixed, 95% CI) 1.56 [0.82, 2.94]
5.3 Long term 1 48 Risk Ratio (M-H, Fixed, 95% CI) 1.3 [0.71, 2.37]
6 Quality of life: 1. General quality
of life - average endpoint QoLI
total score (high = good)
1 Mean Difference (IV, Fixed, 95% CI) Subtotals only
6.1 Short term 1 54 Mean Difference (IV, Fixed, 95% CI) -0.58 [-1.35, 0.19]
6.2 Medium term 1 52 Mean Difference (IV, Fixed, 95% CI) -0.29 [-1.03, 0.45]
6.3 Long term 1 49 Mean Difference (IV, Fixed, 95% CI) 0.11 [-0.74, 0.96]
7 Quality of life: 2. Overall
functioning - average endpoint
GAF total score (high = good)
1 Mean Difference (IV, Fixed, 95% CI) Subtotals only
60Psychological interventions for post-traumatic stress disorder (PTSD) in people with severe mental illness (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Fo
r P
re
vie
w 
On
ly
7.1 Short term 1 49 Mean Difference (IV, Fixed, 95% CI) -0.86 [-6.48, 4.76]
7.2 Medium term 1 50 Mean Difference (IV, Fixed, 95% CI) 0.60 [-4.92, 6.12]
7.3 Long term 1 48 Mean Difference (IV, Fixed, 95% CI) 1.88 [-4.93, 8.69]
8 Quality of life: 3. Social
functioning - average endpoint
CAPS social functioning
subscale total score (high =
poor) - skewed data
1 Mean Difference (IV, Fixed, 95% CI) Subtotals only
8.1 Short term - skewed data 1 54 Mean Difference (IV, Fixed, 95% CI) -0.29 [-0.86, 0.28]
8.2 Medium term - skewed
data
1 52 Mean Difference (IV, Fixed, 95% CI) -0.61 [-1.28, 0.06]
8.3 Long term - skewed data 1 48 Mean Difference (IV, Fixed, 95% CI) 0.19 [-0.46, 0.84]
Analysis 1.1. Comparison 1 TF-CBT versus WAITING LIST/TAU, Outcome 1 PTSD symptom severity: 1.
Clinician-rated severity - average endpoint CAPS total score (high = poor).
Review: Psychological interventions for post-traumatic stress disorder (PTSD) in people with severe mental illness
Comparison: 1 TF-CBT versus WAITING LIST/TAU
Outcome: 1 PTSD symptom severity: 1. Clinician-rated severity - average endpoint CAPS total score (high = poor)
Study or subgroup Individual TF-CBT Usual care/waitlist
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 short term
Mueser 2008 8 60.75 (20.77) 5 47.6 (10.83) 100.0 % 13.15 [ -4.09, 30.39 ]
Total (95% CI) 8 5 100.0 % 13.15 [ -4.09, 30.39 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.49 (P = 0.13)
Test for subgroup differences: Not applicable
-100 -50 0 50 100
Favours individual TF-CBT Favours usual care
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Analysis 1.2. Comparison 1 TF-CBT versus WAITING LIST/TAU, Outcome 2 PTSD symptom severity: 1a.
Clinician-rated severity - average endpoint CAPS total score (high = poor) - skewed data.
Review: Psychological interventions for post-traumatic stress disorder (PTSD) in people with severe mental illness
Comparison: 1 TF-CBT versus WAITING LIST/TAU
Outcome: 2 PTSD symptom severity: 1a. Clinician-rated severity - average endpoint CAPS total score (high = poor) - skewed data
Study or subgroup TF-CBT WAITLIST/TAU
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 short term - skewed data
Steel 2010 30 41.7 (22.3) 31 37.8 (25.9) 48.8 % 3.90 [ -8.22, 16.02 ]
van den Berg 2015 47 36.79 (23.74) 39 55.05 (23.88) 51.2 % -18.26 [ -28.37, -8.15 ]
Subtotal (95% CI) 77 70 100.0 % -7.44 [ -29.15, 14.27 ]
Heterogeneity: Tau2 = 213.12; Chi2 = 7.57, df = 1 (P = 0.01); I2 =87%
Test for overall effect: Z = 0.67 (P = 0.50)
2 medium term - skewed data
Mueser 2008 7 59.28 (24.45) 2 49.5 (30.41) 9.4 % 9.78 [ -36.09, 55.65 ]
Steel 2010 30 34.4 (24.4) 31 30.4 (24) 43.6 % 4.00 [ -8.15, 16.15 ]
van den Berg 2015 45 36.8 (26.34) 40 50.8 (22.47) 47.0 % -14.00 [ -24.38, -3.62 ]
Subtotal (95% CI) 82 73 100.0 % -3.92 [ -19.25, 11.40 ]
Heterogeneity: Tau2 = 101.89; Chi2 = 5.34, df = 2 (P = 0.07); I2 =63%
Test for overall effect: Z = 0.50 (P = 0.62)
Test for subgroup differences: Chi2 = 0.07, df = 1 (P = 0.80), I2 =0.0%
-100 -50 0 50 100
Favours TF-CBT Favours WAITLIST/TAU
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Analysis 1.3. Comparison 1 TF-CBT versus WAITING LIST/TAU, Outcome 3 PTSD symptom severity: 2.
Self-reported trauma-related cognition - average endpoint PTCI total score (high = poor).
Review: Psychological interventions for post-traumatic stress disorder (PTSD) in people with severe mental illness
Comparison: 1 TF-CBT versus WAITING LIST/TAU
Outcome: 3 PTSD symptom severity: 2. Self-reported trauma-related cognition - average endpoint PTCI total score (high = poor)
Study or subgroup Individual TF-CBT Usual care/waitlist
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 short term
Mueser 2008 8 102.88 (23.26) 6 85.5 (26.37) 31.9 % 17.38 [ -9.17, 43.93 ]
Steel 2010 18 140.1 (42.9) 18 142.3 (49.8) 29.3 % -2.20 [ -32.57, 28.17 ]
van den Berg 2015 47 115.94 (45.87) 39 142.59 (29.79) 38.8 % -26.65 [ -42.76, -10.54 ]
Subtotal (95% CI) 73 63 100.0 % -5.45 [ -33.61, 22.70 ]
Heterogeneity: Tau2 = 463.90; Chi2 = 8.27, df = 2 (P = 0.02); I2 =76%
Test for overall effect: Z = 0.38 (P = 0.70)
2 medium term
Mueser 2008 7 100 (18.8) 2 104.5 (65.76) 2.4 % -4.50 [ -96.70, 87.70 ]
Steel 2010 20 127.7 (49.7) 19 132.5 (47.2) 21.9 % -4.80 [ -35.21, 25.61 ]
van den Berg 2015 45 120.31 (45.97) 40 138.92 (30.11) 75.7 % -18.61 [ -34.96, -2.26 ]
Subtotal (95% CI) 72 61 100.0 % -15.25 [ -29.48, -1.02 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.67, df = 2 (P = 0.72); I2 =0.0%
Test for overall effect: Z = 2.10 (P = 0.036)
Test for subgroup differences: Chi2 = 0.37, df = 1 (P = 0.54), I2 =0.0%
-100 -50 0 50 100
Favours individual TF-CBT Favours usual care
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Analysis 1.4. Comparison 1 TF-CBT versus WAITING LIST/TAU, Outcome 4 PTSD symptom severity: 3.
Self-reported frequency of PTSD symptoms - average endpoint PSS-SR total score (high = poor) - skewed data.
Review: Psychological interventions for post-traumatic stress disorder (PTSD) in people with severe mental illness
Comparison: 1 TF-CBT versus WAITING LIST/TAU
Outcome: 4 PTSD symptom severity: 3. Self-reported frequency of PTSD symptoms - average endpoint PSS-SR total score (high = poor) - skewed data
Study or subgroup Individual TF-CBT Usual care/waitlist
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 short term - skewed data
van den Berg 2015 47 15.23 (10.31) 39 24.74 (10.11) 100.0 % -9.51 [ -13.84, -5.18 ]
Subtotal (95% CI) 47 39 100.0 % -9.51 [ -13.84, -5.18 ]
Heterogeneity: not applicable
Test for overall effect: Z = 4.30 (P = 0.000017)
2 medium term - skewed data
van den Berg 2015 45 16.18 (12.36) 40 23.7 (8.88) 100.0 % -7.52 [ -12.06, -2.98 ]
Subtotal (95% CI) 45 40 100.0 % -7.52 [ -12.06, -2.98 ]
Heterogeneity: not applicable
Test for overall effect: Z = 3.25 (P = 0.0012)
Test for subgroup differences: Chi2 = 0.39, df = 1 (P = 0.53), I2 =0.0%
-100 -50 0 50 100
Favours individual TF-CBT Favours waitlist
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Analysis 1.5. Comparison 1 TF-CBT versus WAITING LIST/TAU, Outcome 5 PTSD symptom severity: 4.
Remission from PTSD: Symptoms below diagnostic threshold - CAPS total score < 40.
Review: Psychological interventions for post-traumatic stress disorder (PTSD) in people with severe mental illness
Comparison: 1 TF-CBT versus WAITING LIST/TAU
Outcome: 5 PTSD symptom severity: 4. Remission from PTSD: Symptoms below diagnostic threshold - CAPS total score < 40
Study or subgroup Individual TF-CBT Usual care/waitlist Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 short term
Mueser 2008 2/8 1/5 5.6 % 1.25 [ 0.15, 10.46 ]
van den Berg 2015 30/53 13/47 94.4 % 2.05 [ 1.22, 3.44 ]
Subtotal (95% CI) 61 52 100.0 % 1.99 [ 1.20, 3.30 ]
Total events: 32 (Individual TF-CBT), 14 (Usual care/waitlist)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.20, df = 1 (P = 0.66); I2 =0.0%
Test for overall effect: Z = 2.68 (P = 0.0074)
2 medium term
Mueser 2008 2/7 1/2 20.7 % 0.57 [ 0.09, 3.51 ]
van den Berg 2015 31/53 15/47 79.3 % 1.83 [ 1.14, 2.95 ]
Subtotal (95% CI) 60 49 100.0 % 1.44 [ 0.57, 3.63 ]
Total events: 33 (Individual TF-CBT), 16 (Usual care/waitlist)
Heterogeneity: Tau2 = 0.22; Chi2 = 1.49, df = 1 (P = 0.22); I2 =33%
Test for overall effect: Z = 0.77 (P = 0.44)
Test for subgroup differences: Chi2 = 0.36, df = 1 (P = 0.55), I2 =0.0%
0.01 0.1 1 10 100
Favours usual care Favours individual TF-CBT
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Analysis 1.6. Comparison 1 TF-CBT versus WAITING LIST/TAU, Outcome 6 PTSD symptom severity: 5.
Recovery from PTSD: Asymptomatic or few symptoms - CAPS total score < 20.
Review: Psychological interventions for post-traumatic stress disorder (PTSD) in people with severe mental illness
Comparison: 1 TF-CBT versus WAITING LIST/TAU
Outcome: 6 PTSD symptom severity: 5. Recovery from PTSD: Asymptomatic or few symptoms - CAPS total score < 20
Study or subgroup Individual TF-CBT Usual care/waitlist Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 short term
van den Berg 2015 15/53 3/47 100.0 % 4.43 [ 1.37, 14.37 ]
Subtotal (95% CI) 53 47 100.0 % 4.43 [ 1.37, 14.37 ]
Total events: 15 (Individual TF-CBT), 3 (Usual care/waitlist)
Heterogeneity: not applicable
Test for overall effect: Z = 2.48 (P = 0.013)
2 medium term
van den Berg 2015 14/53 3/47 100.0 % 4.14 [ 1.27, 13.51 ]
Subtotal (95% CI) 53 47 100.0 % 4.14 [ 1.27, 13.51 ]
Total events: 14 (Individual TF-CBT), 3 (Usual care/waitlist)
Heterogeneity: not applicable
Test for overall effect: Z = 2.35 (P = 0.019)
Test for subgroup differences: Chi2 = 0.01, df = 1 (P = 0.94), I2 =0.0%
0.01 0.1 1 10 100
Favours waitlist Favours individual TF-CBT
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Analysis 1.7. Comparison 1 TF-CBT versus WAITING LIST/TAU, Outcome 7 Quality of life: 1. General
quality of life - average endpoint QLS total score (high = good).
Review: Psychological interventions for post-traumatic stress disorder (PTSD) in people with severe mental illness
Comparison: 1 TF-CBT versus WAITING LIST/TAU
Outcome: 7 Quality of life: 1. General quality of life - average endpoint QLS total score (high = good)
Study or subgroup Individual TF-CBT Usual care/waitlist
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 short term
Steel 2010 19 23 (9.8) 19 26 (6.4) 100.0 % -3.00 [ -8.26, 2.26 ]
Subtotal (95% CI) 19 19 100.0 % -3.00 [ -8.26, 2.26 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.12 (P = 0.26)
2 medium term
Steel 2010 20 25.4 (7.2) 19 26 (5) 100.0 % -0.60 [ -4.47, 3.27 ]
Subtotal (95% CI) 20 19 100.0 % -0.60 [ -4.47, 3.27 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.30 (P = 0.76)
Test for subgroup differences: Chi2 = 0.52, df = 1 (P = 0.47), I2 =0.0%
-100 -50 0 50 100
Favours usual care Favours individual TF-CBT
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Analysis 1.8. Comparison 1 TF-CBT versus WAITING LIST/TAU, Outcome 8 Quality of life: 2. Overall
functioning - average endpoint GAF total score (high = good).
Review: Psychological interventions for post-traumatic stress disorder (PTSD) in people with severe mental illness
Comparison: 1 TF-CBT versus WAITING LIST/TAU
Outcome: 8 Quality of life: 2. Overall functioning - average endpoint GAF total score (high = good)
Study or subgroup Individual TF-CBT Usual care/waitlist
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 short term
Steel 2010 23 61.6 (10) 21 60.8 (8.3) 100.0 % 0.80 [ -4.61, 6.21 ]
Subtotal (95% CI) 23 21 100.0 % 0.80 [ -4.61, 6.21 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.29 (P = 0.77)
2 medium term
Steel 2010 23 61.3 (9.8) 23 58.6 (11) 100.0 % 2.70 [ -3.32, 8.72 ]
Subtotal (95% CI) 23 23 100.0 % 2.70 [ -3.32, 8.72 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.88 (P = 0.38)
Test for subgroup differences: Chi2 = 0.21, df = 1 (P = 0.65), I2 =0.0%
-100 -50 0 50 100
Favours individual TF-CBT Favours usual care
68Psychological interventions for post-traumatic stress disorder (PTSD) in people with severe mental illness (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Fo
r P
re
vie
w 
On
ly
Analysis 1.9. Comparison 1 TF-CBT versus WAITING LIST/TAU, Outcome 9 Quality of life: 3. Mental
health functioning - average endpoint SF-12 mental component total score (high = good).
Review: Psychological interventions for post-traumatic stress disorder (PTSD) in people with severe mental illness
Comparison: 1 TF-CBT versus WAITING LIST/TAU
Outcome: 9 Quality of life: 3. Mental health functioning - average endpoint SF-12 mental component total score (high = good)
Study or subgroup TF-CBT usual care
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 short term
Mueser 2008 6 30.96 (7.55) 5 40.85 (13.72) 100.0 % -9.89 [ -23.35, 3.57 ]
Subtotal (95% CI) 6 5 100.0 % -9.89 [ -23.35, 3.57 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.44 (P = 0.15)
2 medium term
Mueser 2008 7 33.85 (7.85) 2 31.89 (21.32) 100.0 % 1.96 [ -28.15, 32.07 ]
Subtotal (95% CI) 7 2 100.0 % 1.96 [ -28.15, 32.07 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.13 (P = 0.90)
Test for subgroup differences: Chi2 = 0.50, df = 1 (P = 0.48), I2 =0.0%
-100 -50 0 50 100
Favours usual care Favours TF-CBT
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Analysis 1.10. Comparison 1 TF-CBT versus WAITING LIST/TAU, Outcome 10 Quality of life: 4. Physical
functioning - average endpoint SF-12 physical component total score (high = good).
Review: Psychological interventions for post-traumatic stress disorder (PTSD) in people with severe mental illness
Comparison: 1 TF-CBT versus WAITING LIST/TAU
Outcome: 10 Quality of life: 4. Physical functioning - average endpoint SF-12 physical component total score (high = good)
Study or subgroup Individual TF-CBT Usual care/waitlist
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 short term
Mueser 2008 6 40.31 (15) 5 38.99 (14.8) 100.0 % 1.32 [ -16.35, 18.99 ]
Subtotal (95% CI) 6 5 100.0 % 1.32 [ -16.35, 18.99 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.15 (P = 0.88)
2 medium term
Mueser 2008 7 40.07 (16.7) 2 42.59 (14.09) 100.0 % -2.52 [ -25.64, 20.60 ]
Subtotal (95% CI) 7 2 100.0 % -2.52 [ -25.64, 20.60 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.21 (P = 0.83)
Test for subgroup differences: Chi2 = 0.07, df = 1 (P = 0.80), I2 =0.0%
-100 -50 0 50 100
Favours individual TF-CBT Favours usual care
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Analysis 1.11. Comparison 1 TF-CBT versus WAITING LIST/TAU, Outcome 11 Symptoms of co-morbid
psychosis: 1. Overall mental state - average endpoint BPRS total score (high = poor).
Review: Psychological interventions for post-traumatic stress disorder (PTSD) in people with severe mental illness
Comparison: 1 TF-CBT versus WAITING LIST/TAU
Outcome: 11 Symptoms of co-morbid psychosis: 1. Overall mental state - average endpoint BPRS total score (high = poor)
Study or subgroup Individual TF-CBT Usual care/waitlist
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 short term
Mueser 2008 8 44 (13.14) 5 43 (6.96) 100.0 % 1.00 [ -9.96, 11.96 ]
Subtotal (95% CI) 8 5 100.0 % 1.00 [ -9.96, 11.96 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.18 (P = 0.86)
2 medium term
Mueser 2008 7 43.57 (8.77) 2 50.5 (19.09) 100.0 % -6.93 [ -34.17, 20.31 ]
Subtotal (95% CI) 7 2 100.0 % -6.93 [ -34.17, 20.31 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.50 (P = 0.62)
Test for subgroup differences: Chi2 = 0.28, df = 1 (P = 0.60), I2 =0.0%
-100 -50 0 50 100
Favours individual TF-CBT Favours usual care
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Analysis 1.12. Comparison 1 TF-CBT versus WAITING LIST/TAU, Outcome 12 Symptoms of co-morbid
psychosis: 2. Positive symptoms - average endpoint PANSS positive subscale total score (high = poor).
Review: Psychological interventions for post-traumatic stress disorder (PTSD) in people with severe mental illness
Comparison: 1 TF-CBT versus WAITING LIST/TAU
Outcome: 12 Symptoms of co-morbid psychosis: 2. Positive symptoms - average endpoint PANSS positive subscale total score (high = poor)
Study or subgroup Individual TF-CBT Usual care/waitlist
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 short term
Steel 2010 30 17.8 (5.6) 31 19.8 (6.6) 100.0 % -2.00 [ -5.07, 1.07 ]
Subtotal (95% CI) 30 31 100.0 % -2.00 [ -5.07, 1.07 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.28 (P = 0.20)
2 medium term
Steel 2010 30 17 (5.6) 31 18.4 (6.4) 100.0 % -1.40 [ -4.42, 1.62 ]
Subtotal (95% CI) 30 31 100.0 % -1.40 [ -4.42, 1.62 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.91 (P = 0.36)
Test for subgroup differences: Chi2 = 0.07, df = 1 (P = 0.78), I2 =0.0%
-100 -50 0 50 100
Favours individual TF-CBT Favours usual care
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Analysis 1.13. Comparison 1 TF-CBT versus WAITING LIST/TAU, Outcome 13 Symptoms of co-morbid
psychosis: 4. Negative symptoms - average endpoint PANSS negative subscale total score (high = poor).
Review: Psychological interventions for post-traumatic stress disorder (PTSD) in people with severe mental illness
Comparison: 1 TF-CBT versus WAITING LIST/TAU
Outcome: 13 Symptoms of co-morbid psychosis: 4. Negative symptoms - average endpoint PANSS negative subscale total score (high = poor)
Study or subgroup Individual TF-CBT Usual care/waitlist
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 short term
Steel 2010 30 15 (5.7) 31 16.4 (5.4) 100.0 % -1.40 [ -4.19, 1.39 ]
Subtotal (95% CI) 30 31 100.0 % -1.40 [ -4.19, 1.39 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.98 (P = 0.33)
2 medium term
Steel 2010 30 15 (4.6) 31 16.1 (4.5) 100.0 % -1.10 [ -3.38, 1.18 ]
Subtotal (95% CI) 30 31 100.0 % -1.10 [ -3.38, 1.18 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.94 (P = 0.35)
Test for subgroup differences: Chi2 = 0.03, df = 1 (P = 0.87), I2 =0.0%
-100 -50 0 50 100
Favours individual TF-CBT Favours usual care
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Analysis 1.14. Comparison 1 TF-CBT versus WAITING LIST/TAU, Outcome 14 Symptoms of co-morbid
psychosis: 3. Hallucinations - average endpoint PSYRATS-hallucinations subscale total score (high = poor) -
skewed data.
Review: Psychological interventions for post-traumatic stress disorder (PTSD) in people with severe mental illness
Comparison: 1 TF-CBT versus WAITING LIST/TAU
Outcome: 14 Symptoms of co-morbid psychosis: 3. Hallucinations - average endpoint PSYRATS-hallucinations subscale total score (high = poor) - skewed data
Study or subgroup Individual TF-CBT Usual care/waitlist
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 short term - skewed data
Steel 2010 30 16.8 (13.4) 31 14 (13.2) 100.0 % 2.80 [ -3.88, 9.48 ]
Subtotal (95% CI) 30 31 100.0 % 2.80 [ -3.88, 9.48 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.82 (P = 0.41)
2 medium term - skewed data
Steel 2010 30 13.7 (13.8) 31 14 (14.8) 100.0 % -0.30 [ -7.48, 6.88 ]
Subtotal (95% CI) 30 31 100.0 % -0.30 [ -7.48, 6.88 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.08 (P = 0.93)
Test for subgroup differences: Chi2 = 0.38, df = 1 (P = 0.54), I2 =0.0%
-100 -50 0 50 100
Favours individual TF-CBT Favours usual care
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Analysis 1.15. Comparison 1 TF-CBT versus WAITING LIST/TAU, Outcome 15 Symptoms of co-morbid
psychosis: 5. Delusions - average endpoint PSYRATS-delusions subscale total score (high = poor) - skewed data.
Review: Psychological interventions for post-traumatic stress disorder (PTSD) in people with severe mental illness
Comparison: 1 TF-CBT versus WAITING LIST/TAU
Outcome: 15 Symptoms of co-morbid psychosis: 5. Delusions - average endpoint PSYRATS-delusions subscale total score (high = poor) - skewed data
Study or subgroup Individual TF-CBT Usual care/waitlist
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 short term - skewed data
Steel 2010 30 10 (8.5) 31 10.7 (7.5) 100.0 % -0.70 [ -4.73, 3.33 ]
Subtotal (95% CI) 30 31 100.0 % -0.70 [ -4.73, 3.33 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.34 (P = 0.73)
2 medium term - skewed data
Steel 2010 30 8.5 (8) 31 10.8 (7.6) 100.0 % -2.30 [ -6.22, 1.62 ]
Subtotal (95% CI) 30 31 100.0 % -2.30 [ -6.22, 1.62 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.15 (P = 0.25)
Test for subgroup differences: Chi2 = 0.31, df = 1 (P = 0.58), I2 =0.0%
-100 -50 0 50 100
Favours individual TF-CBT Favours usual care
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Analysis 1.16. Comparison 1 TF-CBT versus WAITING LIST/TAU, Outcome 16 Anxiety symptoms: 1a.
average endpoint BAI total score (high = poor).
Review: Psychological interventions for post-traumatic stress disorder (PTSD) in people with severe mental illness
Comparison: 1 TF-CBT versus WAITING LIST/TAU
Outcome: 16 Anxiety symptoms: 1a. average endpoint BAI total score (high = poor)
Study or subgroup Individual TF-CBT Usual care/waitlist
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Short term
Mueser 2008 8 43.25 (8.33) 5 39.05 (11.64) 100.0 % 4.20 [ -7.52, 15.92 ]
Subtotal (95% CI) 8 5 100.0 % 4.20 [ -7.52, 15.92 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.70 (P = 0.48)
2 Medium term
Mueser 2008 7 46.57 (5.5) 2 34 (12.73) 100.0 % 12.57 [ -5.54, 30.68 ]
Subtotal (95% CI) 7 2 100.0 % 12.57 [ -5.54, 30.68 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.36 (P = 0.17)
Test for subgroup differences: Chi2 = 0.58, df = 1 (P = 0.45), I2 =0.0%
-100 -50 0 50 100
Favours individual TF-CBT Favours usual care
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Analysis 1.17. Comparison 1 TF-CBT versus WAITING LIST/TAU, Outcome 17 Anxiety symptoms: 1b.
average endpoint BAI total score (high = poor) - skewed data.
Review: Psychological interventions for post-traumatic stress disorder (PTSD) in people with severe mental illness
Comparison: 1 TF-CBT versus WAITING LIST/TAU
Outcome: 17 Anxiety symptoms: 1b. average endpoint BAI total score (high = poor) - skewed data
Study or subgroup TF-CBT WAITLIST/TAU
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Short term - skewed data
Steel 2010 18 21.8 (15.2) 17 19.8 (11.9) 51.9 % 2.00 [ -7.02, 11.02 ]
Subtotal (95% CI) 18 17 51.9 % 2.00 [ -7.02, 11.02 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.43 (P = 0.66)
2 medium term - skewed data
Steel 2010 20 19.4 (14.6) 20 22.4 (15.6) 48.1 % -3.00 [ -12.36, 6.36 ]
Subtotal (95% CI) 20 20 48.1 % -3.00 [ -12.36, 6.36 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.63 (P = 0.53)
Total (95% CI) 38 37 100.0 % -0.41 [ -6.90, 6.09 ]
Heterogeneity: Chi2 = 0.57, df = 1 (P = 0.45); I2 =0.0%
Test for overall effect: Z = 0.12 (P = 0.90)
Test for subgroup differences: Chi2 = 0.57, df = 1 (P = 0.45), I2 =0.0%
-100 -50 0 50 100
Favours TF-CBT Favours WAITLIST/TAU
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Analysis 1.18. Comparison 1 TF-CBT versus WAITING LIST/TAU, Outcome 18 Depressive symptoms: 1.
average endpoint BDI-II total (high = poor) - skewed data.
Review: Psychological interventions for post-traumatic stress disorder (PTSD) in people with severe mental illness
Comparison: 1 TF-CBT versus WAITING LIST/TAU
Outcome: 18 Depressive symptoms: 1. average endpoint BDI-II total (high = poor) - skewed data
Study or subgroup Individual TF-CBT Usual care/waitlist
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 short term - skewed data
Mueser 2008 8 21 (9.26) 5 24.2 (14.17) 26.0 % -3.20 [ -17.18, 10.78 ]
Steel 2010 19 24.3 (14.2) 17 21.4 (11.1) 74.0 % 2.90 [ -5.38, 11.18 ]
Subtotal (95% CI) 27 22 100.0 % 1.31 [ -5.81, 8.44 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.54, df = 1 (P = 0.46); I2 =0.0%
Test for overall effect: Z = 0.36 (P = 0.72)
2 medium term - skewed data
Mueser 2008 7 25 (11.15) 2 22.5 (21.92) 4.8 % 2.50 [ -28.98, 33.98 ]
Steel 2010 20 21.9 (11.3) 19 18.6 (11.3) 95.2 % 3.30 [ -3.80, 10.40 ]
Subtotal (95% CI) 27 21 100.0 % 3.26 [ -3.66, 10.18 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.00, df = 1 (P = 0.96); I2 =0.0%
Test for overall effect: Z = 0.92 (P = 0.36)
Test for subgroup differences: Chi2 = 0.15, df = 1 (P = 0.70), I2 =0.0%
-100 -50 0 50 100
Favours individual TF-CBT Favours usual care
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Analysis 1.19. Comparison 1 TF-CBT versus WAITING LIST/TAU, Outcome 19 Adverse events - incidents
of unspecified severe adverse events.
Review: Psychological interventions for post-traumatic stress disorder (PTSD) in people with severe mental illness
Comparison: 1 TF-CBT versus WAITING LIST/TAU
Outcome: 19 Adverse events - incidents of unspecified severe adverse events
Study or subgroup Individual TF-CBT Usual care/waitlist Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Medium term
van den Berg 2015 2/53 4/47 100.0 % 0.44 [ 0.09, 2.31 ]
Subtotal (95% CI) 53 47 100.0 % 0.44 [ 0.09, 2.31 ]
Total events: 2 (Individual TF-CBT), 4 (Usual care/waitlist)
Heterogeneity: not applicable
Test for overall effect: Z = 0.97 (P = 0.33)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours individual TF-CBT Favours waitlist
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Analysis 1.20. Comparison 1 TF-CBT versus WAITING LIST/TAU, Outcome 20 Leaving the study early.
Review: Psychological interventions for post-traumatic stress disorder (PTSD) in people with severe mental illness
Comparison: 1 TF-CBT versus WAITING LIST/TAU
Outcome: 20 Leaving the study early
Study or subgroup Individual TF-CBT Usual care/waitlist Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 short term
Mueser 2008 2/10 2/7 15.3 % 0.70 [ 0.13, 3.85 ]
Steel 2010 5/30 6/31 38.5 % 0.86 [ 0.29, 2.52 ]
van den Berg 2015 6/53 8/47 46.1 % 0.67 [ 0.25, 1.78 ]
Subtotal (95% CI) 93 85 100.0 % 0.74 [ 0.38, 1.44 ]
Total events: 13 (Individual TF-CBT), 16 (Usual care/waitlist)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.13, df = 2 (P = 0.94); I2 =0.0%
Test for overall effect: Z = 0.88 (P = 0.38)
2 medium term
Mueser 2008 3/10 5/7 27.9 % 0.42 [ 0.15, 1.21 ]
Steel 2010 7/30 7/31 36.7 % 1.03 [ 0.41, 2.59 ]
van den Berg 2015 8/53 7/47 35.5 % 1.01 [ 0.40, 2.58 ]
Subtotal (95% CI) 93 85 100.0 % 0.80 [ 0.46, 1.40 ]
Total events: 18 (Individual TF-CBT), 19 (Usual care/waitlist)
Heterogeneity: Tau2 = 0.00; Chi2 = 2.02, df = 2 (P = 0.37); I2 =1%
Test for overall effect: Z = 0.79 (P = 0.43)
Test for subgroup differences: Chi2 = 0.03, df = 1 (P = 0.86), I2 =0.0%
0.01 0.1 1 10 100
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Analysis 2.1. Comparison 2 EMDR versus WAITING LIST, Outcome 1 PTSD symptom severity: 1.
Clinician-rated severity - average endpoint CAPS total score (high = poor) - skewed data.
Review: Psychological interventions for post-traumatic stress disorder (PTSD) in people with severe mental illness
Comparison: 2 EMDR versus WAITING LIST
Outcome: 1 PTSD symptom severity: 1. Clinician-rated severity - average endpoint CAPS total score (high = poor) - skewed data
Study or subgroup EMDR Waitlist
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Short term - skewed data
van den Berg 2015 44 39.73 (25.72) 39 55.05 (23.88) 100.0 % -15.32 [ -25.99, -4.65 ]
Subtotal (95% CI) 44 39 100.0 % -15.32 [ -25.99, -4.65 ]
Heterogeneity: not applicable
Test for overall effect: Z = 2.81 (P = 0.0049)
2 Medium term - skewed data
van den Berg 2015 43 38.49 (25.91) 40 50.8 (22.47) 100.0 % -12.31 [ -22.72, -1.90 ]
Subtotal (95% CI) 43 40 100.0 % -12.31 [ -22.72, -1.90 ]
Heterogeneity: not applicable
Test for overall effect: Z = 2.32 (P = 0.021)
Test for subgroup differences: Chi2 = 0.16, df = 1 (P = 0.69), I2 =0.0%
-100 -50 0 50 100
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Analysis 2.2. Comparison 2 EMDR versus WAITING LIST, Outcome 2 PTSD symptom severity: 2. Self-
reported trauma-related cognition - average endpoint PTCI total score (high = poor).
Review: Psychological interventions for post-traumatic stress disorder (PTSD) in people with severe mental illness
Comparison: 2 EMDR versus WAITING LIST
Outcome: 2 PTSD symptom severity: 2. Self-reported trauma-related cognition - average endpoint PTCI total score (high = poor)
Study or subgroup EMDR Waitlist
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Short term
van den Berg 2015 44 119.32 (40.67) 39 142.59 (29.79) 100.0 % -23.27 [ -38.50, -8.04 ]
Subtotal (95% CI) 44 39 100.0 % -23.27 [ -38.50, -8.04 ]
Heterogeneity: not applicable
Test for overall effect: Z = 3.00 (P = 0.0027)
2 Medium term
van den Berg 2015 43 118.26 (43.74) 40 138.92 (30.11) 100.0 % -20.66 [ -36.72, -4.60 ]
Subtotal (95% CI) 43 40 100.0 % -20.66 [ -36.72, -4.60 ]
Heterogeneity: not applicable
Test for overall effect: Z = 2.52 (P = 0.012)
Test for subgroup differences: Chi2 = 0.05, df = 1 (P = 0.82), I2 =0.0%
-100 -50 0 50 100
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Analysis 2.3. Comparison 2 EMDR versus WAITING LIST, Outcome 3 PTSD symptom severity: 3. Self-
reported frequency of PTSD symptoms - average endpoint PSS-SR total score (high = poor) - skewed data.
Review: Psychological interventions for post-traumatic stress disorder (PTSD) in people with severe mental illness
Comparison: 2 EMDR versus WAITING LIST
Outcome: 3 PTSD symptom severity: 3. Self-reported frequency of PTSD symptoms - average endpoint PSS-SR total score (high = poor) - skewed data
Study or subgroup EMDR Waitlist
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Short term - skewed data
van den Berg 2015 44 16.14 (10.46) 39 24.74 (10.11) 100.0 % -8.60 [ -13.03, -4.17 ]
Subtotal (95% CI) 44 39 100.0 % -8.60 [ -13.03, -4.17 ]
Heterogeneity: not applicable
Test for overall effect: Z = 3.81 (P = 0.00014)
2 Medium term - skewed data
van den Berg 2015 43 16.33 (13.14) 40 23.7 (8.88) 100.0 % -7.37 [ -12.17, -2.57 ]
Subtotal (95% CI) 43 40 100.0 % -7.37 [ -12.17, -2.57 ]
Heterogeneity: not applicable
Test for overall effect: Z = 3.01 (P = 0.0026)
Test for subgroup differences: Chi2 = 0.14, df = 1 (P = 0.71), I2 =0.0%
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Analysis 2.4. Comparison 2 EMDR versus WAITING LIST, Outcome 4 PTSD symptom severity: 4.
Remission from PTSD: Symptoms below diagnostic threshold - CAPS total score < 40.
Review: Psychological interventions for post-traumatic stress disorder (PTSD) in people with severe mental illness
Comparison: 2 EMDR versus WAITING LIST
Outcome: 4 PTSD symptom severity: 4. Remission from PTSD: Symptoms below diagnostic threshold - CAPS total score < 40
Study or subgroup EMDR Waitlist Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Short term
van den Berg 2015 33/55 13/47 100.0 % 2.17 [ 1.30, 3.61 ]
Subtotal (95% CI) 55 47 100.0 % 2.17 [ 1.30, 3.61 ]
Total events: 33 (EMDR), 13 (Waitlist)
Heterogeneity: not applicable
Test for overall effect: Z = 2.97 (P = 0.0029)
2 Medium term
van den Berg 2015 31/55 15/47 100.0 % 1.77 [ 1.10, 2.85 ]
Subtotal (95% CI) 55 47 100.0 % 1.77 [ 1.10, 2.85 ]
Total events: 31 (EMDR), 15 (Waitlist)
Heterogeneity: not applicable
Test for overall effect: Z = 2.33 (P = 0.020)
Test for subgroup differences: Chi2 = 0.33, df = 1 (P = 0.56), I2 =0.0%
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Analysis 2.5. Comparison 2 EMDR versus WAITING LIST, Outcome 5 PTSD symptom severity: 5.
Recovery from PTSD: Asymptomatic or few symptoms - CAPS total score < 20.
Review: Psychological interventions for post-traumatic stress disorder (PTSD) in people with severe mental illness
Comparison: 2 EMDR versus WAITING LIST
Outcome: 5 PTSD symptom severity: 5. Recovery from PTSD: Asymptomatic or few symptoms - CAPS total score < 20
Study or subgroup EMDR Waitlist Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Short term
van den Berg 2015 9/55 3/47 100.0 % 2.56 [ 0.74, 8.92 ]
Subtotal (95% CI) 55 47 100.0 % 2.56 [ 0.74, 8.92 ]
Total events: 9 (EMDR), 3 (Waitlist)
Heterogeneity: not applicable
Test for overall effect: Z = 1.48 (P = 0.14)
2 Medium term
van den Berg 2015 8/55 3/47 100.0 % 2.28 [ 0.64, 8.10 ]
Subtotal (95% CI) 55 47 100.0 % 2.28 [ 0.64, 8.10 ]
Total events: 8 (EMDR), 3 (Waitlist)
Heterogeneity: not applicable
Test for overall effect: Z = 1.27 (P = 0.20)
Test for subgroup differences: Chi2 = 0.02, df = 1 (P = 0.90), I2 =0.0%
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Analysis 2.6. Comparison 2 EMDR versus WAITING LIST, Outcome 6 Adverse events - incidents of
unspecified severe adverse events.
Review: Psychological interventions for post-traumatic stress disorder (PTSD) in people with severe mental illness
Comparison: 2 EMDR versus WAITING LIST
Outcome: 6 Adverse events - incidents of unspecified severe adverse events
Study or subgroup EMDR Waitlist Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Short term
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (EMDR), 0 (Waitlist)
Heterogeneity: not applicable
Test for overall effect: not applicable
2 Medium term
van den Berg 2015 1/55 4/47 100.0 % 0.21 [ 0.02, 1.85 ]
Subtotal (95% CI) 55 47 100.0 % 0.21 [ 0.02, 1.85 ]
Total events: 1 (EMDR), 4 (Waitlist)
Heterogeneity: not applicable
Test for overall effect: Z = 1.40 (P = 0.16)
Test for subgroup differences: Not applicable
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Analysis 2.7. Comparison 2 EMDR versus WAITING LIST, Outcome 7 Leaving the study early.
Review: Psychological interventions for post-traumatic stress disorder (PTSD) in people with severe mental illness
Comparison: 2 EMDR versus WAITING LIST
Outcome: 7 Leaving the study early
Study or subgroup EMDR Waitlist Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Short term
van den Berg 2015 11/55 8/47 100.0 % 1.18 [ 0.52, 2.68 ]
Subtotal (95% CI) 55 47 100.0 % 1.18 [ 0.52, 2.68 ]
Total events: 11 (EMDR), 8 (Waitlist)
Heterogeneity: not applicable
Test for overall effect: Z = 0.38 (P = 0.70)
2 Medium term
van den Berg 2015 12/55 7/47 100.0 % 1.46 [ 0.63, 3.42 ]
Subtotal (95% CI) 55 47 100.0 % 1.46 [ 0.63, 3.42 ]
Total events: 12 (EMDR), 7 (Waitlist)
Heterogeneity: not applicable
Test for overall effect: Z = 0.88 (P = 0.38)
Test for subgroup differences: Chi2 = 0.13, df = 1 (P = 0.71), I2 =0.0%
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Analysis 3.1. Comparison 3 TF-CBT versus EMDR, Outcome 1 PTSD symptom severity: 1. Clinician-rated
severity - average endpoint CAPS total score (high = poor) - skewed data.
Review: Psychological interventions for post-traumatic stress disorder (PTSD) in people with severe mental illness
Comparison: 3 TF-CBT versus EMDR
Outcome: 1 PTSD symptom severity: 1. Clinician-rated severity - average endpoint CAPS total score (high = poor) - skewed data
Study or subgroup Individual TF-CBT EMDR
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Short term - skewed data
van den Berg 2015 47 36.79 (23.74) 44 39.73 (25.72) 100.0 % -2.94 [ -13.13, 7.25 ]
Subtotal (95% CI) 47 44 100.0 % -2.94 [ -13.13, 7.25 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.57 (P = 0.57)
2 Medium term - skewed data
van den Berg 2015 45 36.8 (26.34) 43 38.49 (25.91) 100.0 % -1.69 [ -12.61, 9.23 ]
Subtotal (95% CI) 45 43 100.0 % -1.69 [ -12.61, 9.23 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.30 (P = 0.76)
Test for subgroup differences: Chi2 = 0.03, df = 1 (P = 0.87), I2 =0.0%
-100 -50 0 50 100
Favours individual TF-CBT Favours EMDR
88Psychological interventions for post-traumatic stress disorder (PTSD) in people with severe mental illness (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Fo
r P
re
vie
w 
On
ly
Analysis 3.2. Comparison 3 TF-CBT versus EMDR, Outcome 2 PTSD symptom severity: 2. Self-reported
trauma-related cognition - average endpoint PTCI total score (high = poor).
Review: Psychological interventions for post-traumatic stress disorder (PTSD) in people with severe mental illness
Comparison: 3 TF-CBT versus EMDR
Outcome: 2 PTSD symptom severity: 2. Self-reported trauma-related cognition - average endpoint PTCI total score (high = poor)
Study or subgroup Individual TF-CBT EMDR
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Short term
van den Berg 2015 47 115.94 (45.87) 44 119.32 (40.67) 100.0 % -3.38 [ -21.17, 14.41 ]
Subtotal (95% CI) 47 44 100.0 % -3.38 [ -21.17, 14.41 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.37 (P = 0.71)
2 Medium term (7-9 months)
van den Berg 2015 45 120.31 (45.97) 43 118.26 (43.74) 100.0 % 2.05 [ -16.69, 20.79 ]
Subtotal (95% CI) 45 43 100.0 % 2.05 [ -16.69, 20.79 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.21 (P = 0.83)
Test for subgroup differences: Chi2 = 0.17, df = 1 (P = 0.68), I2 =0.0%
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Analysis 3.3. Comparison 3 TF-CBT versus EMDR, Outcome 3 PTSD symptom severity: 3. Self-reported
frequency of PTSD symptoms - average endpoint PSS-SR total score (high = poor) - skewed data.
Review: Psychological interventions for post-traumatic stress disorder (PTSD) in people with severe mental illness
Comparison: 3 TF-CBT versus EMDR
Outcome: 3 PTSD symptom severity: 3. Self-reported frequency of PTSD symptoms - average endpoint PSS-SR total score (high = poor) - skewed data
Study or subgroup Individual TF-CBT EMDR
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Short term - skewed data
van den Berg 2015 47 15.23 (10.31) 44 16.14 (10.46) 100.0 % -0.91 [ -5.18, 3.36 ]
Subtotal (95% CI) 47 44 100.0 % -0.91 [ -5.18, 3.36 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.42 (P = 0.68)
2 Medium term - skewed data
van den Berg 2015 45 16.18 (12.36) 43 16.33 (13.14) 100.0 % -0.15 [ -5.49, 5.19 ]
Subtotal (95% CI) 45 43 100.0 % -0.15 [ -5.49, 5.19 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.06 (P = 0.96)
Test for subgroup differences: Chi2 = 0.05, df = 1 (P = 0.83), I2 =0.0%
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Analysis 3.4. Comparison 3 TF-CBT versus EMDR, Outcome 4 PTSD symptom severity: 4. Remission from
PTSD: Symptoms below diagnostic threshold - CAPS total score < 40.
Review: Psychological interventions for post-traumatic stress disorder (PTSD) in people with severe mental illness
Comparison: 3 TF-CBT versus EMDR
Outcome: 4 PTSD symptom severity: 4. Remission from PTSD: Symptoms below diagnostic threshold - CAPS total score < 40
Study or subgroup Individual TF-CBT EMDR Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Short term
van den Berg 2015 30/53 33/55 100.0 % 0.94 [ 0.69, 1.30 ]
Subtotal (95% CI) 53 55 100.0 % 0.94 [ 0.69, 1.30 ]
Total events: 30 (Individual TF-CBT), 33 (EMDR)
Heterogeneity: not applicable
Test for overall effect: Z = 0.36 (P = 0.72)
2 Medium term
van den Berg 2015 31/53 31/55 100.0 % 1.04 [ 0.75, 1.44 ]
Subtotal (95% CI) 53 55 100.0 % 1.04 [ 0.75, 1.44 ]
Total events: 31 (Individual TF-CBT), 31 (EMDR)
Heterogeneity: not applicable
Test for overall effect: Z = 0.22 (P = 0.82)
Test for subgroup differences: Chi2 = 0.17, df = 1 (P = 0.68), I2 =0.0%
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Analysis 3.5. Comparison 3 TF-CBT versus EMDR, Outcome 5 PTSD symptom severity: 5. Recovery from
PTSD: Asymptomatic or few symptoms - CAPS total score < 20.
Review: Psychological interventions for post-traumatic stress disorder (PTSD) in people with severe mental illness
Comparison: 3 TF-CBT versus EMDR
Outcome: 5 PTSD symptom severity: 5. Recovery from PTSD: Asymptomatic or few symptoms - CAPS total score < 20
Study or subgroup Individual TF-CBT EMDR Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Short term
van den Berg 2015 15/53 9/55 100.0 % 1.73 [ 0.83, 3.61 ]
Subtotal (95% CI) 53 55 100.0 % 1.73 [ 0.83, 3.61 ]
Total events: 15 (Individual TF-CBT), 9 (EMDR)
Heterogeneity: not applicable
Test for overall effect: Z = 1.46 (P = 0.14)
2 Medium term
van den Berg 2015 14/53 8/55 100.0 % 1.82 [ 0.83, 3.97 ]
Subtotal (95% CI) 53 55 100.0 % 1.82 [ 0.83, 3.97 ]
Total events: 14 (Individual TF-CBT), 8 (EMDR)
Heterogeneity: not applicable
Test for overall effect: Z = 1.49 (P = 0.14)
Test for subgroup differences: Chi2 = 0.01, df = 1 (P = 0.93), I2 =0.0%
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Analysis 4.1. Comparison 4 Individual TF-CBT versus brief PTSD psychoeducation, Outcome 1 PTSD
symptom severity: 1a. Clinician-rated severity - average endpoint CAPS total score (high = poor).
Review: Psychological interventions for post-traumatic stress disorder (PTSD) in people with severe mental illness
Comparison: 4 Individual TF-CBT versus brief PTSD psychoeducation
Outcome: 1 PTSD symptom severity: 1a. Clinician-rated severity - average endpoint CAPS total score (high = poor)
Study or subgroup Individual TF-CBT
Brief PTSD
psychoeduca-
tio
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Short term
Mueser 2015 28 65.82 (23.91) 26 67.27 (25.39) 56.1 % -1.45 [ -14.63, 11.73 ]
Subtotal (95% CI) 28 26 56.1 % -1.45 [ -14.63, 11.73 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.22 (P = 0.83)
2 Medium term
Mueser 2015 26 67.27 (32.99) 26 67.04 (20.29) 43.9 % 0.23 [ -14.66, 15.12 ]
Subtotal (95% CI) 26 26 43.9 % 0.23 [ -14.66, 15.12 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.03 (P = 0.98)
Total (95% CI) 54 52 100.0 % -0.71 [ -10.58, 9.16 ]
Heterogeneity: Chi2 = 0.03, df = 1 (P = 0.87); I2 =0.0%
Test for overall effect: Z = 0.14 (P = 0.89)
Test for subgroup differences: Chi2 = 0.03, df = 1 (P = 0.87), I2 =0.0%
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Analysis 4.2. Comparison 4 Individual TF-CBT versus brief PTSD psychoeducation, Outcome 2 PTSD
symptom severity: 1b. Clinician-rated severity - average endpoint CAPS total score (high = poor) - skewed data.
Review: Psychological interventions for post-traumatic stress disorder (PTSD) in people with severe mental illness
Comparison: 4 Individual TF-CBT versus brief PTSD psychoeducation
Outcome: 2 PTSD symptom severity: 1b. Clinician-rated severity - average endpoint CAPS total score (high = poor) - skewed data
Study or subgroup Individual TF-CBT
brief
PTSD
psychoed
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Long term - skewed data
Mueser 2015 24 62.75 (32.08) 24 64.88 (29.08) 100.0 % -2.13 [ -19.45, 15.19 ]
Total (95% CI) 24 24 100.0 % -2.13 [ -19.45, 15.19 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.24 (P = 0.81)
Test for subgroup differences: Not applicable
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Analysis 4.3. Comparison 4 Individual TF-CBT versus brief PTSD psychoeducation, Outcome 3 PTSD
symptom severity: 2. Self-reported trauma-related cognition - average endpoint PTCI total score (high = poor).
Review: Psychological interventions for post-traumatic stress disorder (PTSD) in people with severe mental illness
Comparison: 4 Individual TF-CBT versus brief PTSD psychoeducation
Outcome: 3 PTSD symptom severity: 2. Self-reported trauma-related cognition - average endpoint PTCI total score (high = poor)
Study or subgroup Individual TF-CBT
PTSD
psychoedu-
cation
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Short term
Mueser 2015 27 140.41 (51.43) 26 138.77 (45.2) 100.0 % 1.64 [ -24.40, 27.68 ]
Subtotal (95% CI) 27 26 100.0 % 1.64 [ -24.40, 27.68 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.12 (P = 0.90)
2 Medium term
Mueser 2015 25 135.23 (54.45) 26 127.55 (40.08) 100.0 % 7.68 [ -18.64, 34.00 ]
Subtotal (95% CI) 25 26 100.0 % 7.68 [ -18.64, 34.00 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.57 (P = 0.57)
3 Long term
Mueser 2015 24 142.45 (48.9) 25 126.26 (46.13) 100.0 % 16.19 [ -10.45, 42.83 ]
Subtotal (95% CI) 24 25 100.0 % 16.19 [ -10.45, 42.83 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.19 (P = 0.23)
Test for subgroup differences: Chi2 = 0.59, df = 2 (P = 0.74), I2 =0.0%
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Analysis 4.4. Comparison 4 Individual TF-CBT versus brief PTSD psychoeducation, Outcome 4 PTSD
symptom severity: 4. Remission from PTSD: Symptoms below diagnostic threshold - CAPS total score < 40.
Review: Psychological interventions for post-traumatic stress disorder (PTSD) in people with severe mental illness
Comparison: 4 Individual TF-CBT versus brief PTSD psychoeducation
Outcome: 4 PTSD symptom severity: 4. Remission from PTSD: Symptoms below diagnostic threshold - CAPS total score < 40
Study or subgroup Individual TF-CBT
PTSD
psychoedu-
cation Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Short term
Mueser 2015 9/28 8/26 100.0 % 1.04 [ 0.47, 2.30 ]
Subtotal (95% CI) 28 26 100.0 % 1.04 [ 0.47, 2.30 ]
Total events: 9 (Individual TF-CBT), 8 (PTSD psychoeducation)
Heterogeneity: not applicable
Test for overall effect: Z = 0.11 (P = 0.91)
2 Medium term
Mueser 2015 10/26 5/26 100.0 % 2.00 [ 0.79, 5.05 ]
Subtotal (95% CI) 26 26 100.0 % 2.00 [ 0.79, 5.05 ]
Total events: 10 (Individual TF-CBT), 5 (PTSD psychoeducation)
Heterogeneity: not applicable
Test for overall effect: Z = 1.47 (P = 0.14)
3 Long term
Mueser 2015 8/24 7/24 100.0 % 1.14 [ 0.49, 2.65 ]
Subtotal (95% CI) 24 24 100.0 % 1.14 [ 0.49, 2.65 ]
Total events: 8 (Individual TF-CBT), 7 (PTSD psychoeducation)
Heterogeneity: not applicable
Test for overall effect: Z = 0.31 (P = 0.76)
Test for subgroup differences: Chi2 = 1.22, df = 2 (P = 0.54), I2 =0.0%
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Analysis 4.5. Comparison 4 Individual TF-CBT versus brief PTSD psychoeducation, Outcome 5 PTSD
symptom severity: 5. Remission from severe PTSD: Loss of severe PTSD diagnosis - CAPS total score < 65.
Review: Psychological interventions for post-traumatic stress disorder (PTSD) in people with severe mental illness
Comparison: 4 Individual TF-CBT versus brief PTSD psychoeducation
Outcome: 5 PTSD symptom severity: 5. Remission from severe PTSD: Loss of severe PTSD diagnosis - CAPS total score < 65
Study or subgroup Individual TF-CBT
PTSD
psychoedu-
cation Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Short term
Mueser 2015 13/28 10/26 100.0 % 1.21 [ 0.64, 2.26 ]
Subtotal (95% CI) 28 26 100.0 % 1.21 [ 0.64, 2.26 ]
Total events: 13 (Individual TF-CBT), 10 (PTSD psychoeducation)
Heterogeneity: not applicable
Test for overall effect: Z = 0.59 (P = 0.56)
2 Medium term
Mueser 2015 14/26 9/26 100.0 % 1.56 [ 0.82, 2.94 ]
Subtotal (95% CI) 26 26 100.0 % 1.56 [ 0.82, 2.94 ]
Total events: 14 (Individual TF-CBT), 9 (PTSD psychoeducation)
Heterogeneity: not applicable
Test for overall effect: Z = 1.36 (P = 0.17)
3 Long term
Mueser 2015 13/24 10/24 100.0 % 1.30 [ 0.71, 2.37 ]
Subtotal (95% CI) 24 24 100.0 % 1.30 [ 0.71, 2.37 ]
Total events: 13 (Individual TF-CBT), 10 (PTSD psychoeducation)
Heterogeneity: not applicable
Test for overall effect: Z = 0.86 (P = 0.39)
Test for subgroup differences: Chi2 = 0.33, df = 2 (P = 0.85), I2 =0.0%
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Analysis 4.6. Comparison 4 Individual TF-CBT versus brief PTSD psychoeducation, Outcome 6 Quality of
life: 1. General quality of life - average endpoint QoLI total score (high = good).
Review: Psychological interventions for post-traumatic stress disorder (PTSD) in people with severe mental illness
Comparison: 4 Individual TF-CBT versus brief PTSD psychoeducation
Outcome: 6 Quality of life: 1. General quality of life - average endpoint QoLI total score (high = good)
Study or subgroup Individual TF-CBT
PTSD
psychoedu-
cation
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Short term
Mueser 2015 28 3.98 (1.34) 26 4.56 (1.54) 100.0 % -0.58 [ -1.35, 0.19 ]
Subtotal (95% CI) 28 26 100.0 % -0.58 [ -1.35, 0.19 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.47 (P = 0.14)
2 Medium term
Mueser 2015 26 4.13 (1.43) 26 4.42 (1.29) 100.0 % -0.29 [ -1.03, 0.45 ]
Subtotal (95% CI) 26 26 100.0 % -0.29 [ -1.03, 0.45 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.77 (P = 0.44)
3 Long term
Mueser 2015 24 4.35 (1.23) 25 4.24 (1.76) 100.0 % 0.11 [ -0.74, 0.96 ]
Subtotal (95% CI) 24 25 100.0 % 0.11 [ -0.74, 0.96 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.25 (P = 0.80)
Test for subgroup differences: Chi2 = 1.39, df = 2 (P = 0.50), I2 =0.0%
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Analysis 4.7. Comparison 4 Individual TF-CBT versus brief PTSD psychoeducation, Outcome 7 Quality of
life: 2. Overall functioning - average endpoint GAF total score (high = good).
Review: Psychological interventions for post-traumatic stress disorder (PTSD) in people with severe mental illness
Comparison: 4 Individual TF-CBT versus brief PTSD psychoeducation
Outcome: 7 Quality of life: 2. Overall functioning - average endpoint GAF total score (high = good)
Study or subgroup Individual TF-CBT
PTSD
psychoedu-
cation
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Short term
Mueser 2015 24 54.54 (10.45) 25 55.4 (9.59) 100.0 % -0.86 [ -6.48, 4.76 ]
Subtotal (95% CI) 24 25 100.0 % -0.86 [ -6.48, 4.76 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.30 (P = 0.76)
2 Medium term
Mueser 2015 24 53.75 (10.05) 26 53.15 (9.83) 100.0 % 0.60 [ -4.92, 6.12 ]
Subtotal (95% CI) 24 26 100.0 % 0.60 [ -4.92, 6.12 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.21 (P = 0.83)
3 Long term
Mueser 2015 24 55.96 (9.75) 24 54.08 (13.94) 100.0 % 1.88 [ -4.93, 8.69 ]
Subtotal (95% CI) 24 24 100.0 % 1.88 [ -4.93, 8.69 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.54 (P = 0.59)
Test for subgroup differences: Chi2 = 0.38, df = 2 (P = 0.83), I2 =0.0%
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Analysis 4.8. Comparison 4 Individual TF-CBT versus brief PTSD psychoeducation, Outcome 8 Quality of
life: 3. Social functioning - average endpoint CAPS social functioning subscale total score (high = poor) -
skewed data.
Review: Psychological interventions for post-traumatic stress disorder (PTSD) in people with severe mental illness
Comparison: 4 Individual TF-CBT versus brief PTSD psychoeducation
Outcome: 8 Quality of life: 3. Social functioning - average endpoint CAPS social functioning subscale total score (high = poor) - skewed data
Study or subgroup Individual TF-CBT
PTSD
psychoedu-
cation
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Short term - skewed data
Mueser 2015 28 1.71 (1.05) 26 2 (1.09) 100.0 % -0.29 [ -0.86, 0.28 ]
Subtotal (95% CI) 28 26 100.0 % -0.29 [ -0.86, 0.28 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.99 (P = 0.32)
2 Medium term - skewed data
Mueser 2015 26 1.56 (1.29) 26 2.17 (1.16) 100.0 % -0.61 [ -1.28, 0.06 ]
Subtotal (95% CI) 26 26 100.0 % -0.61 [ -1.28, 0.06 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.79 (P = 0.073)
3 Long term - skewed data
Mueser 2015 24 1.75 (1.15) 24 1.56 (1.14) 100.0 % 0.19 [ -0.46, 0.84 ]
Subtotal (95% CI) 24 24 100.0 % 0.19 [ -0.46, 0.84 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.57 (P = 0.57)
Test for subgroup differences: Chi2 = 2.90, df = 2 (P = 0.23), I2 =31%
-100 -50 0 50 100
Favours individual TF-CBT Favours psychoeducation
A D D I T I O N A L T A B L E S
Table 1. Suggested design for future studies
Methods Allocation: randomised, full explicit description of methods of randomisation and allocation concealment
Participants Diagnosis: Individuals with schizophrenia or psychosis (ICD or DSM) and co-morbid PTSD (DSM)
N = 450*
Age: adolescents and adults
Sex: both
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Table 1. Suggested design for future studies (Continued)
Inteventions 1. Trauma-focused cognitive behavioural therapy (modality and format to be specified), n = 150
2. Eye movement desensitisation and reprocessing (or another well-defined trauma-focused therapy as a comparative
treatment), n = 150
3. Standard care/waiting list, n = 150
Outcomes 1. PTSD symptoms
2. Quality of life or well-being
3. Psychotic symptoms
4. Depressive symptoms
5. Anxiety symptoms
6. Adverse events
7. Health economic outcomes
Notes *Powered to be able to identify a difference of 20% between groups for primary outcome with adequate degree of
certainty
ICD: International Classification of Diseases
DSM: Diagnostic and Statistical Manual of Mental Disorders
PTSD: post-traumatic stress disorder
Table 2. Differences between protocol and review
Protocol stated comparisons as: The current review states comparisons as:
We will conduct separate analyses focusing on each category of
active psychological interventions based on a shared modality and
format of delivery (i.e. TF-CBT - individual or group based,
EMDR, or any psychological intervention for PTSD), comparing
them to all the control conditions pooled together. If there are
sufficient data extracted from included studies, we will then pro-
ceed to analyse each category of active psychological intervention
targeting PTSD comparing each modality and format of active
intervention against: 1) active control conditions (i.e. non-PTSD
focused intervention/s); and 2) usual care/treatment as usual/wait-
ing list, for primary outcomes
We conducted separate analyses focusing on each category of active
psychological interventions based on a shared modality and for-
mat of delivery (i.e. TF-CBT - individual or group based, EMDR,
or any psychological intervention for PTSD), comparing them to
all the control conditions pooled together. Whenever there were
sufficient data extracted from included studies, we then proceeded
to analyse each category of active psychological intervention tar-
geting PTSD comparing each modality and format of active in-
tervention against: 1) active control conditions (i.e. non-PTSD
focused intervention/s); 2) usual care/treatment as usual/waiting
list; and 3) other modality and format of active intervention, for
primary outcomes
EMDR: eye movement desensitisation and reprocessing
PTSD: post-traumatic stress disorder
TF-CBT: trauma-focused cognitive behavioural therapy
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Minor changes
Differences made on the presentation of comparisons between interventions whilst both the types of psychological interventions and
control conditions remained the same across the protocol and the review is summarised in Table 2.
The review authors acknowledged the changes made to the comparisons which allowed for comparisons of active trauma-focused
interventions differing in modality and format. The rationale for doing so, was to ascertain comparative effectiveness of interventions,
hence informing treatment options and choices for clinicians and patients (NICE 2011; Roth 2005).
Outcomes of interest for the ’Summary of findings’ tables: We renamed a prespecified outcome ’psychotic symptoms’ to ’symptoms of
co-morbid psychosis’ for consistency between ’Outcomes of interest’ and ’Types of outcome measures’ sections of the review.
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